<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003402.pub2" GROUP_ID="PREG" ID="817101071020413242" MERGED_FROM="" MODIFIED="2012-09-11 11:55:39 +0100" MODIFIED_BY="Denise Atherton" NOTES="&lt;p&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.2&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Short title (no longer in use): Prostaglandin precursor supplements in pregnancy&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-10-29 16:39:39 +0000" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0165" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2012-09-11 11:55:39 +0100" MODIFIED_BY="Denise Atherton">
<TITLE>Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction</TITLE>
<CONTACT MODIFIED="2012-09-11 11:55:39 +0100" MODIFIED_BY="Denise Atherton"><PERSON ID="4805" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Maria</FIRST_NAME><LAST_NAME>Makrides</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>maria.makrides@health.sa.gov.au</EMAIL_1><ADDRESS><DEPARTMENT>Child Nutrition Research Centre</DEPARTMENT><ORGANISATION>Women's and Children's Health Research Institute</ORGANISATION><ADDRESS_1>Women's and Children's Hospital</ADDRESS_1><ADDRESS_2>72 King William Road</ADDRESS_2><CITY>North Adelaide</CITY><ZIP>5006</ZIP><REGION>SA</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 8 8161 6067</PHONE_1><FAX_1>+61 8 8161 8228</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-09-11 11:55:39 +0100" MODIFIED_BY="Denise Atherton"><PERSON ID="4805" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Maria</FIRST_NAME><LAST_NAME>Makrides</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>maria.makrides@health.sa.gov.au</EMAIL_1><ADDRESS><DEPARTMENT>Child Nutrition Research Centre</DEPARTMENT><ORGANISATION>Women's and Children's Health Research Institute</ORGANISATION><ADDRESS_1>Women's and Children's Hospital</ADDRESS_1><ADDRESS_2>72 King William Road</ADDRESS_2><CITY>North Adelaide</CITY><ZIP>5006</ZIP><REGION>SA</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 8 8161 6067</PHONE_1><FAX_1>+61 8 8161 8228</FAX_1></ADDRESS></PERSON><PERSON ID="7397" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Lelia</FIRST_NAME><LAST_NAME>Duley</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>lelia.duley@nottingham.ac.uk</EMAIL_1><MOBILE_PHONE>07979744934</MOBILE_PHONE><ADDRESS><DEPARTMENT>Nottingham Clinical Trials Unit</DEPARTMENT><ORGANISATION>University of Nottingham</ORGANISATION><ADDRESS_1>B39, Medical School</ADDRESS_1><ADDRESS_2>Queen's Medical Centre Campus</ADDRESS_2><CITY>Nottingham</CITY><ZIP>NG7 2UH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 115 8230514</PHONE_1></ADDRESS></PERSON><PERSON ID="15982" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Sjurdur</FIRST_NAME><MIDDLE_INITIALS>F</MIDDLE_INITIALS><LAST_NAME>Olsen</LAST_NAME><POSITION>Professor of Epidemiology</POSITION><EMAIL_1>sfo@ssi.dk</EMAIL_1><ADDRESS><ORGANISATION>Institute of Public Health</ORGANISATION><ADDRESS_1>Vennelyst Boulevard 6</ADDRESS_1><CITY>Aarhus C</CITY><ZIP>DK-8000</ZIP><COUNTRY CODE="DK">Denmark</COUNTRY><PHONE_1>+45 32 683955</PHONE_1><FAX_1>+45 32 688242</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-09-17 21:32:08 +0100" MODIFIED_BY="Lixia Dou" NOTES="&lt;p&gt;New studies found and included or excluded: 12/1/05&lt;/p&gt;" NOTES_MODIFIED="2008-09-17 21:32:08 +0100" NOTES_MODIFIED_BY="Lixia Dou">
<UP_TO_DATE>
<DATE DAY="18" MONTH="4" YEAR="2006"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="12" YEAR="2005"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="3" MONTH="12" YEAR="2006"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2001"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2012-09-11 11:55:39 +0100" MODIFIED_BY="Denise Atherton" NOTES="&lt;p&gt;The title has been updated from 'Fish oil and other prostaglandin precursor supplementation during pregnancy for reducing pre-eclampsia, preterm birth, low birth weight and intrauterine growth restriction' to 'Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia and intrauterine growth restriction' to more clearly identify the types of interventions and types of participants included.&lt;/p&gt;"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-09-11 11:55:39 +0100" MODIFIED_BY="Denise Atherton"><DATE DAY="11" MONTH="9" YEAR="2012"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY>

</WHATS_NEW>
<HISTORY MODIFIED="2012-09-11 11:55:39 +0100" MODIFIED_BY="Denise Atherton"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-09-11 11:55:39 +0100" MODIFIED_BY="Denise Atherton">
<DATE DAY="17" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY></HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Child Health Research Institute</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Women's &amp; Children's Hospital</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Department for International Development</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Medical Research Council</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>National Health and Medical Research Council</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Danish National Research Foundation</NAME>
<COUNTRY CODE="DK">Denmark</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-10-29 16:39:39 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-09-17 22:34:12 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-09-17 22:34:07 +0100" MODIFIED_BY="[Empty name]">Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction</TITLE>
<SUMMARY_BODY MODIFIED="2008-09-17 22:34:12 +0100" MODIFIED_BY="[Empty name]">
<P>Not enough evidence to say if fish oil supplementation in pregnancy helps reduce the risk of pre-eclampsia and small-for-date babies.</P>
<P>Pre-eclampsia in the mother and a baby being born too soon or too small are relatively common complication of pregnancy that can sometimes seriously affect the health of the baby and the mother. Omega-3 fatty acids found in fish/marine oils may prevent these complications. This review identified six trials involving 2755 women. The findings were that fish/marine oil supplements taken in pregnancy increase the length of pregnancy by two to three days, slightly increase a baby's birth weight and slightly reduce the number of babies born before 34 weeks gestation. However, these small effects did not reduce the overall risk of a baby being born too soon or too small, nor the mother developing pre-eclampsia. It is likely that a large number of women participating in trials is needed to address this question fully, and to answer the question is supplementation harmless. Further research is needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Population studies have shown that higher intakes of marine foods during pregnancy are associated with longer gestations, higher infant birthweights and a low incidence of pre-eclampsia. It is suggested that the fatty acids of marine foods may be the underlying cause of these associations.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To estimate the effects of marine oil, and other prostaglandin precursor, supplementation during pregnancy on the risk of pre-eclampsia, preterm birth, low birthweight and small-for-gestational age.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched the Cochrane Pregnancy and Childbirth Group Trials Register (December 2005), The Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I> 2005, Issue 2)<I> </I>and MEDLINE (1966 to April 2005).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All randomised trials comparing oral marine oil, or other prostaglandin precursor, supplementation during pregnancy with either placebo or no treatment. Trials were excluded if their aim was to treat women with established pre-eclampsia or suspected intrauterine growth restriction.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two review authors independently assessed trials for inclusion, data extraction and trial quality. </P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Six trials, involving 2783 women, are included in this review. Three of these were rated as high quality, including the largest trial with 1477 women. Women allocated a marine oil supplement had a mean gestation that was 2.6 days longer than women allocated to placebo or no treatment (weighted mean difference (WMD), 2.55 days, 95% confidence interval (CI) 1.03 to 4.07 days; 3 trials, 1621 women). This was not reflected in a clear difference between the two groups in the relative risk (RR) of birth before 37 completed weeks, although women allocated marine oil did have a lower risk of giving birth before 34 completed weeks' gestation (RR 0.69, 95% CI 0.49 to 0.99; 2 trials, 860 women). Birthweight was slightly greater in infants born to women in the marine oil group compared with control (WMD 47 g, 95% CI 1 g to 93 g; 3 trials, 2440 women). However, there were no overall differences between the groups in the proportion of low birthweight or small-for-gestational age babies. There was no clear difference in the relative risk of pre-eclampsia between the two groups.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>There is not enough evidence to support the routine use of marine oil, or other prostaglandin precursor, supplements during pregnancy to reduce the risk of pre-eclampsia, preterm birth, low birthweight or small-for-gestational age. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-09-17 22:45:11 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>Pre-eclampsia, preterm birth and intrauterine growth restriction (IUGR) are relatively common complications of pregnancy and are all associated with increased morbidity for both mother and child.</P>
<P>Pre-eclampsia is characterised by high blood pressure and protein in the urine, but can also affect the kidneys, liver and blood-clotting systems. Rare but serious and life-threatening complications include eclampsia, which is characterised by one or more convulsions, and HELLP syndrome, which is the combination of haemolysis, elevated liver enzymes and lower platelets. The outcome for pre-eclampsia for both woman and child is usually good, but for a few women it can lead to substantial morbidity (<LINK REF="REF-Pritchard-1984" TYPE="REFERENCE">Pritchard 1984</LINK>) and occasionally death (<LINK REF="REF-DH-1998" TYPE="REFERENCE">DH 1998</LINK>), particularly if eclampsia develops.</P>
<P>Preterm birth and IUGR are associated with increased infant morbidity and on occasion result in death. Although most babies born with weights below 2500 g survive with good long-term outcome, around 12% are either stillborn or die in the neonatal period, as in South Australia for example (<LINK REF="REF-SA-Health-Commission" TYPE="REFERENCE">SA Health Commission</LINK>). The causes of most preterm births in developed countries are unexplained, although pre-eclampsia is a known antecedent in up to 19% of preterm births (<LINK REF="REF-Hewitt-1988" TYPE="REFERENCE">Hewitt 1988</LINK>).</P>
<P>Reducing the frequency of pre-eclampsia, preterm birth and IUGR would improve the health of mothers and their babies, as well as leading to more efficient use of the limited resources available for health services. </P>
<P>The use of fish oil supplements during the second half of pregnancy has been proposed as a possible strategy to prevent pre-eclampsia and preterm birth and to increase birthweight. The hypotheses that fish oil could prevent or improve these conditions were initially developed following population comparisons. The high birthweights (<LINK REF="REF-Olsen-1985" TYPE="REFERENCE">Olsen 1985</LINK>) and long duration of pregnancies (<LINK REF="REF-Olsen-1986" TYPE="REFERENCE">Olsen 1986</LINK>) observed in the fish-eating community of the Faroe Islands, together with an inspiring case report (<LINK REF="REF-Olsen-1987a" TYPE="REFERENCE">Olsen 1987a</LINK>), led to the suggestion that fatty acids from marine food could delay spontaneous delivery and thereby increase birthweight (<LINK REF="REF-Olsen-1986" TYPE="REFERENCE">Olsen 1986</LINK>). The relatively high birthweight for gestational age observed in this population led to the suggestion that fat from marine animals might also increase fetal growth (<LINK REF="REF-Andersen-1989" TYPE="REFERENCE">Andersen 1989</LINK>; <LINK REF="REF-Olsen-1987b" TYPE="REFERENCE">Olsen 1987b</LINK>). Likewise, the low incidence of pre-eclampsia observed in Greenland Inuits provided basis for the first suggestion that fish oil could prevent this condition (<LINK REF="REF-Dyerberg-1985" TYPE="REFERENCE">Dyerberg 1985</LINK>). <BR/> <BR/>These hypotheses have been tested in a number of observational epidemiological studies, several of which have been reviewed elsewhere (<LINK REF="REF-Olsen-1993" TYPE="REFERENCE">Olsen 1993</LINK>; <LINK REF="REF-Olsen-1994" TYPE="REFERENCE">Olsen 1994</LINK>). One trial involving 5644 women, not included in this systematic review because it employed alternate rather than random allocation to intervention, deserves mention here. In the late 1930s the People's <LINK REF="REF-League-of-Health" TYPE="REFERENCE">League of Health</LINK> conducted a trial evaluating a multivitamin and mineral supplement during pregnancy, which included a small amount of fish oil (<LINK REF="REF-League-of-Health" TYPE="REFERENCE">League of Health</LINK>; <LINK REF="REF-Olsen-1990" TYPE="REFERENCE">Olsen 1990</LINK>). A 31% decrease in proteinuric hypertension (or pre-eclampsia) was reported for women allocated supplementation compared with no supplementation. Women in the treated group were also 20% less likely to give birth to a baby before 40 weeks' gestation compared with the treated group (<LINK REF="REF-Olsen-1990" TYPE="REFERENCE">Olsen 1990</LINK>). </P>
<P>Marine oils are a rich source of the n-3 long chain polyunsaturated fatty acids (LCPUFA) eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3). These fatty acids are precursors to the 3-series prostaglandins and have been shown to modulate inflammatory and vascular effects (<LINK REF="REF-Simopoulos-1991" TYPE="REFERENCE">Simopoulos 1991</LINK>). Since pre-eclampsia and gestational hypertension are associated with vasoconstriction and endothelial damage, it is plausible that marine oil fatty acids, especially EPA, can down regulate these responses through direct competition with the thromboxane A2 precursor, arachidonic acid. This mechanism has also been postulated to explain the hypotensive properties of marine oil treatment in normotensive and hypertensive non-pregnant women (<LINK REF="REF-Morris-1993" TYPE="REFERENCE">Morris 1993</LINK>). Alternatively, marine oil fatty acids could delay birth in two ways. Firstly, they could delay initiation of labour and cervical ripening by inhibiting the production of prostaglandins F2a and E2. Secondly, they may relax the myometrium by increasing the production of prostacyclins (PGI2 and PGI3). </P>
<P>Other agents, such as evening primrose oil, contain a fatty acid called gamma-linolenic acid that is a precursor to the 1-series prostaglandins. These prostaglandins have a similar hypothesis for their mode action as those derived from n-3 (marine oil) fatty acids. They are therefore included in this review.</P>
<P>Several randomised trials of prostaglandin precursor supplementation during pregnancy have now been undertaken to determine whether these supplements have a clinically worthwhile benefit for either the woman or her child. This review aims to estimate the overall benefits and hazards of prostaglandin precursor supplementation during pregnancy.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To estimate the effects of marine oil, and other prostaglandin precursor, supplementation during pregnancy on the risk of pre-eclampsia, preterm birth, low birthweight and small-for-gestational age (SGA), and on other substantive measures of maternal morbidity, and of morbidity and mortality for the child. </P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>All randomised trials, with adequate concealment of the allocation, of dietary marine oil or other prostaglandin precursor supplementation during pregnancy. Trials with other methods of allocation, where biases could not be eliminated, were excluded.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>All pregnant women, regardless of their risk for pre-eclampsia, preterm birth or IUGR. </P>
<P>Women at high risk of pre-eclampsia, preterm birth or IUGR were defined as women with previous severe pre-eclampsia, diabetes, chronic hypertension, renal disease, autoimmune disease, previous preterm birth, previous IUGR or report smoking more than 30 cigarettes per day. All other women were defined as having low or moderate risk.</P>
<P>Women with established pre-eclampsia or suspected IUGR at trial entry were excluded.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Marine oil (fish or algal oils), orally administered, compared with placebo or no marine oil treatment. Trials that used foods supplemented with marine oil were included. Treatment with other oils, such as evening primrose or borage, that have fatty acids that may be capable of generating prostaglandins were also included. Trials with a single dose treatment were excluded. Trials in which marine oil, or other prostaglandin precursors, were tested in combination with other nutrients or drugs that may affect pre-eclampsia, preterm birth or IUGR were also excluded.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-09-17 22:37:56 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">For the woman</HEADING>
<UL>
<LI>Hypertension</LI>
<LI>Pre-eclampsia*</LI>
<LI>Eclampsia</LI>
<LI>Other complications of eclampsia</LI>
<LI>Admission to hospital</LI>
<LI>Caesarean section</LI>
<LI>Haemorrhage</LI>
<LI>Length of labour</LI>
<LI>Serious morbidity (such as renal failure, liver failure, eclampsia, death)</LI>
<LI>Length of gestation*</LI>
<LI>Side-effects (gastrointestinal and non-gastrointestinal)</LI>
<LI>Prolonged gestation (&gt; 42 weeks)*</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">For babies</HEADING>
<UL>
<LI>Stillbirths*</LI>
<LI>Neonatal deaths*</LI>
<LI>Preterm birth (&lt; 37 completed weeks)*</LI>
<LI>Neonatal morbidity (such as intraventricular haemorrhage, respiratory distress syndrome)</LI>
<LI>Birthweight*</LI>
<LI>Low birthweight (&lt; 2.5 kg)*</LI>
<LI>SGA (&lt; 10th percentile)*</LI>
<LI>Admission to a neonatal intensive care unit</LI>
</UL>
<P>Long term follow up included measures of neurological and developmental outcome (such as cerebral palsy).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">For health service resources</HEADING>
<UL>
<LI>Admission and length of stay in hospital and intensive care facilities</LI>
<LI>Use of community health services</LI>
</UL>
<P>Outcomes marked with * are the primary outcomes and those used for subgroup analyses.</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-09-17 22:38:27 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2008-09-17 22:42:55 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group Trials Register by contacting the Trials Search Co-ordinator (December 2005).</P>
<P>The Cochrane Pregnancy and Childbirth Group's Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>monthly searches of MEDLINE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness search of a further 37 journals.</LI>
</OL>
<P>Details of the search strategies for CENTRAL and MEDLINE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the 'Search strategies for identification of studies' section within the editorial information about the Cochrane Pregnancy and Childbirth Group.</P>
<P>Trials identified through the searching activities described above are given a code (or codes) depending on the topic. The codes are linked to review topics. The Trials Search Co-ordinator searches the register for each review using these codes rather than keywords.</P>
<P>In addition, we searched the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I> 2005, Issue 2) and MEDLINE (1966 to April 2005) using the search strategy in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>We did not apply any language restrictions.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-09-17 22:43:39 +0100" MODIFIED_BY="[Empty name]">
<P>The review was conducted following the procedures outlined in the Cochrane Handbook (<LINK REF="REF-Higgins-2005" TYPE="REFERENCE">Higgins 2005</LINK>). Potentially eligible trials were evaluated for inclusion and methodological quality, without consideration of their results. Each was separately assessed by two of the authors. Discrepancies were resolved by discussion. There was no blinding of authorship.</P>
<P>We assigned quality scores for concealment of allocation to each trial: A = adequate, B = unclear, C = inadequate. Trials with non-random allocation, where biases could not be eliminated, were excluded.</P>
<P>In addition, we assigned quality scores to each trial for blinding of outcome assessment and completeness of follow up as follows.</P>
<P>For blinding of assessment outcome:<BR/>(A) double-blind, neither the investigator nor participant knew or were likely to guess the allocated treatment;<BR/>(B) single-blind, either the investigator or the participant knew the allocation. Or, the trial was described as double-blind but side-effects of one or other treatment mean that it is likely that for a significant proportion (at least 20%) of participants the allocation could be correctly identified;<BR/>(C) no blinding; both the investigator and participant knew (or were likely to guess) the allocated treatment;<BR/>(D) unclear.</P>
<P>For completeness of follow up:<BR/>(A) less than 3% of participants excluded;<BR/>(B) 3% to 9.9% of participants excluded;<BR/>(C) 10% to 19.9% of participants excluded.</P>
<P>If 20% or more of participants were excluded, we excluded the data for that outcome.</P>
<P>Data were independently extracted by two review authors and cross-checked. Discrepancies were resolved by discussion. Whenever possible, we sought unpublished data from investigators.</P>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analyses</HEADING>
<P>Prespecified subgroup analyses were based on:</P>
<OL>
<LI>type of supplementation: marine (fish or algal) oil or other prostaglandin precursors;</LI>
<LI>gestation at trial entry: before or after 16 weeks' gestation;</LI>
<LI>type of pregnancy: singleton or multiple;</LI>
<LI>risk status at trial entry: high or low/moderate risk of pre-eclampsia, preterm birth or IUGR;</LI>
<LI>dietary intake of marine oil at trial entry: high, medium or low dietary intake.</LI>
</OL>
<P>Subgroup analyses were only conducted for the main outcomes of pre-eclampsia, preterm birth, length of gestation, prolonged gestation, birthweight, low birthweight, SGA, stillbirth and neonatal death. If possible interaction tests were undertaken to determine whether marine oil supplementation has differential effects in different subgroups. It was only possible to undertake interaction analysis for the gestational age at trial entry subgroups. There were insufficient data in each subgroup to conduct an analysis by dietary intake of marine oil at trial entry.</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>A total of 2755 women from six trials have been included in this review. All six trials had a randomised design and have compared a supplement or food that contains marine fatty acids with either placebo or no treatment. Four of the trials used an oil derived from the body of the fish, while another used a combination of evening primrose oil and fish (body) oil (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>). The sixth and most recently published trial assessed consumption of eggs enriched with DHA (<LINK REF="STD-USA-2003" TYPE="STUDY">USA 2003</LINK>). This enrichment was achieved by feeding laying hens an algal oil (<LINK REF="STD-USA-2003" TYPE="STUDY">USA 2003</LINK>). The allocated dose of the active ingredients in the marine oils (EPA and DHA) ranged from 133 mg/day (<LINK REF="STD-USA-2003" TYPE="STUDY">USA 2003</LINK>) to 3 g/day (<LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK>). The most commonly used dose was 2.7 g of EPA and DHA per day (<LINK REF="STD-Denmark-1992" TYPE="STUDY">Denmark 1992</LINK>; <LINK REF="STD-England-1995" TYPE="STUDY">England 1995</LINK>; <LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK>), and these trials also included the majority of women (2242). Most trials commenced supplementation after 16 weeks' gestation (<LINK REF="STD-Denmark-1992" TYPE="STUDY">Denmark 1992</LINK>; <LINK REF="STD-England-1995" TYPE="STUDY">England 1995</LINK>; <LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK>; <LINK REF="STD-USA-2003" TYPE="STUDY">USA 2003</LINK>). Three of the six trials included women with high-risk pregnancies (<LINK REF="STD-England-1995" TYPE="STUDY">England 1995</LINK>; <LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK>; <LINK REF="STD-Netherlands-1994" TYPE="STUDY">Netherlands 1994</LINK>). The main outcome measures reported across trials were preterm birth, pre-eclampsia and birthweight. Data regarding neonatal outcome and later childhood outcomes are scarce. </P>
<P>The Europe trial 2000 also included two subsets of women with pre-eclampsia or suspected IUGR (<LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK>). These women were excluded from this review. Three other studies were excluded because no relevant outcome data were reported (<LINK REF="STD-Australia-2004" TYPE="STUDY">Australia 2004</LINK>), losses to follow up were greater than 20% (<LINK REF="STD-Norway-2001" TYPE="STUDY">Norway 2001</LINK>; <LINK REF="STD-Scotland-2003" TYPE="STUDY">Scotland 2003</LINK>) or the intervention was not a direct prostaglandin precursor (<LINK REF="STD-Netherlands-2004" TYPE="STUDY">Netherlands 2004</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>Three trials (2242 women) reported adequate allocation concealment (<LINK REF="STD-Denmark-1992" TYPE="STUDY">Denmark 1992</LINK>; <LINK REF="STD-England-1995" TYPE="STUDY">England 1995</LINK>; <LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK>). All trials, except one (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>), also used a placebo or control treatment with an identical appearance to the supplement. However, trials that report information regarding the success of blinding indicate that the majority of women taking marine oil could guess their group allocation, largely because of belching and an unpleasant taste associated with taking the fish oil supplements (<LINK REF="STD-Denmark-1992" TYPE="STUDY">Denmark 1992</LINK>; <LINK REF="STD-England-1995" TYPE="STUDY">England 1995</LINK>; <LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK>). Most trials reported outcome for at least 83% of all women recruited. </P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-09-17 22:45:11 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">(1) Pre-eclampsia and high blood pressure (comparisons 01-01, 01-02)</HEADING>
<P>There were no clear differences in the relative risk (RR) of high blood pressure (RR 1.09, 95% confidence interval (CI) 0.90 to 1.33; 5 trials, 1831 women) or the incidence of pre-eclampsia (RR 0.86, 95% CI 0.59 to 1.27; 4 trials, 1683 women) between marine oil treated and control groups.</P>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analyses relating to pre-eclampsia (comparisons 02-01, 03-01, 04-01, 05-01)</HEADING>
<P>Treatment and control groups did not clearly differ in the incidence of pre-eclampsia regardless of the timing of supplementation, whether women were exclusively treated with marine oil, or whether women had high risk pregnancies for pre-eclampsia, preterm birth or IUGR. For women with singleton pregnancies who were allocated marine oil, the relative risk of pre-eclampsia was 0.67 (95% CI 0.43, 1.04; 4 trials, 1186 women) compared with placebo or no treatment. Only one study reported data for women with multiple pregnancies, and for women allocated marine oil the relative risk of pre-eclampsia was 2.38 (95% CI 0.93 to 6.10; 1 trial, 497 women) compared with control.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">(2) Duration of gestation (comparisons 01-17, 01-18, 01-19, 01-20)</HEADING>
<P>Women allocated a marine oil supplement had a mean gestation that was 2.6 days longer than women allocated placebo or no treatment (weighted mean difference (WMD) 2.55 days, 95% CI 1.03 to 4.07 days; 3 trials, 1621 women). This was not reflected in a clear difference between the two groups in the relative risk of birth before 37 completed weeks (RR 0.92, 95% CI 0.79 to 1.07; 5 trials, 1916 women). However, women allocated marine oil did have a lower risk of giving birth before 34 completed weeks' gestation compared with placebo (RR 0.69, 95% CI 0.49 to 0.99; 2 trials, 860 women). Two trials reported data for the risk of prolonging gestation beyond 42 weeks. As there was substantial heterogeneity, this outcome was analysed using the random-effects model (RR 1.68, 95% CI 0.77 to 3.66; 2 trials, 1970 women).</P>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analyses relating to length of gestation, preterm birth and prolonged gestation (comparisons 02-02, 02-03, 02-04, 03-02, 03-03, 03-04, 04-02, 04-03, 04-04, 05-02, 05-03, 05-04)</HEADING>
<P>Trials reporting length of gestation all commenced supplementation after 16 weeks' gestation and treated women with marine oil only. Women with singleton pregnancies who were allocated marine oil had pregnancies that were 3.0 days longer than control women (WMD 3.03 days, 95% CI 1.38 to 4.68 days; 3 trials, 1052 women), but for women with multiple pregnancies there was no clear difference in length of gestation between the two groups. This lengthening of gestation appeared to be slightly greater for women with high risk pregnancies (for high risk WMD 8.5 days, 95% CI 2.05 to 14.95 days; 1 trial, 255 women; for low/moderate risk WMD 2.23 days, 95% CI 0.67 to 3.80 days; 3 trials, 1393 women).</P>
<P>There were no overall differences in the relative risk of preterm birth between marine oil and control treatment in any of the subgroups investigated.</P>
<P>Trials that reported data regarding prolonged gestation all commenced supplementation after 16 weeks' gestation and used marine oil supplements. Only one trial reported data for prolonging gestation beyond 42 weeks in women with singleton and low/moderate risk pregnancies (RR 1.19, 95% CI 0.73 to 1.93; 1 trial, 533 women). These data were analysed using a random-effects model because of significant heterogeneity in the primary analysis. No data were available for women with high-risk pregnancies or women with multiple pregnancies.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">(3) Birth size (comparisons 01-21, 01-22, 01-23, 01-24, 01-25)</HEADING>
<P>Birthweight (WMD 47 g, 95% CI 1 to 93 g; 3 trials, 2440 women) and birth length (WMD 0.48 cm, 95% CI 0.13 to 0.83 cm; 2 trials, 824 women) were slightly greater in infants born to women in the marine oil group compared with control. However, there were no overall differences between the groups in the relative risk for low birthweight or SGA babies. No trials reported data relating to very low birthweight babies.</P>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analyses relating to birthweight, low birthweight and small-for-gestational age (comparisons 02-05, 02-06, 02-07, 03-05, 03-06, 03-07, 04-05, 04-06, 04-07, 05-05, 05-06, 05-07)</HEADING>
<P>Trials reporting birthweight all commenced treatment after 16 weeks' gestation. Women with singleton pregnancies allocated marine oil had babies with slightly higher birthweight than those allocated to control (WMD 72 g, 95% CI 11 to 133 g; 3 trials with 1318 women), while there was no clear difference for women with multiple pregnancies (WMD 14 g, 95% CI -57 to 86 g; 1 trial with 1122 women). There was no clear difference between treatment and control groups for women with high risk pregnancies (WMD 12 g, 95% CI -97 to 122 g; 1 trial with 494 women), while treated women with low/moderate risk pregnancies had babies with a higher mean birthweight compared with control (WMD 56 g, 95% CI 5 to 107 g; 3 trials with 1946 women).</P>
<P>The relative risk of giving birth to a low birthweight (less than 2500 g) or SGA baby did not differ between treatment and control groups in any subgroup.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">(4) Infant mortality and morbidity (comparisons 01-14, 01-15, 01-16, 01-26, 01-27, 01-28, 01-29, 01-30) </HEADING>
<P>Even taken together, there were too few baby deaths for any reliable conclusions about the overall effects of marine oils and other prostaglandin precursors.</P>
<P>There were no clear differences between the groups in the mean length of infant hospital stay or the relative risks of admission to neonatal care, congenital malformation, neonatal bleeding disorders and neonatal non-bleeding disorders.</P>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analyses relating to stillbirth and neonatal death (comparisons 02-08, 02-09, 03-08, 03-09, 04-08, 04-09, 05-08, 05-09)</HEADING>
<P>Similarly, there were insufficient data on stillbirth and neonatal death for any reliable conclusion about the possible effects in any of the prespecified subgroups.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">(5) Maternal mortality and morbidity (comparisons 01-03, 01-04, 01-05, 01-06, 01-10)</HEADING>
<P>There were no maternal deaths in the one trial reporting this outcome (1477 women).</P>
<P>There were no clear differences between the groups in any measure of maternal morbidity, such as length of hospital stay, caesarean section and eclampsia or other serious maternal morbidity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">(6) Maternal side-effects (comparisons 01-07, 01-08, 01-09, 01-12, 01-13)</HEADING>
<P>Women allocated marine oil were more than three times more likely to report belching (RR 3.55, 95% CI 2.78 to 4.52; 3 trials, 1386 women) and six times more likely to complain of an unpleasant taste (RR 6.17, 95% CI 4.03 to 9.44; 3 trials, 1354 women) than those allocated control oil. There were no clear differences in nausea, vomiting, stomach pain, diarrhoea and constipation between women in the two groups.</P>
<P>Also, there were no differences in any bleeding complications such as nasal bleeding, antepartum vaginal bleeding, maternal anaemia, vaginal blood loss after birth and blood loss at birth between women in the two groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">(7) Long-term childhood outcome (comparisons 01-31)</HEADING>
<P>No included trials reported data regarding long-term childhood outcomes.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Data from this systematic review indicate a small but consistent increase in the mean length of gestation associated with marine oil, and other prostaglandin precursor, supplementation during pregnancy. This small increase of two to three days in the mean length of gestation did not translate into a reduction in the risk of birth before 37 weeks' completed gestation, although there does appear to be a reduction in the relative risk of birth before 34 completed weeks. However, the numbers of women for whom this outcome is reported are relatively small, and most had high risk pregnancies. Therefore, there is a potential to be misled by both bias and random error. </P>
<P>Although an increased length of gestation is desirable if it reduces the risk of preterm birth, it may not be so desirable if it also prolongs gestation beyond term. The data in this review are insufficient for any reliable conclusions about the possible effect on prolonged gestation. </P>
<P>Marine oil supplementation was associated with a small increase in birthweight that appears commensurate with the two to three day increase in the mean duration of gestation. The clinical importance of these findings is questionable, however, as they are not reflected in any overall impact on the relative risk of a baby being low birthweight or small-for-gestational age. These findings were consistent across all subgroup analyses. This suggests that marine oil supplementation in pregnancy may not improve fetal growth, and that the small increase in birthweight may be mediated by the small increase in the length of gestation.</P>
<P>The point estimate for the effect of marine oils or other prostaglandin precursors on pre-eclampsia was a 14% reduction in relative risk, with 95% confidence intervals for the true effects being anything from a 39% reduction to a 33% increase, compared with control. Although subgroup analysis by singleton and multiple pregnancy suggests that any reduction in the risk of pre-eclampsia may be confined to women with a singleton pregnancy, only one trial contributed to both the singleton and multiple pregnancy subgroups and the remainder of trials only included women with singleton pregnancies. This imbalance in the subgroups and the limited number of women with multiple pregnancies may result in bias and random error.</P>
<P>The doses of EPA and DHA derived from the marine oils used in the trials in this review ranged from 133 mg/day to 3 g/day, although most trials involving the majority of women assessed a dose of 2.7 g of EPA and DHA per day. Such a dose would be difficult to achieve from food sources. As an example, this would require a woman to eat 300 g of cooked salmon daily. Although the doses appear high compared with what may be achievable through the diet, the marine oil interventions appeared safe. There were no increases in bleeding or haemorrhage either before or after birth. The only side-effects associated with fish oil supplementation were belching and unpleasant taste, and these are relatively minor.</P>
<P>More recent literature has suggested that increasing DHA supply in pregnancy may improve maternal mood as well as improve the neural development of the infant. Prospective cohort studies have indicated a strong association between the dietary dose of DHA in pregnancy and the prevalence of depressive symptoms in the postnatal period (<LINK REF="REF-Hibbeln-2003" TYPE="REFERENCE">Hibbeln 2003</LINK>). Similarly cohort studies have related DHA status of the mother at the end of pregnancy or DHA status in cord blood with changes in neonatal sleeping patterns (<LINK REF="REF-Cheruku-2002" TYPE="REFERENCE">Cheruku 2002</LINK>), altered attention (<LINK REF="REF-Colombo-2004" TYPE="REFERENCE">Colombo 2004</LINK>) and motor development (<LINK REF="REF-Bakker-2003" TYPE="REFERENCE">Bakker 2003</LINK>). There have only been two published randomised trials to assess the effect of fish oil intervention in pregnancy on the subsequent developmental outcome of children (<LINK REF="STD-Norway-2001" TYPE="STUDY">Norway 2001</LINK>; <LINK REF="STD-Scotland-2003" TYPE="STUDY">Scotland 2003</LINK>) and both trials have been excluded from this review because of methodological issues. Nevertheless, the data relating to maternal mood and childhood development have generated substantial interest that has seen the recent initiation of several trials to assess the impact of DHA supply in pregnancy on maternal mood (<LINK REF="STD-DOMInO" TYPE="STUDY">DOMInO</LINK>) and childhood development (<LINK REF="STD-DOMInO" TYPE="STUDY">DOMInO</LINK>; <LINK REF="STD-Mexico" TYPE="STUDY">Mexico</LINK>; <LINK REF="STD-NICHD" TYPE="STUDY">NICHD</LINK>).</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>There is not enough evidence to support the routine use of marine oil, or other prostaglandin precursor, supplements during pregnancy to reduce the risk of pre-eclampsia, preterm birth, low birthweight or small-for-gestational age. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>The review suggests that marine oil supplementation may be of most benefit in prolonging gestation in women with high-risk pregnancies. Further large randomised trials are required to confirm whether or not there are clinically important benefits for mother and child, and to provide reliable information about potential adverse effects. Such trials should include assessment of the longer-term effects, for example on maternal mood in the postnatal period and childhood development. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>Sjurdur Olsen and Marie Louise Osterdal provided unpublished data for the <LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK> trial.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>Sjurdur Olsen was the principal investigator of the <LINK REF="STD-Denmark-1992" TYPE="STUDY">Denmark 1992</LINK> and <LINK REF="STD-Europe-2000" TYPE="STUDY">Europe 2000</LINK> trials. Maria Makrides is the principal investigator of the ongoing <LINK REF="STD-DOMInO" TYPE="STUDY">DOMInO</LINK> trial.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>M Makrides (MM) and SF Olsen (SFO) assessed the trials for inclusion and extracted the data. MM wrote the protocol and review with contributions from L Duley and SFO.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-10-29 16:39:39 +0000" MODIFIED_BY="[Empty name]">
<P>The title has been updated from 'Fish oil and other prostaglandin precursor supplementation during pregnancy for reducing pre-eclampsia, preterm birth, low birth weight and intrauterine growth restriction' to 'Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia and intrauterine growth restriction' to more clearly identify the types of interventions and types of participants included.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Angola-1992" NAME="Angola 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;D'Almeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women &amp;amp; Health 1992;19:117-131.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>D'Almeida A, Carter JP, Anatol A, Prost C</AU>
<TI>Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia</TI>
<SO>Women &amp; Health</SO>
<YR>1992</YR>
<VL>19</VL>
<PG>117-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Denmark-1992" NAME="Denmark 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Dalby Sorensen J, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effect of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol 1993;168:915-922.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dalby Sorensen J, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA</AU>
<TI>Effect of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1993</YR>
<VL>168</VL>
<PG>915-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Dalby Sorensen J, Secher NJ, Olsen SF</AU>
<TI>Effects of n-3 fatty acids on blood pressure in the third trimester of pregnancy</TI>
<SO>7th World Congress of Hypertension in Pregnancy; 1990; Perugia, Italy</SO>
<YR>1990</YR>
<PG>343</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Olsen SF, Dalby Sorensen J, Secher NJ, Hedegaard M, Brink Henriksen T, Hansen HS, Grant A. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992;339:1003-1007.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF, Dalby Sorensen J, Secher NJ, Hedegaard M, Brink Henriksen T, Hansen HS, et al</AU>
<TI>Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration</TI>
<SO>Lancet</SO>
<YR>1992</YR>
<VL>339</VL>
<PG>1003-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Olsen SF, Secher NJ, Sorensen JD, Grant A</AU>
<TI>Gestational age and fish oil supplementation in third trimester: a population-based randomized controlled trial</TI>
<SO>Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore</SO>
<YR>1991</YR>
<PG>31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Olsen SF, Secher NJ</AU>
<TI>Fish oil and preeclampsia</TI>
<SO>8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8-12; Buenos Aires, Argentina</SO>
<YR>1992</YR>
<PG>94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF, Sorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS, et al</AU>
<TI>Fish oil supplementation and duration of pregnancy. A randomized controlled trial</TI>
<SO>Ugeskrift for Laeger</SO>
<YR>1994</YR>
<VL>156</VL>
<PG>1302-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salvig JD, Olsen SF, Secher NJ</AU>
<TI>Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1996</YR>
<VL>103</VL>
<PG>529-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA</AU>
<TI>Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>1993</YR>
<VL>43</VL>
<PG>229</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sorensen JD, Olsen SF, Secher NJ, Jespersen J</AU>
<TI>Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis. A randomised controlled study</TI>
<SO>Fibrinolysis</SO>
<YR>1994</YR>
<VL>8</VL>
<PG>54-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sorensen JD, Olsen SF, Secher NJ</AU>
<TI>Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica Supplement</SO>
<YR>1995</YR>
<VL>73</VL>
<PG>110</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Houwelingen AC, Sorensen JD, Hornstra G, Simonis MMG, Boris J, Olsen SF, et al</AU>
<TI>Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy</TI>
<SO>British Journal of Nutrition</SO>
<YR>1995</YR>
<VL>74</VL>
<PG>723-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-England-1995" NAME="England 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Onwude J, Hjartar H, Tuffnell D, Thornton JG, Lilford RJ</AU>
<TI>Fish oil in high risk pregnancy: a randomised, double blind, placebo-controlled trial</TI>
<SO>Proceedings of 26th British Congress of Obstetrics and Gynaecology; 1992 July 7-10; Manchester, UK</SO>
<YR>1992</YR>
<PG>430</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 1995;102:95-100.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D</AU>
<TI>A randomised double blind placebo controlled trial of fish oil in high risk pregnancy</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1995</YR>
<VL>102</VL>
<PG>95-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Europe-2000" NAME="Europe 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Br J Obstet Gynaecol 2000;107:382-395.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C</AU>
<TI>Randomised clinical trials of fish oil supplementation in high risk pregnancies</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>2000</YR>
<VL>107</VL>
<PG>382-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Netherlands-1994" NAME="Netherlands 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Bulstra-Ramakers MTEW, Huisjes HJ, Visser GHA. The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol 1994;102:123-126.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bulstra-Ramakers MTEW, Huisjes HJ, Visser GHA</AU>
<TI>The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1994</YR>
<VL>102</VL>
<PG>123-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-USA-2003" NAME="USA 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE</AU>
<TI>A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2003</YR>
<VL>101</VL>
<PG>469-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Australia-2004" NAME="Australia 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barden AE, Mori TA, Dunstan JA, Taylor AL, Thornton CA, Croft KD, et al</AU>
<TI>Fish oil supplementation in pregnancy lowers f2-isoprostanes in neonates at high risk of atopy</TI>
<SO>Free Radical Research</SO>
<YR>2004</YR>
<VL>38</VL>
<PG>233-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;there are other papers from this study that need to be entered here too&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunstan JA, Mori TA, Barden A, Beilin LJ, Holt PG, Calder PC, et al</AU>
<TI>Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>58</VL>
<PG>429-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colombia-1993" NAME="Colombia 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herrera JA</AU>
<TI>Nutritional factors and rest reduce pregnancy-induced hypertension and pre-eclampsia in positive roll-over test primigravidas</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>1993</YR>
<VL>41</VL>
<PG>31-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colombia-1998" NAME="Colombia 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herrera JA, Arevalo-Herrera M, Herrera S</AU>
<TI>Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1998</YR>
<VL>91</VL>
<PG>585-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Denmark-1994" NAME="Denmark 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Secher NJ, Sorensen JD</AU>
<TI>Biochemical and epidemiological evidence for the preventive effect of fish oil on pre-eclampsia</TI>
<SO>9th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia</SO>
<YR>1994</YR>
<PG>77</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-England-1984" NAME="England 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Morrison RA, O'Brien PMS, Micklewright A</AU>
<TI>The effect of dietary supplementation with linoleic acid on the development of pregnancy induced hypertension</TI>
<SO>4th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands</SO>
<YR>1984</YR>
<PG>48</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-England-1986" NAME="England 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Morrison RA, O'Brien PMS</AU>
<TI>The effect of dietary supplementation with prostaglandin precursors in pregnancy induced hypertension (PIH)</TI>
<SO>5th International Congress of the International Society for the Study of Hypertension in Pregnancy; 1986 7-10 July; Nottingham, England</SO>
<YR>1986</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Finland-1993" NAME="Finland 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laivuori H, Hovatta O, Viinikka L, Ylikorkala O</AU>
<TI>Dietary supplementation with primrose oil or fish oil does not change urinary excretion of prostacyclin and thromboxane metabolites in pre-eclamptic women</TI>
<SO>Prostaglandins Leukotrienes and Essential Fatty Acids</SO>
<YR>1993</YR>
<VL>49</VL>
<PG>691-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-France-1985" NAME="France 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fievet P, Tribout B, Castier B, Dieval J, Capiod JC, Delobel J, et al</AU>
<TI>Effects of evening primrose oil (EPO) on platelet functions during pregnancy in patients with high risk of toxemia [abstract]</TI>
<SO>Kidney International</SO>
<YR>1985</YR>
<VL>28</VL>
<PG>234</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Netherlands-2000" NAME="Netherlands 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Otto SJ, van Houwelingen AC, Hornstra G</AU>
<TI>The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester</TI>
<SO>Prostaglandins Leukotrienes &amp; Essential Fatty Acids</SO>
<YR>2000</YR>
<VL>63</VL>
<PG>323-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Netherlands-2004" NAME="Netherlands 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Groot RH, Hornstra G, van Houwelingen AC, Roumen F</AU>
<TI>Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>79</VL>
<PG>251-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Norway-2001" NAME="Norway 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haugen G, Helland I</AU>
<TI>Influence of preeclampsia or maternal intake of omega-3 fatty acids on the vasoactive effect of prostaglandin F-two-alpha in human umbilical arteries</TI>
<SO>Gynecologic &amp; Obstetric Investigation</SO>
<YR>2001</YR>
<VL>52</VL>
<PG>75-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T, et al</AU>
<TI>Similar effects on infants of n-3 and n-6 fatty acid supplementation to pregnant and lactating women</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>108</VL>
<PG>e82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA</AU>
<TI>Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age</TI>
<SO>Pediatrics</SO>
<YR>2003</YR>
<VL>111</VL>
<PG>e39-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scotland-2003" NAME="Scotland 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Malcolm CA, Hamilton R, McCulloch DL, Montgomery C, Weaver LT</AU>
<TI>Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy</TI>
<SO>Investigative Opthalmology &amp; Visual Science</SO>
<YR>2003</YR>
<VL>44</VL>
<PG>3685-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malcolm CA, McCulloch DL, Montgomery C, Shepherd A, Weaver LT</AU>
<TI>Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial</TI>
<SO>Archives of Diseases in Childhood Fetal &amp; Neonatal Edition</SO>
<YR>2003</YR>
<VL>90</VL>
<PG>F383-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT</AU>
<TI>Maternal docosahexaenoic acid supplementation and fetal accretion</TI>
<SO>British Journal of Nutrition</SO>
<YR>2003</YR>
<VL>90</VL>
<PG>135-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Slovenia-1994" NAME="Slovenia 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Sajina-Stritar B</AU>
<TI>Prevention of gestational hypertension and its complications with ASA and N-3 fatty acids (comparative study)</TI>
<SO>Proceedings of 14th European Congress of Perinatal Medicine; 1994; Helsinki, Finland</SO>
<YR>1994</YR>
<PG>182</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-South-Africa-1989" NAME="South Africa 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>England MJ, Chetty N, Dukes IAF, Reavis S, Atkinson P, Sonnendecker EWW</AU>
<TI>Eicosapentaenoic acid in pre-eclampsia: a randomized trial</TI>
<SO>Proceedings of Silver Jubilee Congress of Obstetrics and Gynaecology; 1989; London, UK</SO>
<YR>1989</YR>
<PG>154</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Venezuela-2000" NAME="Venezuela 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rivas-Echeverria CA, Echeverria Y, Molina L, Novoa D</AU>
<TI>Synergic use of aspirin, fish oil and vitamins C and E for the prevention of preeclampsia</TI>
<SO>Hypertension in Pregnancy</SO>
<YR>2000</YR>
<VL>19</VL>
<PG>30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Russia-1999" NAME="Russia 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pavlovich SV, Burlev VA, Vikhliaeva EM</AU>
<TI>The effect of n-3 polyunsaturated fatty acids on the lipid spectrum indices in the 2nd-3rd pregnancy trimesters (in Russian)</TI>
<SO>Eksperimentalnaia i Klinicheskaia Farmakologiia</SO>
<YR>1999</YR>
<VL>62</VL>
<PG>35-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-DOMInO" NAME="DOMInO" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Makrides M, Gibson RA, McPhee AJ, Quinlivan J</AU>
<TI>Randomised trial of DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children</TI>
<SO>Australian Clinical Trials Registry www.actr.org.au</SO>
<YR>(accessed 2005)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="ACTRN012605000569606"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mexico" NAME="Mexico" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Ramakrishnan U</AU>
<TI>Randomized controlled trial of prenatal DHA supplementation to improve child growth and development in infancy</TI>
<SO>Personal communication</SO>
<YR>2004</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NICHD" NAME="NICHD" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Spong CY, Thom EA, Harper M</AU>
<TI>Omega-3 fatty acid supplementation to prevent preterm birth in high risk pregnancies</TI>
<SO>www.ClinicalTrials.gov</SO>
<YR>(accessed 2005)</YR>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="NCT001135902"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Andersen-1989" NAME="Andersen 1989" NOTES="&lt;p&gt;Andersen HJ, Andersen LF, Fuchs AR. Diet, pre-eclampsia, and intrauterine growth retardation [letter]. Lancet 1989; i:1146.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Andersen HJ, Andersen LF, Fuchs AR</AU>
<TI>Diet, pre-eclampsia, and intrauterine growth retardation [letter]</TI>
<SO>Lancet</SO>
<YR>1989</YR>
<VL>i</VL>
<PG>1146</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bakker-2003" NAME="Bakker 2003" TYPE="JOURNAL_ARTICLE">
<AU>Bakker EC, Ghys AJ, Kester AD, Vles JS, Dubas JS, Blanco CE, et al</AU>
<TI>Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>57</VL>
<PG>89-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cheruku-2002" NAME="Cheruku 2002" TYPE="JOURNAL_ARTICLE">
<AU>Cheruku SR, Montgomery-Downs HE, Farkas SL, Thoman EB, Lammi-Keefe CJ</AU>
<TI>Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>76</VL>
<PG>608-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Colombo-2004" NAME="Colombo 2004" TYPE="JOURNAL_ARTICLE">
<AU>Colombo J, Kannass KN, Shaddy DJ, Kundurthi S, Maikranz JM, Anderson CJ, et al</AU>
<TI>Maternal DHA and the development of attention in infancy and toddlerhood</TI>
<SO>Child Development</SO>
<YR>2004</YR>
<VL>75</VL>
<PG>1254-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DH-1998" NAME="DH 1998" NOTES="&lt;p&gt;Department of Health, Welsh Office, Scottish Office Home and Health Department, Department of Health and Social Services, Northern Ireland. Why mothers die? Report on confidential enquiries into maternal deaths in the United Kingdom 1994-1996. 1998. London HMSO.&lt;/p&gt;" TYPE="BOOK">
<AU>Department of Health, Welsh Office, Scottish Office Home and Health Department, Department of Health and Social Services, Northern Ireland</AU>
<SO>Why mothers die? Report on confidential enquiries into maternal deaths in the United Kingdom 1994-1996</SO>
<YR>1998</YR>
<PB>HMSO</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dyerberg-1985" NAME="Dyerberg 1985" NOTES="&lt;p&gt;Dyerberg J, Bang HO. Pre-eclampsia and prostaglandins. Lancet 1985; i:1267.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Dyerberg J, Bang HO</AU>
<TI>Pre-eclampsia and prostaglandins</TI>
<SO>Lancet</SO>
<YR>1985</YR>
<VL>i</VL>
<PG>1267</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hewitt-1988" NAME="Hewitt 1988" NOTES="&lt;p&gt;Hewitt BG, Newnham JP. A review of the obstetric and medical complications leading to the delivery of infants of very low birthweight. Med J Aust 1988;149:234&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Hewitt BG, Newnham JP</AU>
<TI>A review of the obstetric and medical complications leading to the delivery of infants of very low birthweight</TI>
<SO>Medical Journal of Australia</SO>
<YR>1988</YR>
<VL>149</VL>
<PG>234</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hibbeln-2003" NAME="Hibbeln 2003" TYPE="CONFERENCE_PROC">
<AU>Hibbeln J, Davis J, Heron J</AU>
<TI>Low dietary omega-3s and increased depression risk in 14,541 pregnancies</TI>
<SO>American Psychiatric Association 156th Annual Meeting; 2003 May 17-22; San Francisco, USA</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2005" NAME="Higgins 2005" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook of Systematic Reviews of Interventions 4.2.5 [updated May 2005]</TI>
<SO>In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley &amp; Sons, Ltd</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-League-of-Health" NAME="League of Health" NOTES="&lt;p&gt;People's League of Health. The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity. J Obstet Gynaecol Br Emp 1946;53:498-509.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>People's League of Health</AU>
<TI>The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity</TI>
<SO>Journal of Obstetrics and Gynaecology of the British Empire</SO>
<YR>1946</YR>
<VL>53</VL>
<PG>498-509</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morris-1993" NAME="Morris 1993" NOTES="&lt;p&gt;Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? a meta-analysis of controlled trials. Circulation 1993;88:523-533.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Morris MC, Sacks F, Rosner B</AU>
<TI>Does fish oil lower blood pressure? a meta-analysis of controlled trials</TI>
<SO>Circulation</SO>
<YR>1993</YR>
<VL>88</VL>
<PG>523-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olsen-1985" NAME="Olsen 1985" NOTES="&lt;p&gt;Olsen SF, Joensen HD. High liveborn birth weights in the Faroes: a comparison between birth weights in the Faroes and in Denmark. J Epidemiol Community Health 1985;39:27-32.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF, Joensen HD</AU>
<TI>High liveborn birth weights in the Faroes: a comparison between birth weights in the Faroes and in Denmark</TI>
<SO>Journal of Epidemiology and Community Health</SO>
<YR>1985</YR>
<VL>39</VL>
<PG>27-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olsen-1986" NAME="Olsen 1986" NOTES="&lt;p&gt;Olsen SF, Hansen HS, Sorensen T, Jensen B, Secher NJ, Sommer S, et al. Intake of marine fat, rich in (n-3) polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 1986; 2:367-369.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF, Hansen HS, Sorensen T, Jensen B, Secher NJ, Sommer S, et al</AU>
<TI>Intake of marine fat, rich in (n-3) polyunsaturated fatty acids, may increase birthweight by prolonging gestation</TI>
<SO>Lancet</SO>
<YR>1986</YR>
<VL>2</VL>
<PG>367-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olsen-1987a" NAME="Olsen 1987a" NOTES="&lt;p&gt;Olsen SF, Hansen HS. Marine fat, birthweight, and gestational age: a case report. Agents Actions 1987;22:373-374.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF, Hansen HS</AU>
<TI>Marine fat, birthweight, and gestational age: a case report</TI>
<SO>Agents Actions</SO>
<YR>1987</YR>
<VL>22</VL>
<PG>373-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olsen-1987b" NAME="Olsen 1987b" NOTES="&lt;p&gt;Olsen SF, Hansen HS, Sorensen T, Jensen B, Secher NJ, Sommer S, et al. Hypothesis: dietary (n-3)-fatty acidsd prolong gestation in human beings. Prog Clin Biol Res 1987;242:51-56.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF, Hansen HS, Sorensen T, Jensen B, Secher NJ, Sommer S, et al</AU>
<TI>Hypothesis: dietary (n-3)-fatty acids prolong gestation in human beings</TI>
<SO>Progress in Clinical and Biological Research</SO>
<YR>1987</YR>
<VL>242</VL>
<PG>51-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olsen-1990" NAME="Olsen 1990" NOTES="&lt;p&gt;Olsen SF, Secher NJ. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br J Nutr 1990;64:599-609.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF, Secher NJ</AU>
<TI>A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial</TI>
<SO>British Journal of Nutrition</SO>
<YR>1990</YR>
<VL>64</VL>
<PG>599-609</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olsen-1993" NAME="Olsen 1993" NOTES="&lt;p&gt;Olsen SF. Consumption of marine n-3 fatty acids during pregnancy as a possible determinant of birth weight. A review of current epidemiological evidence [Erratum appeared in Am J Epidemiol 1994;139:856]. Epidemiologic Reviews 1993;15:399-413.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF</AU>
<TI>Consumption of marine n-3 fatty acids during pregnancy as a possible determinant of birth weight. A review of current epidemiological evidence [Published erratum appeared in Am J Epidemiol 1994;139:856]</TI>
<SO>Epidemiologic Reviews</SO>
<YR>1993</YR>
<VL>15</VL>
<PG>399-413</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Olsen-1994" NAME="Olsen 1994" NOTES="&lt;p&gt;Olsen SF. Further on the association between retarded foetal growth and adult cardiovascular disease. Could low intake of marine diets be a common cause? Journal of Clinical Epidemiology 1994;47:565-569.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Olsen SF</AU>
<TI>Further on the association between retarded foetal growth and adult cardiovascular disease. Could low intake of marine diets be a common cause?</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1994</YR>
<VL>47</VL>
<PG>565-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pritchard-1984" NAME="Pritchard 1984" NOTES="&lt;p&gt;Pritchard JA, Cunningham FG, Pritchard, SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. American Journal of Obstetrics &amp;amp; Gynecology 1984;148:951-963.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Pritchard JA, Cunningham FG, Pritchard, SA</AU>
<TI>The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1984</YR>
<VL>148</VL>
<PG>951-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-SA-Health-Commission" NAME="SA Health Commission" NOTES="&lt;p&gt;South Australian Health Commission. Maternal, Perinatal and Infant Mortality in South Australia 1997. Adelaide: South Australian Health Commission, 1999.&lt;/p&gt;" TYPE="BOOK">
<AU>South Australian Health Commission</AU>
<SO>Maternal, perinatal and infant mortality in South Australia 1997</SO>
<YR>1999</YR>
<PB>South Australian Health Commission</PB>
<CY>South Australia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Simopoulos-1991" NAME="Simopoulos 1991" NOTES="&lt;p&gt;Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438-463.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Simopoulos AP</AU>
<TI>Omega-3 fatty acids in health and disease and in growth and development</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1991</YR>
<VL>54</VL>
<PG>438-63</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-Duley-1995" NAME="Duley 1995" TYPE="OTHER">
<AU>Duley L</AU>
<TI>Prophylactic fish oil in pregnancy. [revised 21 April 1994] In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther CA (eds.) Pregnancy and Childbirth Module</TI>
<SO>The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration, Issue 2, 1995. Oxford: Update Software</SO>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Angola-1992">
<CHAR_METHODS>
<P>3 arm trial: evening primrose + fish oils, magnesium oxide, and olive oil placebo. Women "randomly assigned using a random number table". Outcome assessments partially blinded - olive oil and evening primrose oil + fish oil capsules identical, but both different to magnesium oxide. The number of exclusions was not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>100 primiparous and multiparous women, aged 14-40 years and &lt;/= 16 weeks' gestation. 76% had a recent history of malaria or fever of unknown origin, 34% had a history of sickle cell trait or disease, 37% had a history of anaemia, 21% had a history of pregnancy hypertension or other hypertension and 4% had a previous preterm delivery.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 8 capsules/day evening primrose oil + fish oil, providing a total of 296 mg GLA, 144 mg EPA and 80 mg DHA/day. <BR/>Control: 8 capsules olive oil/day.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Women: PIH, oedema, PE, eclampsia. <BR/>Babies: birthweight (&lt; 2000b and &gt; 2000b).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No estimate of sample size is given.<BR/>Reported dietary intake of women at study entry was poor. 50 women allocated magnesium oxide excluded from this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Denmark-1992">
<CHAR_METHODS>
<P>3 arm trial in a ratio of 2/1/1: fish oil, olive oil and no supplement. Each woman assigned a study number corresponding to a sealed, opaque envelope containing a randomisation number, this identified either a particular package of oil capsules or no treatment. The olive oil capsules were identical to the fish oil capsules. Outcome assessment was blinded, but 85% of women in the fish oil group correctly identified their group allocation, whereas for olive oil 50% identified the correct oil. There were no post-randomisation exclusions.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>533 women at approximately 30 weeks' gestation, aged 18-44 years. Excluded if history of placental abruption, a serious bleed in the current pregnancy, use of prostaglandin inhibitors, multiple pregnancy, fish allergy or regular intake of fish oil.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: fish oil (2.7 g n-3 fatty acids/day) given as 4 x 1 g capsules/day. <BR/>Control: either 4 x 1 g capsules olive oil/day or no supplement.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Women: systolic and diastolic blood pressure, PIH, PE.<BR/>Babies: duration of gestation, birthweight, birth length.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Sample size estimates were done but not reported in the papers because they were regarded as post-festum by authors (personal communication). <BR/>Women completed baseline information regarding fish intake.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-England-1995">
<CHAR_METHODS>
<P>Random numbers were generated by computer and kept in sealed, opaque, numbered envelopes in the hospital pharmacy. Pharmacy staff allocated the trial treatments. Placebo capsules were identical to treatment capsules. Outcome assessments were blinded, but 44% of a subgroup of women identified that they were in the fish oil group. There was only 0.4% post-randomisation exclusions.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>232 women at 19-26 weeks with high-risk singleton pregnancy: history of 1 or more small babies (birthweight &lt; 3rd percentile), history of pregnancy hypertension, history of unexplained stillbirth, or primigravida with abnormal uterine Doppler at 24 weeks' gestation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: fish oil (2.7 g of MaxEPA/day) given as 9 capsules/day. This provided 1.62 g EPA and 1.08 g DHA/day. <BR/>Control: matching air filled capsules. <BR/>Treatment stopped at 38 weeks' gestation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Women: PIH, PE.<BR/>Babies: birthweight &lt; 3rd percentile.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Sample size estimate is given for proteinuric hypertension.<BR/>All women were asked to avoid non-steroidal anti-inflammatory drugs.<BR/>Compliance: 50% of women in the fish oil group and 57% of women in the placebo group took &lt; 70% of capsules.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Europe-2000">
<CHAR_METHODS>
<P>Multicentre study with 6 different subsets (A to F) of eligibility criteria. The 6 subsets had a standard protocol, and were mutually exclusive. The 4 subsets labelled A-D were included in this review. "Randomisation identified a package number at the relevant centre, where packages were ordered in a random way as to oil type". Placebo capsules were identical looking but contained olive oil. Outcome assessments were blinded, but a questionnaire completed by a subgroup of women indicated that 80% of women in the fish oil group could guess their allocation. There were 3.2% post-randomisation exclusions.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Subset A to D recruited 1477 women who were at least 16 weeks' gestation. Subset A included 232 women with a previous preterm birth. Subset B included 280 women with previous IUGR. Subset C included 386 women with previous PIH. Subset D included 579 women with twins. All subsets excluded women with diabetes mellitus, severe fetal malformation, previous placental abruption, drug or alcohol abuse, use of non-steroidal anti-inflammatory drugs, use of fish oil or fish allergy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: fish oil (1.3 g EPA and 0.9 g DHA/day), given as 4 capsules/day. <BR/>Control: matching olive oil capsules.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Subset A: preterm birth, low birthweight.<BR/>Subset B: small-for-gestational age, low birthweight.<BR/>Subset C: PIH and PE.<BR/>Subset D: Preterm birth, small for gestational age, low birthweight.<BR/>For the combined subsets: prolonged gestation, maternal morbidity and mortality, infant morbidity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Sample size estimates were modified during the course of the study.</P>
<P>We excluded subsets E and F because these were "therapeutic" subsets and included women with pre-eclampsia (subset E) or suspected IUGR (subset F).<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Netherlands-1994">
<CHAR_METHODS>
<P>"Randomisation was performed by the hospital pharmacy". Placebo capsules were identical to treatment capsules. Outcome assessments were blinded, but there was no comment whether a significant proportion of women could guess their treatment. There were 7.3% post-randomisation exclusions.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>63 women at 12-14 weeks' gestation with a history of IUGR, +/- PIH in the previous (index) pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: 3 g EPA/day, given as 12 capsules/day. Each capsule contained 250 mg EPA. No information about the DHA content of the capsules.<BR/>Control: 12 capsules coconut oil/day.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary outcomes: pregnancy induced hypertension and birthweight &lt; 10th percentile.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Sample size estimate was based on the first randomised study of aspirin in high-risk pregnancies.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-USA-2003">
<CHAR_METHODS>
<P>Trial comparing DHA-enriched eggs vs ordinary eggs. Participants were assigned to an egg group using a computer-generated randomization schedule. Ordinary eggs were the control. Outcome assessments were blinded. 17% post-randomisation exclusions.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>350 women with singleton pregnancies, aged 16-36 years. 24-28 weeks' gestation at enrolment and excluded if diabetic. Majority of women were socially disadvantaged and were black (73%).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Treatment: DHA-enriched eggs. Each egg had 133 mg DHA. Women were asked to eat 12 eggs per week but reported eating 5.5 per week.<BR/>Control: ordinary eggs. Each egg had 33 mg DHA. Women were asked to eat 12 eggs per week but reported eating 5.4 per week.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Duration of gestation, birthweight.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Initial sample size was 285. Because there were no published data for low-level DHA supplementation on which to base a power analysis, a blinded reveiw of the data were undertaken after that first 100 births to refine power analysis. Sample size was increased to 350 after the blinded analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>DHA: docosahexaenoic acid<BR/>EPA: eicosapentaenoic acid<BR/>GLA: gamma linolenic acid<BR/>IUGR: intrauterine growth restriction<BR/>PE: pre-eclampsia<BR/>PIH: pregnancy-induced hypertension<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Australia-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Did not report any outcomes of interest to this review. Main focus was the effect of marine oil supplementation during pregnancy on neonatal allergen-specific immune responses.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Colombia-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (linoleic acid) is not a direct prostaglandin precursor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Colombia-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (linoleic acid) is not a direct prostaglandin precursor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Denmark-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not a randomised controlled trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-England-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (linoleic acid) is not a direct prostaglandin precursor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-England-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Women who "developed significant hypertension in the third trimester" were recruited.<BR/>Trial does not appear to be randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Finland-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Women had pre-eclampsia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-France-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Women had pre-eclampsia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Netherlands-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Did not report any outcomes of interest to this review. Main focus was the effect of DHA+AA supplementation on plasma and erythrocyte phospholipids in mid-pregnancy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Netherlands-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>The intervention (alpha-linolenic acid) is not a direct prostaglandin precursor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Norway-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Completeness of follow up &lt; 80%. 341 of 590 women assessed at birth. There was post-randomisation exclusion of women with pregnancy outcomes of primary interest to this review, including "premature birth" and "anomalies in the infants that required special attention". No differences between groups for length of gestation and birthweight.<BR/>84 children of 590 mothers assessed at 4 years of age. Children from the cod liver oil group had higher IQ than children from the control group.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Scotland-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Completeness of follow up &lt; 80%. Assessed 63 of 100 women at birth. There was post-randomisation exclusion of women with pregnancy outcomes of primary interest to this review. No differences between groups for length of gestation, birthweight and visual evoked potentials in early infancy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Slovenia-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Trial compared n-3 fatty acids with aspirin. There was no placebo or no treatment group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-South-Africa-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Women had pre-eclampsia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Venezuela-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Fish oil used in combination with aspirin and vitamins C and E.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>DHA: docosahexaenoic acid</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Russia-1999">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR STUDY_ID="STD-DOMInO">
<CHAR_STUDY_NAME>
<P>Randomised trial of DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS>
<P>Women with a singleton pregnancy, no known fetal abnormality, and not taking medication where tuna oil is contraindicated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Tuna oil capsules providing 1 g DHA + 300 mg EPA or a matching placebo vegetable oil blend daily from 20 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>EPDS score &gt; 12 at 6 weeks and 6 months postpartum. Bayley Scales of infant development at 18 months in 600 randomly selected infants.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>November 2005.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION>
<P>Maria Makrides, Child Health Research Institute.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES>
<P>Australian Clinical Trials Registry<BR/>ACTRN012605000569606.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR STUDY_ID="STD-Mexico">
<CHAR_STUDY_NAME>
<P>Randomized controlled trial of prenatal DHA supplementation to improve child growth and development in infancy.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS>
<P>Women with a singleton, uncomplicated pregnancy who are planning to breastfeed.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Algal oil capsules providing 200 mg DHA or matching placebo daily.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Length of gestation, birthweight, birth length, growth in infancy, mental and motor development to 18 months of age.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>June 2004.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION>
<P>Usha Ramakrishnan, Emory University.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR STUDY_ID="STD-NICHD">
<CHAR_STUDY_NAME>
<P>A randomized trial of omega-3 fatty acid supplementation to prevent preterm birth in pregnancies at high risk.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS>
<P>Women with a singleton pregnancy and previous preterm birth.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>800 mg DHA+1200 mg EPA or matching placebo daily from 16-22 weeks.<BR/>All women also receive weekly injections of 17 alpha hydroxyprogesterone caproate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Birth &lt; 37 completed weeks' gestation including any miscarriages occurring after randomisation.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>February 2005.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION>
<P>Catherine Spong, NICHD<BR/>Elizabeth Thom, George Washington University<BR/>Margaret Harper, Wake Forest University.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES>
<P>ClinicalTrials.gov Identifier NCT00135902.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>DHA: docosahexaenoic acid<BR/>EPA: eicosapentaenoic acid<BR/>EPDS: Edinburgh Postnatal Depression Scale<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Angola-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Denmark-1992">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-England-1995">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Europe-2000">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Netherlands-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-USA-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Prostagladin precursor supplementation versus none or placebo - all women</NAME>
<DICH_OUTCOME CHI2="2.55252650134072" CI_END="1.3288425794317327" CI_START="0.8990590499388516" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.09302696534998" ESTIMABLE="YES" EVENTS_1="160" EVENTS_2="152" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.1234735355450658" LOG_CI_START="-0.04621178299379975" LOG_EFFECT_SIZE="0.03863087627563301" METHOD="MH" NO="1" P_CHI2="0.6352555644684221" P_Q="0.0" P_Z="0.3721688739969159" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="902" TOTAL_2="929" WEIGHT="100.00000000000001" Z="0.8924181165870444">
<NAME>High blood pressure (without proteinuria)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.471637171617545" CI_START="0.32568485634376343" EFFECT_SIZE="0.6923076923076923" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" LOG_CI_END="0.16780074900449615" LOG_CI_START="-0.48720243473951985" LOG_EFFECT_SIZE="-0.1597008428675119" ORDER="113816" O_E="0.0" SE="0.38475211244928603" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.14803418803418805" WEIGHT="8.718993284418783"/>
<DICH_DATA CI_END="3.118494339099184" CI_START="0.4219861365629852" EFFECT_SIZE="1.1471535982814178" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.49394496002729205" LOG_CI_START="-0.37470181660490204" LOG_EFFECT_SIZE="0.05962157171119499" ORDER="113817" O_E="0.0" SE="0.5102474164646426" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.26035242600884234" WEIGHT="4.686034202796297"/>
<DICH_DATA CI_END="1.672297106110498" CI_START="0.781726261738144" EFFECT_SIZE="1.143362831858407" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="35" LOG_CI_END="0.2233134382235443" LOG_CI_START="-0.10694529787225322" LOG_EFFECT_SIZE="0.05818407017564554" ORDER="113818" O_E="0.0" SE="0.193995616389781" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.03763429917845107" WEIGHT="22.867120981350322"/>
<DICH_DATA CI_END="1.402256069183251" CI_START="0.8357190887080198" EFFECT_SIZE="1.0825396825396825" ESTIMABLE="YES" EVENTS_1="93" EVENTS_2="90" LOG_CI_END="0.1468273283799615" LOG_CI_START="-0.07793967797416712" LOG_EFFECT_SIZE="0.034443825202897176" ORDER="113819" O_E="0.0" SE="0.13202925214704062" STUDY_ID="STD-Europe-2000" TOTAL_1="441" TOTAL_2="462" VAR="0.01743172342250683" WEIGHT="58.95848768354741"/>
<DICH_DATA CI_END="3.661152060268669" CI_START="0.7533071266570448" EFFECT_SIZE="1.6607142857142858" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="0.5636177670034017" LOG_CI_START="-0.1230279239079322" LOG_EFFECT_SIZE="0.22029492154773472" ORDER="113820" O_E="0.0" SE="0.4033390777923051" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.16268241167434713" WEIGHT="4.769363847887197"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.246022002591105" CI_END="1.2738959558661587" CI_START="0.5862846497319659" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8642138880392739" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="51" I2="29.345632260754392" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.1051339588954047" LOG_CI_START="-0.23189147648546488" LOG_EFFECT_SIZE="-0.06337875879503013" METHOD="MH" NO="2" P_CHI2="0.23609456921009175" P_Q="0.0" P_Z="0.4610277684489331" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="827" TOTAL_2="856" WEIGHT="100.0" Z="0.7371555472228986">
<NAME>Pre-eclampsia (hypertension with proteinuria)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="113821" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="9.919528720437453"/>
<DICH_DATA CI_END="1.6420362108565234" CI_START="0.005070828994107558" EFFECT_SIZE="0.09124957439564181" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2153827301292026" LOG_CI_START="-2.2949210351172256" LOG_EFFECT_SIZE="-1.0397691524940114" ORDER="113822" O_E="0.0" SE="1.474564857909797" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="2.17434152018254" WEIGHT="10.891086299784972"/>
<DICH_DATA CI_END="1.656028379777145" CI_START="0.4650576241579175" EFFECT_SIZE="0.8775811209439528" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.21906777512700218" LOG_CI_START="-0.33249323140402987" LOG_EFFECT_SIZE="-0.056712728138513795" ORDER="113823" O_E="0.0" SE="0.32398966550734376" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.10496930335556051" WEIGHT="34.78676106443066"/>
<DICH_DATA CI_END="1.9869890408152977" CI_START="0.66215751171156" EFFECT_SIZE="1.1470395455538562" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="23" LOG_CI_END="0.29819547177686706" LOG_CI_START="-0.17903868981955243" LOG_EFFECT_SIZE="0.05957839097865735" ORDER="113824" O_E="0.0" SE="0.28032970886893616" STUDY_ID="STD-Europe-2000" TOTAL_1="398" TOTAL_2="420" VAR="0.07858474567454249" WEIGHT="44.402623915346915"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.695941239682091" CI_START="0.007569958486080607" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.43071042215114275" LOG_CI_START="-2.1209065021796567" LOG_EFFECT_SIZE="-0.8450980400142569" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.19418976014097394" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.2982840065365528">
<NAME>Eclampsia or other serious maternal morbidity</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.695941239682091" CI_START="0.007569958486080607" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43071042215114275" LOG_CI_START="-2.1209065021796567" LOG_EFFECT_SIZE="-0.8450980400142569" ORDER="113825" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="724" TOTAL_2="753" WEIGHT="0.0" Z="0.0">
<NAME>Maternal death</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="113826" O_E="0.0" SE="0.0" STUDY_ID="STD-Europe-2000" TOTAL_1="724" TOTAL_2="753" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.2831833337561918" CI_START="0.6658146495209813" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2329545454545454" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.3585407856215978" LOG_CI_START="-0.17664665355283848" LOG_EFFECT_SIZE="0.09094706603437967" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.5053261770127754" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="32" TOTAL_2="31" WEIGHT="100.0" Z="0.6661328756218112">
<NAME>Maternal antepartum hospitalisation</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.2831833337561918" CI_START="0.6658146495209813" EFFECT_SIZE="1.2329545454545454" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="11" LOG_CI_END="0.3585407856215978" LOG_CI_START="-0.17664665355283848" LOG_EFFECT_SIZE="0.09094706603437967" ORDER="113827" O_E="0.0" SE="0.3143717509916139" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.0988295978215333" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.2473972086400282" CI_START="-2.8673972086400275" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8099999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.06" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.44032743938620755" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="724" TOTAL_2="753" UNITS="" WEIGHT="100.0" Z="0.7716404109087193">
<NAME>Mother's length stay in hospital (days)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.2473972086400282" CI_START="-2.8673972086400275" EFFECT_SIZE="-0.8099999999999996" ESTIMABLE="YES" MEAN_1="5.73" MEAN_2="6.54" ORDER="113828" SD_1="14.2" SD_2="24.9" SE="1.049711742087362" STUDY_ID="STD-Europe-2000" TOTAL_1="724" TOTAL_2="753" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.3121363172135547" CI_END="1.5623680643355877" CI_START="0.706208655625103" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0504084207135955" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.19378335315193113" LOG_CI_START="-0.1510669638230732" LOG_EFFECT_SIZE="0.02135819466442896" METHOD="MH" NO="7" P_CHI2="0.5763723163318955" P_Q="0.0" P_Z="0.8081762238739039" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="974" TOTAL_2="1002" WEIGHT="100.0" Z="0.2427794916025003">
<NAME>Antepartum vaginal bleeding</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.6293951397241226" CI_START="0.5987195227716217" EFFECT_SIZE="1.2546992481203008" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="12" LOG_CI_END="0.41985585583126184" LOG_CI_START="-0.22277658034813247" LOG_EFFECT_SIZE="0.09853963774156464" ORDER="113829" O_E="0.0" SE="0.3774854740936391" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.14249528315169946" WEIGHT="26.416275990409048"/>
<DICH_DATA CI_END="1.5657592878978182" CI_START="0.6097127667344664" EFFECT_SIZE="0.9770687936191426" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="34" LOG_CI_END="0.19472499656418507" LOG_CI_START="-0.2148747112200316" LOG_EFFECT_SIZE="-0.010074857327923266" ORDER="113830" O_E="0.0" SE="0.24060089590370232" STUDY_ID="STD-Europe-2000" TOTAL_1="708" TOTAL_2="735" VAR="0.0578887911096642" WEIGHT="73.58372400959095"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.4827667520742531" CI_START="0.9058461087654296" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1589471483088505" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="94" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.17107283932638773" LOG_CI_START="-0.04294557692669723" LOG_EFFECT_SIZE="0.06406363119984526" METHOD="MH" NO="8" P_CHI2="1.0" P_Q="0.0" P_Z="0.2406436795653386" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="407" TOTAL_2="439" WEIGHT="99.99999999999999" Z="1.1733794882592805">
<NAME>Maternal anaemia</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.482766752074253" CI_START="0.9058461087654297" EFFECT_SIZE="1.1589471483088505" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="94" LOG_CI_END="0.1710728393263877" LOG_CI_START="-0.042945576926697177" LOG_EFFECT_SIZE="0.06406363119984526" ORDER="113831" O_E="0.0" SE="0.12571547711530845" STUDY_ID="STD-Europe-2000" TOTAL_1="407" TOTAL_2="439" VAR="0.015804381186329645" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="122.50733952794397" CI_END="2.2817777171757023" CI_START="1.7521523806605683" CI_STUDY="95" CI_TOTAL="95" DF="17.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.999505503690261" ESTIMABLE="YES" EVENTS_1="728" EVENTS_2="285" I2="86.1232803965004" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.3582733346895702" LOG_CI_START="0.24357187306623573" LOG_EFFECT_SIZE="0.300922603877903" METHOD="MH" NO="9" P_CHI2="-2.220446049250313E-16" P_Q="0.0" P_Z="8.316284521734312E-25" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="5160" TOTAL_2="4506" WEIGHT="800.0" Z="10.284044464429332">
<NAME>Maternal side-effects</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.05249571008939322" CI_END="4.519005335626496" CI_START="2.78429912213095" DF="2.0" EFFECT_SIZE="3.547148515200616" ESTIMABLE="YES" EVENTS_1="320" EVENTS_2="64" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="0.6550428541065452" LOG_CI_START="0.4447158904617155" LOG_EFFECT_SIZE="0.5498793722841303" NO="1" P_CHI2="0.9740936450332154" P_Z="1.2048045156949477E-24" STUDIES="3" TAU2="0.0" TOTAL_1="762" TOTAL_2="624" WEIGHT="100.0" Z="10.248270091877789">
<NAME>Belching</NAME>
<DICH_DATA CI_END="4.981978889471051" CI_START="2.490066930553505" EFFECT_SIZE="3.5221386800334167" ESTIMABLE="YES" EVENTS_1="186" EVENTS_2="27" LOG_CI_END="0.6974018829343984" LOG_CI_START="0.39621102066176067" LOG_EFFECT_SIZE="0.5468064517980795" ORDER="113832" O_E="0.0" SE="0.17692100341776087" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="136" VAR="0.03130104145034735" WEIGHT="48.735080107596"/>
<DICH_DATA CI_END="59.460253109101" CI_START="0.10511223335245733" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7742267535680767" LOG_CI_START="-0.9783467362240015" LOG_EFFECT_SIZE="0.3979400086720376" ORDER="113833" O_E="0.0" SE="1.6168752933623898" STUDY_ID="STD-England-1995" TOTAL_1="41" TOTAL_2="34" VAR="2.6142857142857143" WEIGHT="0.7439622618384442"/>
<DICH_DATA CI_END="5.040615828578378" CI_START="2.552143837387665" EFFECT_SIZE="3.586694386694387" ESTIMABLE="YES" EVENTS_1="133" EVENTS_2="37" LOG_CI_END="0.7024835988691448" LOG_CI_START="0.40690514733101996" LOG_EFFECT_SIZE="0.5546943731000823" ORDER="113834" O_E="0.0" SE="0.1736242455704268" STUDY_ID="STD-Europe-2000" TOTAL_1="455" TOTAL_2="454" VAR="0.030145378649899867" WEIGHT="50.52095763056556"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3651780874458797" CI_END="9.443103883412865" CI_START="4.034331722881917" DF="2.0" EFFECT_SIZE="6.172245422803759" ESTIMABLE="YES" EVENTS_1="193" EVENTS_2="22" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.9751147673780818" LOG_CI_START="0.6057716052039868" LOG_EFFECT_SIZE="0.7904431862910344" NO="2" P_CHI2="0.5053070833747456" P_Z="4.8961136314615446E-17" STUDIES="3" TAU2="0.0" TOTAL_1="743" TOTAL_2="611" WEIGHT="100.0" Z="8.38916398417175">
<NAME>Unpleasant taste</NAME>
<DICH_DATA CI_END="10.570452287370253" CI_START="3.1021087489278467" EFFECT_SIZE="5.726315789473684" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="10" LOG_CI_END="1.0240935702503544" LOG_CI_START="0.49165701856831" LOG_EFFECT_SIZE="0.7578752944093321" ORDER="113835" O_E="0.0" SE="0.3127558660614701" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="136" VAR="0.09781623175586024" WEIGHT="52.17670545507431"/>
<DICH_DATA CI_END="13.063503632645492" CI_START="0.6448616333868937" EFFECT_SIZE="2.902439024390244" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.116059670373862" LOG_CI_START="-0.1905334610282713" LOG_EFFECT_SIZE="0.46276310467279524" ORDER="113836" O_E="0.0" SE="0.7674992731259238" STUDY_ID="STD-England-1995" TOTAL_1="41" TOTAL_2="34" VAR="0.5890551342488214" WEIGHT="8.62131788782491"/>
<DICH_DATA CI_END="14.29380496897461" CI_START="3.9194018002061477" EFFECT_SIZE="7.484862385321101" ESTIMABLE="YES" EVENTS_1="74" EVENTS_2="10" LOG_CI_END="1.1551478520987168" LOG_CI_START="0.5932197877617406" LOG_EFFECT_SIZE="0.8741838199302288" ORDER="113837" O_E="0.0" SE="0.3300793265803192" STUDY_ID="STD-Europe-2000" TOTAL_1="436" TOTAL_2="441" VAR="0.10895236183571702" WEIGHT="39.20197665710078"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.199086494220725" CI_END="1.6002525906231777" CI_START="0.7448249504442199" DF="2.0" EFFECT_SIZE="1.0917454174436194" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="48" I2="61.53170365172443" ID="CMP-001.09.03" LOG_CI_END="0.2041885389407479" LOG_CI_START="-0.12794578361270728" LOG_EFFECT_SIZE="0.038121377664020316" NO="3" P_CHI2="0.0743076238931154" P_Z="0.6527699072955947" STUDIES="3" TAU2="0.0" TOTAL_1="724" TOTAL_2="628" WEIGHT="100.0" Z="0.4499175314861008">
<NAME>Nausea</NAME>
<DICH_DATA CI_END="4.560830814430403" CI_START="0.9170448238689168" EFFECT_SIZE="2.045112781954887" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="7" LOG_CI_END="0.6590439622382871" LOG_CI_START="-0.037609436104061346" LOG_EFFECT_SIZE="0.3107172630671129" ORDER="113838" O_E="0.0" SE="0.40921765467623383" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="136" VAR="0.16745908889871736" WEIGHT="19.107178458759922"/>
<DICH_DATA CI_END="28.29575596085829" CI_START="0.388855997882106" EFFECT_SIZE="3.317073170731707" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.4517213012133374" LOG_CI_START="-0.41021119791237354" LOG_EFFECT_SIZE="0.520755051650482" ORDER="113839" O_E="0.0" SE="1.0937083667009586" STUDY_ID="STD-England-1995" TOTAL_1="41" TOTAL_2="34" VAR="1.1961979913916787" WEIGHT="2.2550985704065956"/>
<DICH_DATA CI_END="1.2604123082444048" CI_START="0.5030628231186041" EFFECT_SIZE="0.7962829736211031" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="40" LOG_CI_END="0.10051263551793094" LOG_CI_START="-0.29837777631572016" LOG_EFFECT_SIZE="-0.09893257039889462" ORDER="113840" O_E="0.0" SE="0.23431020245047027" STUDY_ID="STD-Europe-2000" TOTAL_1="417" TOTAL_2="458" VAR="0.05490127097238036" WEIGHT="78.63772297083348"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.371197079430143" CI_END="1.6928300234408469" CI_START="0.5299970971335104" DF="1.0" EFFECT_SIZE="0.947203778689729" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="22" I2="0.0" ID="CMP-001.09.04" LOG_CI_END="0.22861335291833557" LOG_CI_START="-0.2757265090828914" LOG_EFFECT_SIZE="-0.02355657808227792" NO="4" P_CHI2="0.5423527610590941" P_Z="0.8547266180697182" STUDIES="2" TAU2="0.0" TOTAL_1="678" TOTAL_2="585" WEIGHT="99.99999999999999" Z="0.18309099922051378">
<NAME>Vomiting</NAME>
<DICH_DATA CI_END="3.411781665557238" CI_START="0.44132222173823404" EFFECT_SIZE="1.2270676691729323" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="5" LOG_CI_END="0.5329812310307579" LOG_CI_START="-0.35524420412924484" LOG_EFFECT_SIZE="0.08886851345075654" ORDER="113841" O_E="0.0" SE="0.5217480173998001" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="136" VAR="0.27222099366062213" WEIGHT="28.912036090243788"/>
<DICH_DATA CI_END="1.6944752779023884" CI_START="0.4098754201495225" EFFECT_SIZE="0.8333809251856082" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.22903523693917072" LOG_CI_START="-0.3873481251416679" LOG_EFFECT_SIZE="-0.07915644410124857" ORDER="113842" O_E="0.0" SE="0.3620666380331352" STUDY_ID="STD-Europe-2000" TOTAL_1="412" TOTAL_2="449" VAR="0.13109225037661734" WEIGHT="71.0879639097562"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5258500437119024" CI_END="4.408519311760562" CI_START="0.5435795040599746" DF="1.0" EFFECT_SIZE="1.548024786986832" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="4" I2="0.0" ID="CMP-001.09.05" LOG_CI_END="0.6442927475832508" LOG_CI_START="-0.264736926923844" LOG_EFFECT_SIZE="0.1897779103297034" NO="5" P_CHI2="0.4683569040597051" P_Z="0.4131502721903517" STUDIES="2" TAU2="0.0" TOTAL_1="307" TOTAL_2="170" WEIGHT="100.0" Z="0.8183624357679591">
<NAME>Stomach pain</NAME>
<DICH_DATA CI_END="4.000518144009439" CI_START="0.408393025247311" EFFECT_SIZE="1.2781954887218046" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="4" LOG_CI_END="0.602116244455671" LOG_CI_START="-0.38892168363329477" LOG_EFFECT_SIZE="0.10659728041118814" ORDER="113843" O_E="0.0" SE="0.5821405846763209" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="136" VAR="0.3388876603272888" WEIGHT="90.6584043377227"/>
<DICH_DATA CI_END="83.94499751422745" CI_START="0.20681531508972484" EFFECT_SIZE="4.166666666666667" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9239948205848556" LOG_CI_START="-0.6844173040080674" LOG_EFFECT_SIZE="0.619788758288394" ORDER="113844" O_E="0.0" SE="1.5321941938341392" STUDY_ID="STD-England-1995" TOTAL_1="41" TOTAL_2="34" VAR="2.3476190476190477" WEIGHT="9.341595662277305"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.966997591616483E-4" CI_END="1.1195035374654771" CI_START="0.418627553678179" DF="1.0" EFFECT_SIZE="0.6845838350583808" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="29" I2="0.0" ID="CMP-001.09.06" LOG_CI_END="0.04902547022349874" LOG_CI_START="-0.37817219019568016" LOG_EFFECT_SIZE="-0.16457335998609066" NO="6" P_CHI2="0.9805116624348004" P_Z="0.13101520429725413" STUDIES="2" TAU2="0.0" TOTAL_1="673" TOTAL_2="578" WEIGHT="99.99999999999999" Z="1.5101106034662257">
<NAME>Diarrhoea</NAME>
<DICH_DATA CI_END="1.211648701515265" CI_START="0.3835440903039084" EFFECT_SIZE="0.681704260651629" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="18" LOG_CI_END="0.08337672122590743" LOG_CI_START="-0.41618470453100653" LOG_EFFECT_SIZE="-0.16640399165254954" ORDER="113845" O_E="0.0" SE="0.29344485435855067" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="136" VAR="0.08610988254951102" WEIGHT="69.31243292571263"/>
<DICH_DATA CI_END="1.7656651228605598" CI_START="0.2704942835658396" EFFECT_SIZE="0.6910877819968729" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.24690833849150642" LOG_CI_START="-0.5678419085316992" LOG_EFFECT_SIZE="-0.16046678502009631" ORDER="113846" O_E="0.0" SE="0.4785883281801984" STUDY_ID="STD-Europe-2000" TOTAL_1="407" TOTAL_2="442" VAR="0.2290467878703173" WEIGHT="30.68756707428736"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.1503013716545705" CI_START="0.08164928013340884" DF="0.0" EFFECT_SIZE="0.4190114068441065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-001.09.07" LOG_CI_END="0.33249933195013714" LOG_CI_START="-1.0880476398981205" LOG_EFFECT_SIZE="-0.3777741539739916" NO="7" P_CHI2="1.0" P_Z="0.297203671036364" STUDIES="1" TAU2="0.0" TOTAL_1="526" TOTAL_2="551" WEIGHT="100.0" Z="1.042448790152649">
<NAME>Constipation</NAME>
<DICH_DATA CI_END="2.15030137165457" CI_START="0.08164928013340889" EFFECT_SIZE="0.4190114068441065" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.33249933195013703" LOG_CI_START="-1.0880476398981203" LOG_EFFECT_SIZE="-0.3777741539739916" ORDER="113847" O_E="0.0" SE="0.8344363230845847" STUDY_ID="STD-Europe-2000" TOTAL_1="526" TOTAL_2="551" VAR="0.6962839772829215" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.003537833595038564" CI_END="1.24063916416138" CI_START="0.7108695227197531" DF="1.0" EFFECT_SIZE="0.9391126505882208" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="91" I2="0.0" ID="CMP-001.09.08" LOG_CI_END="0.09364548673601569" LOG_CI_START="-0.14821010498454654" LOG_EFFECT_SIZE="-0.027282309124265425" NO="8" P_CHI2="0.9525700809284987" P_Z="0.6583560237253625" STUDIES="2" TAU2="0.0" TOTAL_1="747" TOTAL_2="759" WEIGHT="100.0" Z="0.4421840563473943">
<NAME>Nasal bleeding</NAME>
<DICH_DATA CI_END="1.5712875009412541" CI_START="0.5463606098214029" EFFECT_SIZE="0.9265471370734528" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.19625565585391996" LOG_CI_START="-0.2625206189053274" LOG_EFFECT_SIZE="-0.03313248152570373" ORDER="113848" O_E="0.0" SE="0.26948745477276786" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.0726234882799046" WEIGHT="28.765529999705475"/>
<DICH_DATA CI_END="1.310200860690182" CI_START="0.6804213932390019" EFFECT_SIZE="0.9441867903406365" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="65" LOG_CI_END="0.11733788039043629" LOG_CI_START="-0.16722204012180303" LOG_EFFECT_SIZE="-0.0249420798656834" ORDER="113849" O_E="0.0" SE="0.16715190590321344" STUDY_ID="STD-Europe-2000" TOTAL_1="481" TOTAL_2="492" VAR="0.027939759647076717" WEIGHT="71.23447000029452"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.1853075982175705" CI_END="1.406125830413231" CI_START="0.795045656207882" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.057324091067512" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="76" I2="28.320680628644038" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.1480241862662533" LOG_CI_START="-0.09960793087836026" LOG_EFFECT_SIZE="0.02420812769394652" METHOD="MH" NO="10" P_CHI2="0.24213712897065143" P_Q="0.0" P_Z="0.7015670192627922" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="553" TOTAL_2="566" WEIGHT="100.0" Z="0.3832060151193835">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.5154242778307463" CI_START="0.42550530876246173" EFFECT_SIZE="0.8030075187969925" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="20" LOG_CI_END="0.1805342405770414" LOG_CI_START="-0.37109501712613774" LOG_EFFECT_SIZE="-0.09528038827454817" ORDER="113850" O_E="0.0" SE="0.32402975658371175" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.10499528315169948" WEIGHT="26.627463777190908"/>
<DICH_DATA CI_END="2.3559270611403447" CI_START="0.9761131854765173" EFFECT_SIZE="1.5164601769911505" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="25" LOG_CI_END="0.37216184068441277" LOG_CI_START="-0.010499820675691367" LOG_EFFECT_SIZE="0.18083101000436072" ORDER="113851" O_E="0.0" SE="0.2247773540886983" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.05052485891111606" WEIGHT="32.48447457213409"/>
<DICH_DATA CI_END="1.70359383064259" CI_START="0.3525634979397913" EFFECT_SIZE="0.775" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.23136605866002807" LOG_CI_START="-0.45276265364740753" LOG_EFFECT_SIZE="-0.1106982974936897" ORDER="113852" O_E="0.0" SE="0.40186059210113023" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.16149193548387097" WEIGHT="13.550484013121139"/>
<DICH_DATA CI_END="1.6161764622554333" CI_START="0.5005108440421391" EFFECT_SIZE="0.8993963782696177" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="21" LOG_CI_END="0.20848877747808667" LOG_CI_START="-0.30058650868087794" LOG_EFFECT_SIZE="-0.046048865601395636" ORDER="113853" O_E="0.0" SE="0.2990333430530837" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.08942094025750325" WEIGHT="27.337577637553863"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.11" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of labour (hours)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.5736653520014424" CI_END="36.245713525845524" CI_START="-9.852727043913385" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="13.196493240966069" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.12" NO="12" P_CHI2="0.44880619264773736" P_Q="1.0" P_Z="0.2617992589677386" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="991" TOTAL_2="1018" UNITS="" WEIGHT="100.00000000000001" Z="1.1221486520950668">
<NAME>Blood loss at delivery (mls)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_DATA CI_END="66.36082629786205" CI_START="-14.360826297862054" EFFECT_SIZE="26.0" ESTIMABLE="YES" MEAN_1="316.0" MEAN_2="290.0" ORDER="113854" SD_1="260.0" SD_2="213.0" SE="20.592636709767678" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="32.61312232087404"/>
<CONT_DATA CI_END="35.078155280391464" CI_START="-21.078155280391464" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="351.7" MEAN_2="344.7" ORDER="113855" SD_1="282.7" SD_2="267.1" SE="14.325852669675754" STUDY_ID="STD-Europe-2000" TOTAL_1="725" TOTAL_2="751" WEIGHT="67.38687767912597"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.414710590741545" CI_START="0.4877466405528825" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2905477980665951" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.5333539015255737" LOG_CI_START="-0.31180571320842104" LOG_EFFECT_SIZE="0.1107740941585763" METHOD="MH" NO="13" P_CHI2="1.0" P_Q="0.0" P_Z="0.6074055140836194" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="266" TOTAL_2="267" WEIGHT="100.0" Z="0.513780429603685">
<NAME>Vaginal blood loss after delivery</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.414710590741544" CI_START="0.4877466405528825" EFFECT_SIZE="1.2905477980665951" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.5333539015255735" LOG_CI_START="-0.31180571320842104" LOG_EFFECT_SIZE="0.1107740941585763" ORDER="113856" O_E="0.0" SE="0.49645094130231376" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.2464635371199534" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.4469447806362226" CI_START="0.19647447320876396" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6933701657458563" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.3886241688877224" LOG_CI_START="-0.7066938669919776" LOG_EFFECT_SIZE="-0.15903484905212759" METHOD="MH" NO="14" P_CHI2="1.0" P_Q="0.0" P_Z="0.569251320584203" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="724" TOTAL_2="753" WEIGHT="100.0" Z="0.5691544669555112">
<NAME>Miscarriage (&lt; 24 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4469447806362226" CI_START="0.19647447320876396" EFFECT_SIZE="0.6933701657458563" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3886241688877224" LOG_CI_START="-0.7066938669919776" LOG_EFFECT_SIZE="-0.15903484905212759" ORDER="113857" O_E="0.0" SE="0.6433952361874569" STUDY_ID="STD-Europe-2000" TOTAL_1="724" TOTAL_2="753" VAR="0.4139574299487134" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4166850507132294" CI_END="1.5744851907318815" CI_START="0.4566383365822244" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8479211628855319" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.19713858011154534" LOG_CI_START="-0.3404276305873392" LOG_EFFECT_SIZE="-0.07164452523789694" METHOD="MH" NO="15" P_CHI2="0.7016286034182193" P_Q="0.0" P_Z="0.601370116535675" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1378" TOTAL_2="1424" WEIGHT="100.00000000000001" Z="0.5224312330687205">
<NAME>Stillbirth (= or &gt; 24 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.964295586063871" CI_START="0.06311164339434223" EFFECT_SIZE="1.0037593984962405" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.203149760342757" LOG_CI_START="-1.1998905108757405" LOG_EFFECT_SIZE="0.0016296247335081983" ORDER="113858" O_E="0.0" SE="1.411557750554932" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="1.9924952831516995" WEIGHT="4.625875357518557"/>
<DICH_DATA CI_END="4.337849891608346" CI_START="0.010217349780966297" EFFECT_SIZE="0.21052631578947367" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6372745194683728" LOG_CI_START="-1.9906617387181058" LOG_EFFECT_SIZE="-0.6766936096248666" ORDER="113859" O_E="0.0" SE="1.543662766553014" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.3828947368421054" WEIGHT="11.289338670134573"/>
<DICH_DATA CI_END="1.712088275221757" CI_START="0.4398629147161884" EFFECT_SIZE="0.8678042054463978" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.23352615312930158" LOG_CI_START="-0.3566826522833186" LOG_EFFECT_SIZE="-0.06157824957700849" ORDER="113860" O_E="0.0" SE="0.34669157388007854" STUDY_ID="STD-Europe-2000" TOTAL_1="967" TOTAL_2="1007" VAR="0.12019504739944598" WEIGHT="81.73185012320305"/>
<DICH_DATA CI_END="68.80620475148235" CI_START="0.12299486576714651" EFFECT_SIZE="2.909090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8376276034655539" LOG_CI_START="-0.9101130171421922" LOG_EFFECT_SIZE="0.4637572931616809" ORDER="113861" O_E="0.0" SE="1.6140364420804247" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="2.6051136363636362" WEIGHT="2.3529358491438375"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9488592829346223" CI_END="3.290427305349286" CI_START="0.4146099552938908" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1680085264965598" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.5172523004742884" LOG_CI_START="-0.382360274173428" LOG_EFFECT_SIZE="0.06744601315043018" METHOD="MH" NO="16" P_CHI2="0.37740763780856135" P_Q="0.0" P_Z="0.7688450403162719" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1136" TOTAL_2="1167" WEIGHT="100.0" Z="0.2938859691404906">
<NAME>Neonatal death</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="76.72531804581301" CI_START="0.12997403494659443" EFFECT_SIZE="3.1578947368421053" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.884938697367859" LOG_CI_START="-0.8861433985062295" LOG_EFFECT_SIZE="0.49939764943081466" ORDER="113862" O_E="0.0" SE="1.62774734019404" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.649561403508772" WEIGHT="7.499737431683094"/>
<DICH_DATA CI_END="7.13778676811069" CI_START="0.40985338496859014" EFFECT_SIZE="1.710393541876892" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.853563569843218" LOG_CI_START="-0.3873714737355668" LOG_EFFECT_SIZE="0.2330960480538256" ORDER="113863" O_E="0.0" SE="0.7289313873257125" STUDY_ID="STD-Europe-2000" TOTAL_1="991" TOTAL_2="1017" VAR="0.5313409674285879" WEIGHT="45.584611867863266"/>
<DICH_DATA CI_END="2.9395435041096536" CI_START="0.035473254083611405" EFFECT_SIZE="0.3229166666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.46827989196342445" LOG_CI_START="-1.4500989703740157" LOG_EFFECT_SIZE="-0.4909095392052957" ORDER="113864" O_E="0.0" SE="1.1268652398655326" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="1.2698252688172043" WEIGHT="46.91565070045364"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.06535857756614506" CI_END="4.074134016120352" CI_START="1.0337746326084662" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.553954324364409" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.17" NO="17" P_CHI2="0.9678489101238875" P_Q="1.0" P_Z="9.919250158293325E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="802" TOTAL_2="819" UNITS="" WEIGHT="100.0" Z="3.2928071076469836">
<NAME>Length of gestation (days)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.688976919437192" CI_START="0.7110230805627846" EFFECT_SIZE="2.6999999999999886" ESTIMABLE="YES" MEAN_1="283.3" MEAN_2="280.6" ORDER="113865" SD_1="11.1" SD_2="12.3" SE="1.0148027898094047" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="58.41580500401551"/>
<CONT_DATA CI_END="5.520539578899012" CI_START="-1.120539578899034" EFFECT_SIZE="2.1999999999999886" ESTIMABLE="YES" MEAN_1="258.5" MEAN_2="256.3" ORDER="113866" SD_1="22.8" SD_2="25.0" SE="1.6941839774052048" STUDY_ID="STD-Europe-2000" TOTAL_1="394" TOTAL_2="403" WEIGHT="20.959095214537687"/>
<CONT_DATA CI_END="5.847317417244364" CI_START="-0.8473174172443643" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="274.1" MEAN_2="271.6" ORDER="113867" SD_1="13.5" SD_2="15.6" SE="1.7078463908763513" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="20.62509978144681"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.268922351883363" CI_END="1.0742530556494725" CI_START="0.7893805154196193" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9208661307484827" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="228" I2="0.0" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.031106597682742917" LOG_CI_START="-0.10271359766456811" LOG_EFFECT_SIZE="-0.0358034999909126" METHOD="MH" NO="18" P_CHI2="0.6864328415724347" P_Q="0.0" P_Z="0.2942821637193118" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="947" TOTAL_2="969" WEIGHT="100.00000000000001" Z="1.0487739958911797">
<NAME>Preterm birth (&lt; 37 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.352141093422313" CI_START="0.26825000481791217" EFFECT_SIZE="0.6022556390977444" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.13102201179615602" LOG_CI_START="-0.5714602615618523" LOG_EFFECT_SIZE="-0.22021912488284812" ORDER="113868" O_E="0.0" SE="0.4126415647138291" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.17027306092947722" WEIGHT="6.643987591724067"/>
<DICH_DATA CI_END="2.128846018088149" CI_START="0.6984429628920461" EFFECT_SIZE="1.2193758733115976" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="19" LOG_CI_END="0.32814424954866056" LOG_CI_START="-0.155869053991684" LOG_EFFECT_SIZE="0.08613759777848831" ORDER="113869" O_E="0.0" SE="0.28431181040409165" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.08083320553525217" WEIGHT="8.213479652338851"/>
<DICH_DATA CI_END="1.1037870022344882" CI_START="0.7852114186608694" EFFECT_SIZE="0.9309705462172102" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="167" LOG_CI_END="0.042885275676812655" LOG_CI_START="-0.10501339345136351" LOG_EFFECT_SIZE="-0.031064058887275425" ORDER="113870" O_E="0.0" SE="0.08687641035611014" STUDY_ID="STD-Europe-2000" TOTAL_1="394" TOTAL_2="403" VAR="0.007547510676363243" WEIGHT="73.27190747685357"/>
<DICH_DATA CI_END="1.70359383064259" CI_START="0.3525634979397913" EFFECT_SIZE="0.775" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.23136605866002807" LOG_CI_START="-0.45276265364740753" LOG_EFFECT_SIZE="-0.1106982974936897" ORDER="113871" O_E="0.0" SE="0.40186059210113023" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.16149193548387097" WEIGHT="4.50808976267835"/>
<DICH_DATA CI_END="1.6869725706932552" CI_START="0.4426353098063892" EFFECT_SIZE="0.8641259320629661" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.22710802124152246" LOG_CI_START="-0.3539539445831591" LOG_EFFECT_SIZE="-0.06342296167081833" ORDER="113872" O_E="0.0" SE="0.3413186750285372" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.11649843792323619" WEIGHT="7.362535516405165"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3236624280413018" CI_END="0.9898173321043305" CI_START="0.4871649593993803" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6944093320278819" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="66" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="-0.004444945785149854" LOG_CI_START="-0.3123239570064894" LOG_EFFECT_SIZE="-0.1583844513958196" METHOD="MH" NO="19" P_CHI2="0.5694150635619334" P_Q="0.0" P_Z="0.04374174192781081" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="426" TOTAL_2="434" WEIGHT="99.99999999999999" Z="2.0165572132734266">
<NAME>Early preterm birth (&lt; 34 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0355897730138979" CI_START="0.49502368156847676" EFFECT_SIZE="0.715989847715736" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="60" LOG_CI_END="0.015187752900762427" LOG_CI_START="-0.3053740242411781" LOG_EFFECT_SIZE="-0.14509313567020785" ORDER="113873" O_E="0.0" SE="0.18829957469956443" STUDY_ID="STD-Europe-2000" TOTAL_1="394" TOTAL_2="403" VAR="0.03545672983203685" WEIGHT="90.68258537797196"/>
<DICH_DATA CI_END="1.768274192396508" CI_START="0.13268255660454173" EFFECT_SIZE="0.484375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.24754960853445623" LOG_CI_START="-0.8771861688336853" LOG_EFFECT_SIZE="-0.3148182801496145" ORDER="113874" O_E="0.0" SE="0.6606753631579363" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.436491935483871" WEIGHT="9.317414622028025"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.035503792483688" CI_END="3.655891262449265" CI_START="0.7692182789856509" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6769550933343154" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="36" I2="67.05653926454866" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="0.5629932699883395" LOG_CI_START="-0.11395040414198064" LOG_EFFECT_SIZE="0.22452143292317947" METHOD="MH" NO="20" P_CHI2="0.0814614793248627" P_Q="0.0" P_Z="0.19355992746312423" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.21636109972250805" TOTALS="YES" TOTAL_1="972" TOTAL_2="998" WEIGHT="100.0" Z="1.3001197562030586">
<NAME>Prolonged gestation (&gt; 42 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9287310367870647" CI_START="0.7337700961376807" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" ORDER="113875" O_E="0.0" SE="0.24654070696081104" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.060782320188736506" WEIGHT="57.05263413103196"/>
<DICH_DATA CI_END="5.6786416994533" CI_START="1.2329672406137822" EFFECT_SIZE="2.6460497324519987" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="9" LOG_CI_END="0.7542444672290968" LOG_CI_START="0.09095153773955264" LOG_EFFECT_SIZE="0.4225980024843247" ORDER="113876" O_E="0.0" SE="0.38962155013511246" STUDY_ID="STD-Europe-2000" TOTAL_1="706" TOTAL_2="731" VAR="0.15180495232968794" WEIGHT="42.94736586896804"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3370764439231337" CI_START="0.9564984625768858" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.130889721838627" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" I2="0.0" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.1261562376471265" LOG_CI_START="-0.019315723697230527" LOG_EFFECT_SIZE="0.05342025697494797" METHOD="MH" NO="21" P_CHI2="1.0" P_Q="0.0" P_Z="0.15001538896427305" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="685" TOTAL_2="689" WEIGHT="100.00000000000001" Z="1.4394771163898126">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3370764439231337" CI_START="0.9564984625768858" EFFECT_SIZE="1.130889721838627" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" LOG_CI_END="0.1261562376471265" LOG_CI_START="-0.019315723697230527" LOG_EFFECT_SIZE="0.05342025697494797" ORDER="113877" O_E="0.0" SE="0.08545095019149757" STUDY_ID="STD-Europe-2000" TOTAL_1="685" TOTAL_2="689" VAR="0.007301864888629798" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.7035240548361792" CI_END="1.1244124778612503" CI_START="0.8816331499551711" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9956501969596114" ESTIMABLE="YES" EVENTS_1="342" EVENTS_2="352" I2="0.0" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="0.050925656426881696" LOG_CI_START="-0.05471208844245168" LOG_EFFECT_SIZE="-0.001893216007785013" METHOD="MH" NO="22" P_CHI2="0.7900774013234109" P_Q="0.0" P_Z="0.9439930297936968" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1136" TOTAL_2="1166" WEIGHT="100.0" Z="0.07025207126114115">
<NAME>Low birthweight (&lt; 2500 g)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="113878" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="1.4382031869776983"/>
<DICH_DATA CI_END="1.481054656313895" CI_START="0.6656680934423176" EFFECT_SIZE="0.9929203539823008" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.17057108586592873" LOG_CI_START="-0.17674225899248308" LOG_EFFECT_SIZE="-0.003085586563277145" ORDER="113879" O_E="0.0" SE="0.2040135779986155" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.041621540007797164" WEIGHT="9.807057938787581"/>
<DICH_DATA CI_END="1.1506629114666558" CI_START="0.8835100968094521" EFFECT_SIZE="1.0082768966434523" ESTIMABLE="YES" EVENTS_1="283" EVENTS_2="287" LOG_CI_END="0.060948115001402646" LOG_CI_START="-0.05378848298395868" LOG_EFFECT_SIZE="0.0035798160087219732" ORDER="113880" O_E="0.0" SE="0.06739684561192112" STUDY_ID="STD-Europe-2000" TOTAL_1="799" TOTAL_2="817" VAR="0.004542334798437132" WEIGHT="81.63333846916262"/>
<DICH_DATA CI_END="2.4555876018543237" CI_START="0.570910920665477" EFFECT_SIZE="1.1840277777777777" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.390155431981494" LOG_CI_START="-0.24343164951496027" LOG_EFFECT_SIZE="0.07336189123326683" ORDER="113881" O_E="0.0" SE="0.37217218797765234" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.13851213750407299" WEIGHT="2.6298572561877913"/>
<DICH_DATA CI_END="1.7079346013994083" CI_START="0.4255703380041483" EFFECT_SIZE="0.8525528169014085" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.23247123708183273" LOG_CI_START="-0.3710286497215737" LOG_EFFECT_SIZE="-0.06927870631987043" ORDER="113882" O_E="0.0" SE="0.35449882088094037" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.12566941400597703" WEIGHT="4.491543148884303"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="23" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Very low birthweight (&lt; 1500 g)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.2385195684063732" CI_END="93.43922940246483" CI_START="1.0494738805176596" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="47.24435164149125" ESTIMABLE="YES" I2="38.24338690088046" I2_Q="0.0" ID="CMP-001.24" NO="24" P_CHI2="0.1980453943045628" P_Q="1.0" P_Z="0.04501746462788027" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1207" TOTAL_2="1233" UNITS="" WEIGHT="99.99999999999999" Z="2.004491237521939">
<NAME>Birthweight (gm)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_DATA CI_END="184.97446927698533" CI_START="7.025530723014668" EFFECT_SIZE="96.0" ESTIMABLE="YES" MEAN_1="3571.0" MEAN_2="3475.0" ORDER="113883" SD_1="528.0" SD_2="520.0" SE="45.3959715478471" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="26.956085930231694"/>
<CONT_DATA CI_END="72.13455701131316" CI_START="-47.85455701131251" EFFECT_SIZE="12.140000000000327" ESTIMABLE="YES" MEAN_1="2668.34" MEAN_2="2656.2" ORDER="113884" SD_1="629.34" SD_2="600.43" SE="30.610030329405152" STUDY_ID="STD-Europe-2000" TOTAL_1="799" TOTAL_2="817" WEIGHT="59.28760988707101"/>
<CONT_DATA CI_END="227.5497720394755" CI_START="-21.549772039475485" EFFECT_SIZE="103.0" ESTIMABLE="YES" MEAN_1="3209.0" MEAN_2="3106.0" ORDER="113885" SD_1="533.0" SD_2="551.0" SE="63.54696975143839" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="13.756304182697292"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.5358331658688754" CI_END="0.8325681577005322" CI_START="0.12525171770967525" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.4789099377051037" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.25" NO="25" P_CHI2="0.4641648275621326" P_Q="1.0" P_Z="0.007951895879284502" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="408" TOTAL_2="416" UNITS="" WEIGHT="100.0" Z="2.6541055082855354">
<NAME>Birth length (cm)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.8119644807028854" CI_START="-0.011964480702888303" EFFECT_SIZE="0.3999999999999986" ESTIMABLE="YES" MEAN_1="52.1" MEAN_2="51.7" ORDER="113886" SD_1="2.5" SD_2="2.35" SE="0.21018982182958978" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="73.69668743163139"/>
<CONT_DATA CI_END="1.3895702774683074" CI_START="0.01042972253168395" EFFECT_SIZE="0.6999999999999957" ESTIMABLE="YES" MEAN_1="50.3" MEAN_2="49.6" ORDER="113887" SD_1="3.0" SD_2="3.0" SE="0.35182803505960014" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="26.30331256836861"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.4947182980977805" CI_START="0.1453919086181393" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6022556390977444" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.26" LOG_CI_END="0.39702151248895584" LOG_CI_START="-0.8374597622546521" LOG_EFFECT_SIZE="-0.22021912488284812" METHOD="MH" NO="26" P_CHI2="1.0" P_Q="0.0" P_Z="0.4843795782027005" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="266" TOTAL_2="267" WEIGHT="100.00000000000001" Z="0.6992759830511892">
<NAME>Congenital malformation</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4947182980977805" CI_START="0.1453919086181393" EFFECT_SIZE="0.6022556390977444" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.39702151248895584" LOG_CI_START="-0.8374597622546521" LOG_EFFECT_SIZE="-0.22021912488284812" ORDER="113888" O_E="0.0" SE="0.7251404115652587" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.5258286164850328" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.1735853917533266" CI_END="1.085826666045559" CI_START="0.8080077598081634" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9366730336523194" ESTIMABLE="YES" EVENTS_1="255" EVENTS_2="280" I2="0.0" I2_Q="0.0" ID="CMP-001.27" LOG_CI_END="0.03576050298022059" LOG_CI_START="-0.09258446840154796" LOG_EFFECT_SIZE="-0.02841198271066369" METHOD="MH" NO="27" P_CHI2="0.6769451153548389" P_Q="0.0" P_Z="0.38552448949659424" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1114" TOTAL_2="1147" WEIGHT="99.99999999999999" Z="0.8677622853899494">
<NAME>Baby admitted to neonatal care</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0811388688322252" CI_START="0.7959380341664227" EFFECT_SIZE="0.9276419276419277" ESTIMABLE="YES" EVENTS_1="234" EVENTS_2="259" LOG_CI_END="0.033881481274371045" LOG_CI_START="-0.09912074189439597" LOG_EFFECT_SIZE="-0.03261963031001245" ORDER="113889" O_E="0.0" SE="0.07812616426095655" STUDY_ID="STD-Europe-2000" TOTAL_1="972" TOTAL_2="998" VAR="0.006103697542129963" WEIGHT="92.57639093817603"/>
<DICH_DATA CI_END="1.8360202828395813" CI_START="0.5996783548551404" EFFECT_SIZE="1.0492957746478873" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.26387747461939115" LOG_CI_START="-0.2220816265609561" LOG_EFFECT_SIZE="0.02089792402921753" ORDER="113890" O_E="0.0" SE="0.2854547815696828" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.08148443232099531" WEIGHT="7.423609061823955"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.9932681769100116" CI_START="-1.6332681769100121" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.3200000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.28" NO="28" P_CHI2="1.0" P_Q="1.0" P_Z="0.6329503307505668" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="972" TOTAL_2="998" UNITS="" WEIGHT="99.99999999999999" Z="0.4775783698105968">
<NAME>Baby's length of stay in hospital (days)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.9932681769100116" CI_START="-1.6332681769100121" EFFECT_SIZE="-0.3200000000000003" ESTIMABLE="YES" MEAN_1="7.22" MEAN_2="7.54" ORDER="113891" SD_1="9.6" SD_2="18.8" SE="0.6700470964103951" STUDY_ID="STD-Europe-2000" TOTAL_1="972" TOTAL_2="998" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="9.21873337153036" CI_START="0.6200176623444367" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.390769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.29" LOG_CI_END="0.964671254291844" LOG_CI_START="-0.20759593864776407" LOG_EFFECT_SIZE="0.37853765782203996" METHOD="MH" NO="29" P_CHI2="1.0" P_Q="0.0" P_Z="0.20558944319166828" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="975" TOTAL_2="999" WEIGHT="100.0" Z="1.2657868113887696">
<NAME>Neonatal morbidity - bleeding disorders (eg IVH)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.21873337153036" CI_START="0.6200176623444367" EFFECT_SIZE="2.390769230769231" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.964671254291844" LOG_CI_START="-0.20759593864776407" LOG_EFFECT_SIZE="0.37853765782203996" ORDER="113892" O_E="0.0" SE="0.6885955519489174" STUDY_ID="STD-Europe-2000" TOTAL_1="975" TOTAL_2="999" VAR="0.4741638341638342" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="59.46025310910105" CI_START="0.10511223335245728" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.30" LOG_CI_END="1.7742267535680771" LOG_CI_START="-0.9783467362240017" LOG_EFFECT_SIZE="0.3979400086720376" METHOD="MH" NO="30" P_CHI2="1.0" P_Q="0.0" P_Z="0.5709148702167072" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="41" TOTAL_2="34" WEIGHT="100.0" Z="0.5667046405098275">
<NAME>Neonatal morbidity - non-bleeding disorders (eg RDS)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<DICH_DATA CI_END="59.460253109101" CI_START="0.10511223335245733" EFFECT_SIZE="2.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7742267535680767" LOG_CI_START="-0.9783467362240015" LOG_EFFECT_SIZE="0.3979400086720376" ORDER="113893" O_E="0.0" SE="1.6168752933623898" STUDY_ID="STD-England-1995" TOTAL_1="41" TOTAL_2="34" VAR="2.6142857142857143" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.31" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="31" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Childhood disability</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Prostaglandin precursor supplementation versus none or placebo - subgroups by gestation at trial entry</NAME>
<DICH_OUTCOME CHI2="4.246022002591105" CI_END="1.2738959558661587" CI_START="0.5862846497319659" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8642138880392739" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="51" I2="29.345632260754392" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.1051339588954047" LOG_CI_START="-0.23189147648546488" LOG_EFFECT_SIZE="-0.06337875879503013" METHOD="MH" NO="1" P_CHI2="0.23609456921009175" P_Q="0.0" P_Z="0.4610277684489331" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="827" TOTAL_2="856" WEIGHT="100.0" Z="0.7371555472228986">
<NAME>Pre-eclampsia (hypertension with proteinuria)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9659813518147353" CI_START="0.08138429179519381" DF="0.0" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" NO="1" P_CHI2="1.0" P_Z="0.25937234174702095" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="9.919528720437453" Z="1.1278759235693374">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="113894" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="9.919528720437453"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.1098198340196896" CI_END="1.3684844021446865" CI_START="0.6122345780354113" DF="2.0" EFFECT_SIZE="0.915332437147889" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="46" I2="35.687592634109585" ID="CMP-002.01.02" LOG_CI_END="0.1362398517270726" LOG_CI_START="-0.21308214578426302" LOG_EFFECT_SIZE="-0.0384211470285952" NO="2" P_CHI2="0.21120850797915913" P_Z="0.6663635757141932" STUDIES="3" TAU2="0.0" TOTAL_1="777" TOTAL_2="806" WEIGHT="90.08047127956254" Z="0.4311441303854395">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="1.6420362108565234" CI_START="0.005070828994107558" EFFECT_SIZE="0.09124957439564181" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2153827301292026" LOG_CI_START="-2.2949210351172256" LOG_EFFECT_SIZE="-1.0397691524940114" ORDER="113895" O_E="0.0" SE="1.474564857909797" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="2.17434152018254" WEIGHT="10.891086299784972"/>
<DICH_DATA CI_END="1.656028379777145" CI_START="0.4650576241579175" EFFECT_SIZE="0.8775811209439528" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.21906777512700218" LOG_CI_START="-0.33249323140402987" LOG_EFFECT_SIZE="-0.056712728138513795" ORDER="113896" O_E="0.0" SE="0.32398966550734376" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.10496930335556051" WEIGHT="34.78676106443066"/>
<DICH_DATA CI_END="1.9869890408152977" CI_START="0.66215751171156" EFFECT_SIZE="1.1470395455538562" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="23" LOG_CI_END="0.29819547177686706" LOG_CI_START="-0.17903868981955243" LOG_EFFECT_SIZE="0.05957839097865735" ORDER="113897" O_E="0.0" SE="0.28032970886893616" STUDY_ID="STD-Europe-2000" TOTAL_1="398" TOTAL_2="420" VAR="0.07858474567454249" WEIGHT="44.402623915346915"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.06535857756614506" CI_END="4.074134016120352" CI_START="1.0337746326084662" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.553954324364409" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="0.9678489101238875" P_Q="1.0" P_Z="9.919250158293325E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="802" TOTAL_2="819" UNITS="" WEIGHT="100.0" Z="3.2928071076469836">
<NAME>Length of gestation (days)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.06535857756614506" CI_END="4.074134016120352" CI_START="1.0337746326084662" DF="2.0" EFFECT_SIZE="2.553954324364409" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.02" NO="2" P_CHI2="0.9678489101238875" P_Z="9.919250158293325E-4" STUDIES="3" TAU2="0.0" TOTAL_1="802" TOTAL_2="819" WEIGHT="100.0" Z="3.2928071076469836">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<CONT_DATA CI_END="4.688976919437192" CI_START="0.7110230805627846" EFFECT_SIZE="2.6999999999999886" ESTIMABLE="YES" MEAN_1="283.3" MEAN_2="280.6" ORDER="113898" SD_1="11.1" SD_2="12.3" SE="1.0148027898094047" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="58.41580500401551"/>
<CONT_DATA CI_END="5.520539578899012" CI_START="-1.120539578899034" EFFECT_SIZE="2.1999999999999886" ESTIMABLE="YES" MEAN_1="258.5" MEAN_2="256.3" ORDER="113899" SD_1="22.8" SD_2="25.0" SE="1.6941839774052048" STUDY_ID="STD-Europe-2000" TOTAL_1="394" TOTAL_2="403" WEIGHT="20.959095214537687"/>
<CONT_DATA CI_END="5.847317417244364" CI_START="-0.8473174172443643" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="274.1" MEAN_2="271.6" ORDER="113900" SD_1="13.5" SD_2="15.6" SE="1.7078463908763513" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="20.62509978144681"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.268922351883363" CI_END="1.0742530556494725" CI_START="0.7893805154196193" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9208661307484827" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="228" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.031106597682742917" LOG_CI_START="-0.10271359766456811" LOG_EFFECT_SIZE="-0.0358034999909126" METHOD="MH" NO="3" P_CHI2="0.6864328415724347" P_Q="0.0" P_Z="0.2942821637193118" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="947" TOTAL_2="969" WEIGHT="100.00000000000001" Z="1.0487739958911797">
<NAME>Preterm birth (&lt; 37 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.70359383064259" CI_START="0.3525634979397913" DF="0.0" EFFECT_SIZE="0.775" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.23136605866002807" LOG_CI_START="-0.45276265364740753" LOG_EFFECT_SIZE="-0.1106982974936897" NO="1" P_CHI2="1.0" P_Z="0.5258979261949992" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="4.50808976267835" Z="0.6342802818661182">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="1.70359383064259" CI_START="0.3525634979397913" EFFECT_SIZE="0.775" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.23136605866002807" LOG_CI_START="-0.45276265364740753" LOG_EFFECT_SIZE="-0.1106982974936897" ORDER="113901" O_E="0.0" SE="0.40186059210113023" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.16149193548387097" WEIGHT="4.50808976267835"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.0656016173329803" CI_END="1.0855811421684558" CI_START="0.7928697150782258" DF="3.0" EFFECT_SIZE="0.9277523435084378" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="218" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.03566229050713974" LOG_CI_START="-0.10079817040137028" LOG_EFFECT_SIZE="-0.032567939947115286" NO="2" P_CHI2="0.558903120271016" P_Z="0.34951099974839617" STUDIES="4" TAU2="0.0" TOTAL_1="915" TOTAL_2="938" WEIGHT="95.49191023732166" Z="0.9355382346217558">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="1.352141093422313" CI_START="0.26825000481791217" EFFECT_SIZE="0.6022556390977444" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.13102201179615602" LOG_CI_START="-0.5714602615618523" LOG_EFFECT_SIZE="-0.22021912488284812" ORDER="113902" O_E="0.0" SE="0.4126415647138291" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.17027306092947722" WEIGHT="6.643987591724067"/>
<DICH_DATA CI_END="2.128846018088149" CI_START="0.6984429628920461" EFFECT_SIZE="1.2193758733115976" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="19" LOG_CI_END="0.32814424954866056" LOG_CI_START="-0.155869053991684" LOG_EFFECT_SIZE="0.08613759777848831" ORDER="113903" O_E="0.0" SE="0.28431181040409165" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.08083320553525217" WEIGHT="8.213479652338851"/>
<DICH_DATA CI_END="1.1037870022344882" CI_START="0.7852114186608694" EFFECT_SIZE="0.9309705462172102" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="167" LOG_CI_END="0.042885275676812655" LOG_CI_START="-0.10501339345136351" LOG_EFFECT_SIZE="-0.031064058887275425" ORDER="113904" O_E="0.0" SE="0.08687641035611014" STUDY_ID="STD-Europe-2000" TOTAL_1="394" TOTAL_2="403" VAR="0.007547510676363243" WEIGHT="73.27190747685357"/>
<DICH_DATA CI_END="1.6869725706932552" CI_START="0.4426353098063892" EFFECT_SIZE="0.8641259320629661" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.22710802124152246" LOG_CI_START="-0.3539539445831591" LOG_EFFECT_SIZE="-0.06342296167081833" ORDER="113905" O_E="0.0" SE="0.3413186750285372" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.11649843792323619" WEIGHT="7.362535516405165"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.035503792483688" CI_END="3.655891262449265" CI_START="0.7692182789856509" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6769550933343154" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="36" I2="67.05653926454866" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.5629932699883395" LOG_CI_START="-0.11395040414198064" LOG_EFFECT_SIZE="0.22452143292317947" METHOD="MH" NO="4" P_CHI2="0.0814614793248627" P_Q="0.0" P_Z="0.19355992746312423" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.21636109972250805" TOTALS="YES" TOTAL_1="972" TOTAL_2="998" WEIGHT="100.0" Z="1.3001197562030586">
<NAME>Prolonged gestation (&gt; 42 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.035503792483688" CI_END="3.655891262449265" CI_START="0.7692182789856509" DF="1.0" EFFECT_SIZE="1.6769550933343154" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="36" I2="67.05653926454866" ID="CMP-002.04.02" LOG_CI_END="0.5629932699883395" LOG_CI_START="-0.11395040414198064" LOG_EFFECT_SIZE="0.22452143292317947" NO="2" P_CHI2="0.0814614793248627" P_Z="0.19355992746312423" STUDIES="2" TAU2="0.21636109972250805" TOTAL_1="972" TOTAL_2="998" WEIGHT="100.0" Z="1.3001197562030586">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="1.9287310367870647" CI_START="0.7337700961376807" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" ORDER="113906" O_E="0.0" SE="0.24654070696081104" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.060782320188736506" WEIGHT="57.05263413103196"/>
<DICH_DATA CI_END="5.6786416994533" CI_START="1.2329672406137822" EFFECT_SIZE="2.6460497324519987" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="9" LOG_CI_END="0.7542444672290968" LOG_CI_START="0.09095153773955264" LOG_EFFECT_SIZE="0.4225980024843247" ORDER="113907" O_E="0.0" SE="0.38962155013511246" STUDY_ID="STD-Europe-2000" TOTAL_1="706" TOTAL_2="731" VAR="0.15180495232968794" WEIGHT="42.94736586896804"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.2385195684063737" CI_END="93.43922940246485" CI_START="1.0494738805176667" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="47.24435164149126" ESTIMABLE="YES" I2="38.243386900880466" I2_Q="0.0" ID="CMP-002.05" NO="5" P_CHI2="0.1980453943045628" P_Q="1.0" P_Z="0.04501746462788022" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1207" TOTAL_2="1233" UNITS="" WEIGHT="100.0" Z="2.0044912375219393">
<NAME>Birthweight (gm)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.2385195684063737" CI_END="93.43922940246485" CI_START="1.0494738805176667" DF="2.0" EFFECT_SIZE="47.24435164149126" ESTIMABLE="YES" I2="38.243386900880466" ID="CMP-002.05.02" NO="2" P_CHI2="0.1980453943045628" P_Z="0.04501746462788022" STUDIES="3" TAU2="0.0" TOTAL_1="1207" TOTAL_2="1233" WEIGHT="100.0" Z="2.0044912375219393">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<CONT_DATA CI_END="184.97446927698533" CI_START="7.025530723014668" EFFECT_SIZE="96.0" ESTIMABLE="YES" MEAN_1="3571.0" MEAN_2="3475.0" ORDER="113908" SD_1="528.0" SD_2="520.0" SE="45.3959715478471" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="26.956085930231698"/>
<CONT_DATA CI_END="72.13455701131316" CI_START="-47.85455701131251" EFFECT_SIZE="12.140000000000327" ESTIMABLE="YES" MEAN_1="2668.34" MEAN_2="2656.2" ORDER="113909" SD_1="629.34" SD_2="600.43" SE="30.610030329405152" STUDY_ID="STD-Europe-2000" TOTAL_1="799" TOTAL_2="817" WEIGHT="59.287609887071014"/>
<CONT_DATA CI_END="227.5497720394755" CI_START="-21.549772039475485" EFFECT_SIZE="103.0" ESTIMABLE="YES" MEAN_1="3209.0" MEAN_2="3106.0" ORDER="113910" SD_1="533.0" SD_2="551.0" SE="63.54696975143839" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="13.756304182697294"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.4158330908019538" CI_END="1.133919036845222" CI_START="0.8894613396482051" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0042794160814776" ESTIMABLE="YES" EVENTS_1="345" EVENTS_2="352" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.054582046526352984" LOG_CI_START="-0.05087292373782464" LOG_EFFECT_SIZE="0.0018545613942641825" METHOD="MH" NO="6" P_CHI2="0.9811601996286836" P_Q="0.0" P_Z="0.9450397834656098" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1136" TOTAL_2="1166" WEIGHT="100.0" Z="0.0689369790872897">
<NAME>Low birthweight (&lt; 2500 g)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.058157228217797494" CI_END="2.0890743225938384" CI_START="0.5993507008184811" DF="1.0" EFFECT_SIZE="1.1189674523007855" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" I2="0.0" ID="CMP-002.06.01" LOG_CI_END="0.319953891066094" LOG_CI_START="-0.2223189825165323" LOG_EFFECT_SIZE="0.04881745427478089" NO="1" P_CHI2="0.8094325878040396" P_Z="0.7241733557448682" STUDIES="2" TAU2="0.0" TOTAL_1="82" TOTAL_2="81" WEIGHT="4.068060443165489" Z="0.3528867360204496">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="3.241312663216471" CI_START="0.30851698182293347" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.5107209259289135" LOG_CI_START="-0.5107209259289135" LOG_EFFECT_SIZE="0.0" ORDER="113911" O_E="0.0" SE="0.6" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.36" WEIGHT="1.4382031869776983"/>
<DICH_DATA CI_END="2.4555876018543237" CI_START="0.570910920665477" EFFECT_SIZE="1.1840277777777777" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.390155431981494" LOG_CI_START="-0.24343164951496027" LOG_EFFECT_SIZE="0.07336189123326683" ORDER="113912" O_E="0.0" SE="0.37217218797765234" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.13851213750407299" WEIGHT="2.6298572561877913"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.21918346980404818" CI_END="1.1310539523262206" CI_START="0.8830987414085226" DF="2.0" EFFECT_SIZE="0.9994159903485738" ESTIMABLE="YES" EVENTS_1="329" EVENTS_2="338" I2="0.0" ID="CMP-002.06.02" LOG_CI_END="0.05348332167055663" LOG_CI_START="-0.05399073418987219" LOG_EFFECT_SIZE="-2.537062596578074E-4" NO="2" P_CHI2="0.8961999499673768" P_Z="0.9926168873579133" STUDIES="3" TAU2="0.0" TOTAL_1="1054" TOTAL_2="1085" WEIGHT="95.93193955683451" Z="0.009253491507335135">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="1.481054656313895" CI_START="0.6656680934423176" EFFECT_SIZE="0.9929203539823008" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.17057108586592873" LOG_CI_START="-0.17674225899248308" LOG_EFFECT_SIZE="-0.003085586563277145" ORDER="113913" O_E="0.0" SE="0.2040135779986155" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.041621540007797164" WEIGHT="9.807057938787581"/>
<DICH_DATA CI_END="1.1506629114666558" CI_START="0.8835100968094521" EFFECT_SIZE="1.0082768966434523" ESTIMABLE="YES" EVENTS_1="283" EVENTS_2="287" LOG_CI_END="0.060948115001402646" LOG_CI_START="-0.05378848298395868" LOG_EFFECT_SIZE="0.0035798160087219732" ORDER="113914" O_E="0.0" SE="0.06739684561192112" STUDY_ID="STD-Europe-2000" TOTAL_1="799" TOTAL_2="817" VAR="0.004542334798437132" WEIGHT="81.63333846916262"/>
<DICH_DATA CI_END="1.7079346013994083" CI_START="0.4255703380041483" EFFECT_SIZE="0.8525528169014085" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.23247123708183273" LOG_CI_START="-0.3710286497215737" LOG_EFFECT_SIZE="-0.06927870631987043" ORDER="113915" O_E="0.0" SE="0.35449882088094037" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.12566941400597703" WEIGHT="4.491543148884303"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3370764439231337" CI_START="0.9564984625768858" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.130889721838627" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.1261562376471265" LOG_CI_START="-0.019315723697230527" LOG_EFFECT_SIZE="0.05342025697494797" METHOD="MH" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.15001538896427305" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="685" TOTAL_2="689" WEIGHT="100.00000000000001" Z="1.4394771163898126">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3370764439231337" CI_START="0.9564984625768858" DF="0.0" EFFECT_SIZE="1.130889721838627" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" I2="0.0" ID="CMP-002.07.02" LOG_CI_END="0.1261562376471265" LOG_CI_START="-0.019315723697230527" LOG_EFFECT_SIZE="0.05342025697494797" NO="2" P_CHI2="1.0" P_Z="0.15001538896427305" STUDIES="1" TAU2="0.0" TOTAL_1="685" TOTAL_2="689" WEIGHT="100.00000000000001" Z="1.4394771163898126">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="1.3370764439231337" CI_START="0.9564984625768858" EFFECT_SIZE="1.130889721838627" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" LOG_CI_END="0.1261562376471265" LOG_CI_START="-0.019315723697230527" LOG_EFFECT_SIZE="0.05342025697494797" ORDER="113916" O_E="0.0" SE="0.08545095019149757" STUDY_ID="STD-Europe-2000" TOTAL_1="685" TOTAL_2="689" VAR="0.007301864888629798" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4166850507132291" CI_END="1.5744851907318815" CI_START="0.4566383365822244" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8479211628855319" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.19713858011154534" LOG_CI_START="-0.3404276305873392" LOG_EFFECT_SIZE="-0.07164452523789694" METHOD="MH" NO="8" P_CHI2="0.7016286034182193" P_Q="0.0" P_Z="0.6013701165356748" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1378" TOTAL_2="1424" WEIGHT="99.99999999999999" Z="0.5224312330687206">
<NAME>Stillbirth (= or &gt; 24 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="68.80620475148235" CI_START="0.12299486576714651" DF="0.0" EFFECT_SIZE="2.909090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-002.08.01" LOG_CI_END="1.8376276034655539" LOG_CI_START="-0.9101130171421922" LOG_EFFECT_SIZE="0.4637572931616809" NO="1" P_CHI2="1.0" P_Z="0.5082299471469534" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="2.352935849143837" Z="0.6615963569106003">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="68.80620475148235" CI_START="0.12299486576714651" EFFECT_SIZE="2.909090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8376276034655539" LOG_CI_START="-0.9101130171421922" LOG_EFFECT_SIZE="0.4637572931616809" ORDER="113917" O_E="0.0" SE="1.6140364420804247" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="2.6051136363636362" WEIGHT="2.352935849143837"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8298792919348005" CI_END="1.5090593114939708" CI_START="0.4222566344910105" DF="2.0" EFFECT_SIZE="0.7982545371739302" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" I2="0.0" ID="CMP-002.08.02" LOG_CI_END="0.17870630945639443" LOG_CI_START="-0.3744235180738269" LOG_EFFECT_SIZE="-0.09785860430871621" NO="2" P_CHI2="0.6603801511917635" P_Z="0.48799226407295615" STUDIES="3" TAU2="0.0" TOTAL_1="1346" TOTAL_2="1393" WEIGHT="97.64706415085615" Z="0.6935056851981487">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="15.964295586063871" CI_START="0.06311164339434223" EFFECT_SIZE="1.0037593984962405" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.203149760342757" LOG_CI_START="-1.1998905108757405" LOG_EFFECT_SIZE="0.0016296247335081983" ORDER="113918" O_E="0.0" SE="1.411557750554932" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="1.9924952831516995" WEIGHT="4.625875357518556"/>
<DICH_DATA CI_END="4.337849891608346" CI_START="0.010217349780966297" EFFECT_SIZE="0.21052631578947367" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6372745194683728" LOG_CI_START="-1.9906617387181058" LOG_EFFECT_SIZE="-0.6766936096248666" ORDER="113919" O_E="0.0" SE="1.543662766553014" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.3828947368421054" WEIGHT="11.28933867013457"/>
<DICH_DATA CI_END="1.712088275221757" CI_START="0.4398629147161884" EFFECT_SIZE="0.8678042054463978" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.23352615312930158" LOG_CI_START="-0.3566826522833186" LOG_EFFECT_SIZE="-0.06157824957700849" ORDER="113920" O_E="0.0" SE="0.34669157388007854" STUDY_ID="STD-Europe-2000" TOTAL_1="967" TOTAL_2="1007" VAR="0.12019504739944598" WEIGHT="81.73185012320303"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9488592829346223" CI_END="3.290427305349286" CI_START="0.4146099552938908" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1680085264965598" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="0.5172523004742884" LOG_CI_START="-0.382360274173428" LOG_EFFECT_SIZE="0.06744601315043018" METHOD="MH" NO="9" P_CHI2="0.37740763780856135" P_Q="0.0" P_Z="0.7688450403162719" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1136" TOTAL_2="1167" WEIGHT="100.0" Z="0.2938859691404906">
<NAME>Neonatal death</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.939543504109655" CI_START="0.03547325408361139" DF="0.0" EFFECT_SIZE="0.3229166666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-002.09.01" LOG_CI_END="0.46827989196342457" LOG_CI_START="-1.450098970374016" LOG_EFFECT_SIZE="-0.4909095392052957" NO="1" P_CHI2="1.0" P_Z="0.31581157294033246" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="46.91565070045364" Z="1.0031021873720891">
<NAME>&lt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="2.9395435041096536" CI_START="0.035473254083611405" EFFECT_SIZE="0.3229166666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.46827989196342445" LOG_CI_START="-1.4500989703740157" LOG_EFFECT_SIZE="-0.4909095392052957" ORDER="113921" O_E="0.0" SE="1.1268652398655326" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="1.2698252688172043" WEIGHT="46.91565070045364"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.118452761484493" CI_END="6.997727335799279" CI_START="0.5240024997950098" DF="1.0" EFFECT_SIZE="1.9148959806847723" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" I2="0.0" ID="CMP-002.09.02" LOG_CI_END="0.8449570163313993" LOG_CI_START="-0.28066664117545453" LOG_EFFECT_SIZE="0.28214518757797236" NO="2" P_CHI2="0.7307187451635414" P_Z="0.3258257880959504" STUDIES="2" TAU2="0.0" TOTAL_1="1104" TOTAL_2="1136" WEIGHT="53.08434929954636" Z="0.9825564741397711">
<NAME>= or &gt; 16 weeks' gestation at trial entry</NAME>
<DICH_DATA CI_END="76.72531804581301" CI_START="0.12997403494659443" EFFECT_SIZE="3.1578947368421053" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.884938697367859" LOG_CI_START="-0.8861433985062295" LOG_EFFECT_SIZE="0.49939764943081466" ORDER="113922" O_E="0.0" SE="1.62774734019404" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.649561403508772" WEIGHT="7.499737431683094"/>
<DICH_DATA CI_END="7.13778676811069" CI_START="0.40985338496859014" EFFECT_SIZE="1.710393541876892" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.853563569843218" LOG_CI_START="-0.3873714737355668" LOG_EFFECT_SIZE="0.2330960480538256" ORDER="113923" O_E="0.0" SE="0.7289313873257125" STUDY_ID="STD-Europe-2000" TOTAL_1="991" TOTAL_2="1017" VAR="0.5313409674285879" WEIGHT="45.584611867863266"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Prostaglandin precursor supplementation versus none or placebo - subgroups by singleton or multiple pregnancy</NAME>
<DICH_OUTCOME CHI2="7.920138871056894" CI_END="1.284811854443761" CI_START="0.5906562981164496" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8711384584105345" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="51" I2="49.49583504630867" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.10883953501412051" LOG_CI_START="-0.2286651608317251" LOG_EFFECT_SIZE="-0.05991281290880229" METHOD="MH" NO="1" P_CHI2="0.09454784960293505" P_Q="0.0" P_Z="0.4865204237358537" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="827" TOTAL_2="856" WEIGHT="99.99999999999999" Z="0.6958537582385129">
<NAME>Pre-eclampsia (hypertension with proteinuria)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.970817304410359" CI_END="1.0404152023712994" CI_START="0.42879314559745263" DF="3.0" EFFECT_SIZE="0.6679243275642831" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="45" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.017206689407851878" LOG_CI_START="-0.36775216560305635" LOG_EFFECT_SIZE="-0.17527273809760222" NO="1" P_CHI2="0.3961466707445539" P_Z="0.07430137440099112" STUDIES="4" TAU2="0.0" TOTAL_1="581" TOTAL_2="605" WEIGHT="88.13579868829889" Z="1.7847530959291096">
<NAME>Singleton pregnancy</NAME>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="113924" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="9.987310386035647"/>
<DICH_DATA CI_END="1.6420362108565234" CI_START="0.005070828994107558" EFFECT_SIZE="0.09124957439564181" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2153827301292026" LOG_CI_START="-2.2949210351172256" LOG_EFFECT_SIZE="-1.0397691524940114" ORDER="113925" O_E="0.0" SE="1.474564857909797" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="2.17434152018254" WEIGHT="10.965506767770727"/>
<DICH_DATA CI_END="1.656028379777145" CI_START="0.4650576241579175" EFFECT_SIZE="0.8775811209439528" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.21906777512700218" LOG_CI_START="-0.33249323140402987" LOG_EFFECT_SIZE="-0.056712728138513795" ORDER="113926" O_E="0.0" SE="0.32398966550734376" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.10496930335556051" WEIGHT="35.02446435378708"/>
<DICH_DATA CI_END="1.4870250879840932" CI_START="0.3480610814364739" EFFECT_SIZE="0.7194272445820433" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="17" LOG_CI_END="0.17231829567806867" LOG_CI_START="-0.45834453478036447" LOG_EFFECT_SIZE="-0.1430131195511479" ORDER="113927" O_E="0.0" SE="0.3704544684426427" STUDY_ID="STD-Europe-2000" TOTAL_1="152" TOTAL_2="169" VAR="0.13723651318912095" WEIGHT="32.15851718070544"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.095063826329801" CI_START="0.9299348885278601" DF="0.0" EFFECT_SIZE="2.3807588075880757" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="6" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="0.7849782578260489" LOG_CI_START="-0.03154745848154222" LOG_EFFECT_SIZE="0.37671539967225337" NO="2" P_CHI2="1.0" P_Z="0.07052672226958027" STUDIES="1" TAU2="0.0" TOTAL_1="246" TOTAL_2="251" WEIGHT="11.864201311701098" Z="1.808512827049987">
<NAME>Multiple pregnancy</NAME>
<DICH_DATA CI_END="6.095063826329801" CI_START="0.9299348885278601" EFFECT_SIZE="2.3807588075880757" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="6" LOG_CI_END="0.7849782578260489" LOG_CI_START="-0.03154745848154222" LOG_EFFECT_SIZE="0.37671539967225337" ORDER="113928" O_E="0.0" SE="0.4796312476265612" STUDY_ID="STD-Europe-2000" TOTAL_1="246" TOTAL_2="251" VAR="0.23004613369981167" WEIGHT="11.864201311701098"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.824811181345135" CI_END="4.099449234240365" CI_START="1.0593133372809873" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.579381285760676" ESTIMABLE="YES" I2="37.821400936904354" I2_Q="46.35002631642251" ID="CMP-003.02" NO="2" P_CHI2="0.1850841897750165" P_Q="0.17217166270836604" P_Z="8.815425490508223E-4" Q="1.8639338127133223" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="802" TOTAL_2="819" UNITS="" WEIGHT="100.0" Z="3.3258344980853303">
<NAME>Length of gestation (days)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.9608773686318126" CI_END="4.68444693515559" CI_START="1.3786873806394866" DF="2.0" EFFECT_SIZE="3.031567157897538" ESTIMABLE="YES" I2="32.452454087141845" ID="CMP-003.02.01" NO="1" P_CHI2="0.22753790854993705" P_Z="3.246482455269698E-4" STUDIES="3" TAU2="0.0" TOTAL_1="516" TOTAL_2="536" WEIGHT="84.57528523886316" Z="3.594794084812609">
<NAME>Singleton pregnancy</NAME>
<CONT_DATA CI_END="4.688976919437192" CI_START="0.7110230805627846" EFFECT_SIZE="2.6999999999999886" ESTIMABLE="YES" MEAN_1="283.3" MEAN_2="280.6" ORDER="113929" SD_1="11.1" SD_2="12.3" SE="1.0148027898094047" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="58.40721742247942"/>
<CONT_DATA CI_END="14.954655467869785" CI_START="2.0453445321302155" EFFECT_SIZE="8.5" ESTIMABLE="YES" MEAN_1="269.2" MEAN_2="260.7" ORDER="113930" SD_1="19.7" SD_2="29.5" SE="3.293252079519462" STUDY_ID="STD-Europe-2000" TOTAL_1="108" TOTAL_2="120" WEIGHT="5.546000086383479"/>
<CONT_DATA CI_END="5.847317417244364" CI_START="-0.8473174172443643" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="274.1" MEAN_2="271.6" ORDER="113931" SD_1="13.5" SD_2="15.6" SE="1.7078463908763513" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="20.62206773000027"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.970387344233431" CI_START="-3.7703873442334426" DF="0.0" EFFECT_SIZE="0.09999999999999432" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.02" NO="2" P_CHI2="1.0" P_Z="0.9596123917356458" STUDIES="1" TAU2="0.0" TOTAL_1="286" TOTAL_2="283" WEIGHT="15.424714761136833" Z="0.050639995696041384">
<NAME>Multiple pregnancy</NAME>
<CONT_DATA CI_END="3.970387344233431" CI_START="-3.7703873442334426" EFFECT_SIZE="0.09999999999999432" ESTIMABLE="YES" MEAN_1="254.5" MEAN_2="254.4" ORDER="113932" SD_1="24.0" SD_2="23.1" SE="1.9747237065387722" STUDY_ID="STD-Europe-2000" TOTAL_1="286" TOTAL_2="283" WEIGHT="15.424714761136833"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.817387376083824" CI_END="1.0651327054387603" CI_START="0.7839297844072394" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9137774631384312" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="228" I2="14.050764084307488" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.027403720121559654" LOG_CI_START="-0.10572283477742898" LOG_EFFECT_SIZE="-0.03915955732793464" METHOD="MH" NO="3" P_CHI2="0.32439564171632584" P_Q="0.0" P_Z="0.24888658365158944" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="947" TOTAL_2="969" WEIGHT="100.0" Z="1.153058036715807">
<NAME>Preterm birth (&lt; 37 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.7192179469161117" CI_END="1.0402217086797216" CI_START="0.6075366583415974" DF="4.0" EFFECT_SIZE="0.7949671822318609" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="101" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="0.017125912947210217" LOG_CI_START="-0.21642751191048085" LOG_EFFECT_SIZE="-0.0996507994816353" NO="1" P_CHI2="0.44533704683508746" P_Z="0.09442083040491178" STUDIES="5" TAU2="0.0" TOTAL_1="661" TOTAL_2="686" WEIGHT="43.457641462516605" Z="1.6725250604536033">
<NAME>Singleton pregnancy</NAME>
<DICH_DATA CI_END="1.352141093422313" CI_START="0.26825000481791217" EFFECT_SIZE="0.6022556390977444" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.13102201179615602" LOG_CI_START="-0.5714602615618523" LOG_EFFECT_SIZE="-0.22021912488284812" ORDER="113933" O_E="0.0" SE="0.4126415647138291" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.17027306092947722" WEIGHT="6.630741834126027"/>
<DICH_DATA CI_END="2.128846018088149" CI_START="0.6984429628920461" EFFECT_SIZE="1.2193758733115976" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="19" LOG_CI_END="0.32814424954866056" LOG_CI_START="-0.155869053991684" LOG_EFFECT_SIZE="0.08613759777848831" ORDER="113934" O_E="0.0" SE="0.28431181040409165" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.08083320553525217" WEIGHT="8.197104883570946"/>
<DICH_DATA CI_END="0.9941184152255416" CI_START="0.41059395550284916" EFFECT_SIZE="0.6388888888888888" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="40" LOG_CI_END="-0.002561881180136199" LOG_CI_START="-0.3865874483192526" LOG_EFFECT_SIZE="-0.1945746647496944" ORDER="113935" O_E="0.0" SE="0.22557851909473256" STUDY_ID="STD-Europe-2000" TOTAL_1="108" TOTAL_2="120" VAR="0.05088566827697262" WEIGHT="16.782835287324918"/>
<DICH_DATA CI_END="1.70359383064259" CI_START="0.3525634979397913" EFFECT_SIZE="0.775" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.23136605866002807" LOG_CI_START="-0.45276265364740753" LOG_EFFECT_SIZE="-0.1106982974936897" ORDER="113936" O_E="0.0" SE="0.40186059210113023" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.16149193548387097" WEIGHT="4.49910222870086"/>
<DICH_DATA CI_END="1.6869725706932552" CI_START="0.4426353098063892" EFFECT_SIZE="0.8641259320629661" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.22710802124152246" LOG_CI_START="-0.3539539445831591" LOG_EFFECT_SIZE="-0.06342296167081833" ORDER="113937" O_E="0.0" SE="0.3413186750285372" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.11649843792323619" WEIGHT="7.34785722879386"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2053819147143143" CI_START="0.8380850860856717" DF="0.0" EFFECT_SIZE="1.0050933318649855" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="127" I2="0.0" ID="CMP-003.03.02" LOG_CI_END="0.08112467112168951" LOG_CI_START="-0.07671188764461077" LOG_EFFECT_SIZE="0.0022063917385393723" NO="2" P_CHI2="1.0" P_Z="0.9563005600667467" STUDIES="1" TAU2="0.0" TOTAL_1="286" TOTAL_2="283" WEIGHT="56.542358537483395" Z="0.054796536076624075">
<NAME>Multiple pregnancy</NAME>
<DICH_DATA CI_END="1.2053819147143143" CI_START="0.8380850860856717" EFFECT_SIZE="1.0050933318649855" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="127" LOG_CI_END="0.08112467112168951" LOG_CI_START="-0.07671188764461077" LOG_EFFECT_SIZE="0.0022063917385393723" ORDER="113938" O_E="0.0" SE="0.09271397592289138" STUDY_ID="STD-Europe-2000" TOTAL_1="286" TOTAL_2="283" VAR="0.008595881331430483" WEIGHT="56.542358537483395"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.9287310367870647" CI_START="0.7337700961376807" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.4812137308294133" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="266" TOTAL_2="267" WEIGHT="100.0" Z="0.704351782529571">
<NAME>Prolonged gestation (&gt; 42 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9287310367870647" CI_START="0.7337700961376807" DF="0.0" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" I2="0.0" ID="CMP-003.04.01" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" NO="1" P_CHI2="1.0" P_Z="0.4812137308294133" STUDIES="1" TAU2="0.0" TOTAL_1="266" TOTAL_2="267" WEIGHT="100.0" Z="0.704351782529571">
<NAME>Singleton pregnancy</NAME>
<DICH_DATA CI_END="1.9287310367870647" CI_START="0.7337700961376807" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" ORDER="113939" O_E="0.0" SE="0.24654070696081104" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.060782320188736506" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Multiple pregnancy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.1443260554109465" CI_END="94.1750730083605" CI_START="1.809784885763726" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="47.992428947062116" ESTIMABLE="YES" I2="4.590047370010545" I2_Q="32.28266150948146" ID="CMP-003.05" NO="5" P_CHI2="0.36990407681856174" P_Q="0.22428769722627595" P_Z="0.04167307790452781" Q="1.4767266733910624" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1207" TOTAL_2="1233" UNITS="" WEIGHT="100.0" Z="2.036770180199916">
<NAME>Birthweight (gm)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.667599382019884" CI_END="132.4966455393041" CI_START="11.728437033955608" DF="2.0" EFFECT_SIZE="72.11254128662985" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.01" NO="1" P_CHI2="0.4343958317470682" P_Z="0.01925026350332086" STUDIES="3" TAU2="0.0" TOTAL_1="651" TOTAL_2="667" WEIGHT="58.49413602375512" Z="2.3406488430138923">
<NAME>Singleton pregnancy</NAME>
<CONT_DATA CI_END="184.97446927698533" CI_START="7.025530723014668" EFFECT_SIZE="96.0" ESTIMABLE="YES" MEAN_1="3571.0" MEAN_2="3475.0" ORDER="113940" SD_1="528.0" SD_2="520.0" SE="45.3959715478471" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="26.941810365097847"/>
<CONT_DATA CI_END="121.56319863605178" CI_START="-97.34319863605153" EFFECT_SIZE="12.110000000000127" ESTIMABLE="YES" MEAN_1="3025.1" MEAN_2="3012.99" ORDER="113941" SD_1="635.39" SD_2="604.78" SE="55.844494847560725" STUDY_ID="STD-Europe-2000" TOTAL_1="243" TOTAL_2="251" WEIGHT="17.803306621765987"/>
<CONT_DATA CI_END="227.5497720394755" CI_START="-21.549772039475485" EFFECT_SIZE="103.0" ESTIMABLE="YES" MEAN_1="3209.0" MEAN_2="3106.0" ORDER="113942" SD_1="533.0" SD_2="551.0" SE="63.54696975143839" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="13.74901903689128"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="85.6843025936176" CI_START="-57.6843025936176" DF="0.0" EFFECT_SIZE="14.0" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.02" NO="2" P_CHI2="1.0" P_Z="0.7018810469134975" STUDIES="1" TAU2="0.0" TOTAL_1="556" TOTAL_2="566" WEIGHT="41.50586397624489" Z="0.3827824892029267">
<NAME>Multiple pregnancy</NAME>
<CONT_DATA CI_END="85.6843025936176" CI_START="-57.6843025936176" EFFECT_SIZE="14.0" ESTIMABLE="YES" MEAN_1="2512.0" MEAN_2="2498.0" ORDER="113943" SD_1="626.0" SD_2="598.5" SE="36.57429583352257" STUDY_ID="STD-Europe-2000" TOTAL_1="556" TOTAL_2="566" WEIGHT="41.50586397624489"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.7155828287043964" CI_END="1.119347907672087" CI_START="0.882495608155983" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9938911472184494" ESTIMABLE="YES" EVENTS_1="342" EVENTS_2="352" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="0.04896509179978083" LOG_CI_START="-0.054287447252738145" LOG_EFFECT_SIZE="-0.0026611777264786704" METHOD="MH" NO="6" P_CHI2="0.8869307771304339" P_Q="0.0" P_Z="0.9195264841632836" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1136" TOTAL_2="1166" WEIGHT="100.0" Z="0.10103020319346098">
<NAME>Birthweight &lt; 2500 g</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.7129028081774327" CI_END="1.240065743370182" CI_START="0.770952130081922" DF="4.0" EFFECT_SIZE="0.9777685443359609" ESTIMABLE="YES" EVENTS_1="104" EVENTS_2="110" I2="0.0" ID="CMP-003.06.01" LOG_CI_END="0.09344471034451082" LOG_CI_START="-0.11297258730143177" LOG_EFFECT_SIZE="-0.009763938478460443" NO="1" P_CHI2="0.7883725262983737" P_Z="0.8528994700212098" STUDIES="5" TAU2="0.0" TOTAL_1="580" TOTAL_2="600" WEIGHT="31.073061167140597" Z="0.1854201947539492">
<NAME>Singleton pregnancy</NAME>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="113944" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="1.4369170538243252"/>
<DICH_DATA CI_END="1.481054656313895" CI_START="0.6656680934423176" EFFECT_SIZE="0.9929203539823008" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.17057108586592873" LOG_CI_START="-0.17674225899248308" LOG_EFFECT_SIZE="-0.003085586563277145" ORDER="113945" O_E="0.0" SE="0.2040135779986155" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.041621540007797164" WEIGHT="9.79828784116415"/>
<DICH_DATA CI_END="1.5008730476271124" CI_START="0.7108712283865276" EFFECT_SIZE="1.0329218106995885" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="45" LOG_CI_END="0.17634395870113337" LOG_CI_START="-0.14820906293568137" LOG_EFFECT_SIZE="0.014067447882725983" ORDER="113946" O_E="0.0" SE="0.1906440514728324" STUDY_ID="STD-Europe-2000" TOTAL_1="243" TOTAL_2="251" VAR="0.03634515436197597" WEIGHT="12.72282427819352"/>
<DICH_DATA CI_END="2.4555876018543237" CI_START="0.570910920665477" EFFECT_SIZE="1.1840277777777777" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.390155431981494" LOG_CI_START="-0.24343164951496027" LOG_EFFECT_SIZE="0.07336189123326683" ORDER="113947" O_E="0.0" SE="0.37217218797765234" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.13851213750407299" WEIGHT="2.627505469850195"/>
<DICH_DATA CI_END="1.7079346013994083" CI_START="0.4255703380041483" EFFECT_SIZE="0.8525528169014085" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.23247123708183273" LOG_CI_START="-0.3710286497215737" LOG_EFFECT_SIZE="-0.06927870631987043" ORDER="113948" O_E="0.0" SE="0.35449882088094037" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.12566941400597703" WEIGHT="4.487526524108408"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.146259081814557" CI_START="0.8744272269938166" DF="0.0" EFFECT_SIZE="1.0011594030560675" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="242" I2="0.0" ID="CMP-003.06.02" LOG_CI_END="0.05928278960834827" LOG_CI_START="-0.058276328243759015" LOG_EFFECT_SIZE="5.032306822946377E-4" NO="2" P_CHI2="1.0" P_Z="0.9866122201484164" STUDIES="1" TAU2="0.0" TOTAL_1="556" TOTAL_2="566" WEIGHT="68.9269388328594" Z="0.016779881156539795">
<NAME>Multiple pregnancy</NAME>
<DICH_DATA CI_END="1.146259081814557" CI_START="0.8744272269938166" EFFECT_SIZE="1.0011594030560675" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="242" LOG_CI_END="0.05928278960834827" LOG_CI_START="-0.058276328243759015" LOG_EFFECT_SIZE="5.032306822946377E-4" ORDER="113949" O_E="0.0" SE="0.06905480775334638" STUDY_ID="STD-Europe-2000" TOTAL_1="556" TOTAL_2="566" VAR="0.004768566473851628" WEIGHT="68.9269388328594"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.04322806778380559" CI_END="1.337072827957284" CI_START="0.9565514089063276" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1309194920032584" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" I2="0.0" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="0.12615506314723468" LOG_CI_START="-0.019291684283452282" LOG_EFFECT_SIZE="0.053431689431891215" METHOD="MH" NO="7" P_CHI2="0.8352965503409554" P_Q="0.0" P_Z="0.14985756149712456" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="685" TOTAL_2="689" WEIGHT="100.00000000000001" Z="1.440034772445397">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6903697180537964" CI_START="0.8112543343134981" DF="0.0" EFFECT_SIZE="1.1710336290488963" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="37" I2="0.0" ID="CMP-003.07.01" LOG_CI_END="0.22798170399223647" LOG_CI_START="-0.09084296986688212" LOG_EFFECT_SIZE="0.06856936706267716" NO="1" P_CHI2="1.0" P_Z="0.3991972641868877" STUDIES="1" TAU2="0.0" TOTAL_1="131" TOTAL_2="132" WEIGHT="19.982316169858134" Z="0.8430557664112265">
<NAME>Singleton pregnancy</NAME>
<DICH_DATA CI_END="1.6903697180537964" CI_START="0.811254334313498" EFFECT_SIZE="1.1710336290488963" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="37" LOG_CI_END="0.22798170399223647" LOG_CI_START="-0.09084296986688217" LOG_EFFECT_SIZE="0.06856936706267716" ORDER="113950" O_E="0.0" SE="0.18727919163243492" STUDY_ID="STD-Europe-2000" TOTAL_1="131" TOTAL_2="132" VAR="0.035073495618498284" WEIGHT="19.982316169858134"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.352967413296725" CI_START="0.9286412733870394" DF="0.0" EFFECT_SIZE="1.1209020392233389" ESTIMABLE="YES" EVENTS_1="165" EVENTS_2="148" I2="0.0" ID="CMP-003.07.02" LOG_CI_END="0.13128733658591193" LOG_CI_START="-0.0321520180574158" LOG_EFFECT_SIZE="0.04956765926424805" NO="2" P_CHI2="1.0" P_Z="0.23450648087470005" STUDIES="1" TAU2="0.0" TOTAL_1="554" TOTAL_2="557" WEIGHT="80.01768383014188" Z="1.18883028102859">
<NAME>Multiple pregnancy</NAME>
<DICH_DATA CI_END="1.352967413296725" CI_START="0.9286412733870393" EFFECT_SIZE="1.1209020392233389" ESTIMABLE="YES" EVENTS_1="165" EVENTS_2="148" LOG_CI_END="0.13128733658591193" LOG_CI_START="-0.03215201805741585" LOG_EFFECT_SIZE="0.04956765926424805" ORDER="113951" O_E="0.0" SE="0.0960050859553442" STUDY_ID="STD-Europe-2000" TOTAL_1="554" TOTAL_2="557" VAR="0.009216976529293028" WEIGHT="80.01768383014188"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.422320475643149" CI_END="3.40724488363562" CI_START="0.16905939625089683" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7589642698483212" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-003.08" LOG_CI_END="0.5324033480644269" LOG_CI_START="-0.7719606863208087" LOG_EFFECT_SIZE="-0.11977866912819082" METHOD="MH" NO="8" P_CHI2="0.49107417180344337" P_Q="0.0" P_Z="0.7188742509787182" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="411" TOTAL_2="417" WEIGHT="100.0" Z="0.35996373929160064">
<NAME>Stillbirth (= or &gt; 24 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.422320475643149" CI_END="3.40724488363562" CI_START="0.16905939625089683" DF="2.0" EFFECT_SIZE="0.7589642698483212" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" ID="CMP-003.08.01" LOG_CI_END="0.5324033480644269" LOG_CI_START="-0.7719606863208087" LOG_EFFECT_SIZE="-0.11977866912819082" NO="1" P_CHI2="0.49107417180344337" P_Z="0.7188742509787182" STUDIES="3" TAU2="0.0" TOTAL_1="411" TOTAL_2="417" WEIGHT="100.0" Z="0.35996373929160064">
<NAME>Singleton pregnancy</NAME>
<DICH_DATA CI_END="15.964295586063871" CI_START="0.06311164339434223" EFFECT_SIZE="1.0037593984962405" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.203149760342757" LOG_CI_START="-1.1998905108757405" LOG_EFFECT_SIZE="0.0016296247335081983" ORDER="113952" O_E="0.0" SE="1.411557750554932" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="1.9924952831516995" WEIGHT="25.322079075966236"/>
<DICH_DATA CI_END="4.337849891608346" CI_START="0.010217349780966297" EFFECT_SIZE="0.21052631578947367" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6372745194683728" LOG_CI_START="-1.9906617387181058" LOG_EFFECT_SIZE="-0.6766936096248666" ORDER="113953" O_E="0.0" SE="1.543662766553014" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.3828947368421054" WEIGHT="61.79793107825093"/>
<DICH_DATA CI_END="68.80620475148235" CI_START="0.12299486576714651" EFFECT_SIZE="2.909090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8376276034655539" LOG_CI_START="-0.9101130171421922" LOG_EFFECT_SIZE="0.4637572931616809" ORDER="113954" O_E="0.0" SE="1.6140364420804247" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="2.6051136363636362" WEIGHT="12.879989845782827"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Multiple pregnancy</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9694148540226983" CI_END="3.286836984093207" CI_START="0.4138291477946133" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1662713869709351" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-003.09" LOG_CI_END="0.5167781650903265" LOG_CI_START="-0.38317892333547265" LOG_EFFECT_SIZE="0.0667996208774269" METHOD="MH" NO="9" P_CHI2="0.5787790014964738" P_Q="0.0" P_Z="0.7710834524505518" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1136" TOTAL_2="1167" WEIGHT="100.00000000000001" Z="0.29095798629621283">
<NAME>Neonatal death</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.7372819048686454" CI_END="3.2398246480055963" CI_START="0.31716434384177183" DF="2.0" EFFECT_SIZE="1.0136847925499792" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" ID="CMP-003.09.01" LOG_CI_END="0.510521505125004" LOG_CI_START="-0.49871564273896146" LOG_EFFECT_SIZE="0.00590293119302129" NO="1" P_CHI2="0.4195216675923822" P_Z="0.9817082779143006" STUDIES="3" TAU2="0.0" TOTAL_1="847" TOTAL_2="877" WEIGHT="84.63742228555832" Z="0.022927282385565212">
<NAME>Singleton pregnancy</NAME>
<DICH_DATA CI_END="76.72531804581301" CI_START="0.12997403494659443" EFFECT_SIZE="3.1578947368421053" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.884938697367859" LOG_CI_START="-0.8861433985062295" LOG_EFFECT_SIZE="0.49939764943081466" ORDER="113955" O_E="0.0" SE="1.62774734019404" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.649561403508772" WEIGHT="7.497281405224608"/>
<DICH_DATA CI_END="9.268707406152073" CI_START="0.26035021638652805" EFFECT_SIZE="1.5534188034188035" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9670191726000368" LOG_CI_START="-0.5844420570302091" LOG_EFFECT_SIZE="0.1912885577849138" ORDER="113956" O_E="0.0" SE="0.9113360061417523" STUDY_ID="STD-Europe-2000" TOTAL_1="702" TOTAL_2="727" VAR="0.8305333160903999" WEIGHT="30.239854195018868"/>
<DICH_DATA CI_END="2.9395435041096536" CI_START="0.035473254083611405" EFFECT_SIZE="0.3229166666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.46827989196342445" LOG_CI_START="-1.4500989703740157" LOG_EFFECT_SIZE="-0.4909095392052957" ORDER="113957" O_E="0.0" SE="1.1268652398655326" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="1.2698252688172043" WEIGHT="46.90028668531484"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="22.010575393900154" CI_START="0.18299065249165425" DF="0.0" EFFECT_SIZE="2.0069204152249136" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-003.09.02" LOG_CI_END="1.3426313958986205" LOG_CI_START="-0.7375710942858417" LOG_EFFECT_SIZE="0.30253015080638945" NO="2" P_CHI2="1.0" P_Z="0.5686186938017537" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="290" WEIGHT="15.362577714441697" Z="0.5700870012567044">
<NAME>Multiple pregnancy</NAME>
<DICH_DATA CI_END="22.010575393900154" CI_START="0.18299065249165425" EFFECT_SIZE="2.0069204152249136" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3426313958986205" LOG_CI_START="-0.7375710942858417" LOG_EFFECT_SIZE="0.30253015080638945" ORDER="113958" O_E="0.0" SE="1.2219212399027501" STUDY_ID="STD-Europe-2000" TOTAL_1="289" TOTAL_2="290" VAR="1.4930915165254743" WEIGHT="15.362577714441697"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Prostaglandin precursor supplementation versus none or placebo in singleton pregnancy - subgroups by risk</NAME>
<DICH_OUTCOME CHI2="7.920138871056895" CI_END="1.284811854443761" CI_START="0.5906562981164496" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8711384584105345" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="51" I2="49.49583504630868" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.10883953501412051" LOG_CI_START="-0.2286651608317251" LOG_EFFECT_SIZE="-0.05991281290880229" METHOD="MH" NO="1" P_CHI2="0.09454784960293505" P_Q="0.0" P_Z="0.4865204237358537" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="827" TOTAL_2="856" WEIGHT="99.99999999999999" Z="0.6958537582385129">
<NAME>Pre-eclampsia (hypertension with proteinuria)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.1471422903173885" CI_END="1.9784899285259365" CI_START="0.5185904722677038" DF="2.0" EFFECT_SIZE="1.0129294281494448" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="16" I2="72.0167877067523" ID="CMP-004.01.01" LOG_CI_END="0.296333843837961" LOG_CI_START="-0.28517546650915093" LOG_EFFECT_SIZE="0.0055791886644050576" NO="1" P_CHI2="0.028055532992393384" P_Z="0.9699993853658065" STUDIES="3" TAU2="0.0" TOTAL_1="562" TOTAL_2="568" WEIGHT="32.81701846550747" Z="0.03760905853308097">
<NAME>Low/moderate risk at trial entry</NAME>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="113959" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="9.987310386035647"/>
<DICH_DATA CI_END="1.6420362108565234" CI_START="0.005070828994107558" EFFECT_SIZE="0.09124957439564181" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2153827301292026" LOG_CI_START="-2.2949210351172256" LOG_EFFECT_SIZE="-1.0397691524940114" ORDER="113960" O_E="0.0" SE="1.474564857909797" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="2.17434152018254" WEIGHT="10.965506767770727"/>
<DICH_DATA CI_END="6.095063826329801" CI_START="0.9299348885278601" EFFECT_SIZE="2.3807588075880757" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="6" LOG_CI_END="0.7849782578260489" LOG_CI_START="-0.03154745848154222" LOG_EFFECT_SIZE="0.37671539967225337" ORDER="113961" O_E="0.0" SE="0.4796312476265612" STUDY_ID="STD-Europe-2000" TOTAL_1="246" TOTAL_2="251" VAR="0.23004613369981167" WEIGHT="11.864201311701098"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.16331348641883606" CI_END="1.293071492793369" CI_START="0.49727145645989773" DF="1.0" EFFECT_SIZE="0.801877512172609" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="35" I2="0.0" ID="CMP-004.01.02" LOG_CI_END="0.11162253730677164" LOG_CI_START="-0.30340646869403576" LOG_EFFECT_SIZE="-0.09589196569363205" NO="2" P_CHI2="0.6861242397180327" P_Z="0.36509744399509614" STUDIES="2" TAU2="0.0" TOTAL_1="265" TOTAL_2="288" WEIGHT="67.18298153449251" Z="0.905694765661288">
<NAME>High risk at trial entry</NAME>
<DICH_DATA CI_END="1.656028379777145" CI_START="0.4650576241579175" EFFECT_SIZE="0.8775811209439528" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.21906777512700218" LOG_CI_START="-0.33249323140402987" LOG_EFFECT_SIZE="-0.056712728138513795" ORDER="113962" O_E="0.0" SE="0.32398966550734376" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.10496930335556051" WEIGHT="35.02446435378708"/>
<DICH_DATA CI_END="1.4870250879840932" CI_START="0.3480610814364739" EFFECT_SIZE="0.7194272445820433" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="17" LOG_CI_END="0.17231829567806867" LOG_CI_START="-0.45834453478036447" LOG_EFFECT_SIZE="-0.1430131195511479" ORDER="113963" O_E="0.0" SE="0.3704544684426427" STUDY_ID="STD-Europe-2000" TOTAL_1="152" TOTAL_2="169" VAR="0.13723651318912095" WEIGHT="32.15851718070544"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="4.824811181345135" CI_END="4.099449234240365" CI_START="1.0593133372809873" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.579381285760676" ESTIMABLE="YES" I2="37.821400936904354" I2_Q="70.77623839977355" ID="CMP-004.02" NO="2" P_CHI2="0.1850841897750165" P_Q="0.06433807914928424" P_Z="8.815425490508223E-4" Q="3.421872973369216" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="802" TOTAL_2="819" UNITS="" WEIGHT="100.0" Z="3.3258344980853303">
<NAME>Length of gestation (days)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.402938207975919" CI_END="3.795801685690647" CI_START="0.6676858962983387" DF="2.0" EFFECT_SIZE="2.231743790994493" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.01" NO="1" P_CHI2="0.49585636436056457" P_Z="0.005163390933889125" STUDIES="3" TAU2="0.0" TOTAL_1="694" TOTAL_2="699" WEIGHT="94.45399991361651" Z="2.796659553270466">
<NAME>Low/moderate risk at trial entry</NAME>
<CONT_DATA CI_END="4.688976919437192" CI_START="0.7110230805627846" EFFECT_SIZE="2.6999999999999886" ESTIMABLE="YES" MEAN_1="283.3" MEAN_2="280.6" ORDER="113964" SD_1="11.1" SD_2="12.3" SE="1.0148027898094047" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="58.40721742247942"/>
<CONT_DATA CI_END="3.970387344233431" CI_START="-3.7703873442334426" EFFECT_SIZE="0.09999999999999432" ESTIMABLE="YES" MEAN_1="254.5" MEAN_2="254.4" ORDER="113965" SD_1="24.0" SD_2="23.1" SE="1.9747237065387722" STUDY_ID="STD-Europe-2000" TOTAL_1="286" TOTAL_2="283" WEIGHT="15.424714761136833"/>
<CONT_DATA CI_END="5.847317417244364" CI_START="-0.8473174172443643" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="274.1" MEAN_2="271.6" ORDER="113966" SD_1="13.5" SD_2="15.6" SE="1.7078463908763513" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="20.62206773000027"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="14.954655467869785" CI_START="2.0453445321302155" DF="0.0" EFFECT_SIZE="8.5" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.02" NO="2" P_CHI2="1.0" P_Z="0.009850449750658338" STUDIES="1" TAU2="0.0" TOTAL_1="108" TOTAL_2="120" WEIGHT="5.546000086383479" Z="2.5810353397667285">
<NAME>High risk at trial entry</NAME>
<CONT_DATA CI_END="14.954655467869785" CI_START="2.0453445321302155" EFFECT_SIZE="8.5" ESTIMABLE="YES" MEAN_1="269.2" MEAN_2="260.7" ORDER="113967" SD_1="19.7" SD_2="29.5" SE="3.293252079519462" STUDY_ID="STD-Europe-2000" TOTAL_1="108" TOTAL_2="120" WEIGHT="5.546000086383479"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="5.817387376083824" CI_END="1.0651327054387603" CI_START="0.7839297844072393" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9137774631384311" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="228" I2="14.050764084307488" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.027403720121559654" LOG_CI_START="-0.10572283477742905" LOG_EFFECT_SIZE="-0.039159557327934684" METHOD="MH" NO="3" P_CHI2="0.32439564171632584" P_Q="0.0" P_Z="0.24888658365158878" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="947" TOTAL_2="969" WEIGHT="100.0" Z="1.1530580367158083">
<NAME>Preterm birth (&lt; 37 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.6513886597210703" CI_END="1.1341692177109213" CI_START="0.7999781353828537" DF="2.0" EFFECT_SIZE="0.9525285171547425" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="159" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="0.05467785599908698" LOG_CI_START="-0.09692188277348154" LOG_EFFECT_SIZE="-0.021122013387197287" NO="1" P_CHI2="0.43793105292912116" P_Z="0.5849602337862962" STUDIES="3" TAU2="0.0" TOTAL_1="694" TOTAL_2="699" WEIGHT="70.52095760040328" Z="0.5461537843674761">
<NAME>Low/moderate risk at trial entry</NAME>
<DICH_DATA CI_END="1.352141093422313" CI_START="0.26825000481791217" EFFECT_SIZE="0.6022556390977444" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.13102201179615602" LOG_CI_START="-0.5714602615618523" LOG_EFFECT_SIZE="-0.22021912488284812" ORDER="113968" O_E="0.0" SE="0.4126415647138291" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.17027306092947722" WEIGHT="6.6307418341260265"/>
<DICH_DATA CI_END="1.2053819147143143" CI_START="0.8380850860856717" EFFECT_SIZE="1.0050933318649855" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="127" LOG_CI_END="0.08112467112168951" LOG_CI_START="-0.07671188764461077" LOG_EFFECT_SIZE="0.0022063917385393723" ORDER="113969" O_E="0.0" SE="0.09271397592289138" STUDY_ID="STD-Europe-2000" TOTAL_1="286" TOTAL_2="283" VAR="0.008595881331430483" WEIGHT="56.54235853748339"/>
<DICH_DATA CI_END="1.6869725706932552" CI_START="0.4426353098063892" EFFECT_SIZE="0.8641259320629661" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.22710802124152246" LOG_CI_START="-0.3539539445831591" LOG_EFFECT_SIZE="-0.06342296167081833" ORDER="113970" O_E="0.0" SE="0.3413186750285372" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.11649843792323619" WEIGHT="7.347857228793859"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.192500323245242" CI_END="1.1239590952558154" CI_START="0.5998129146217317" DF="2.0" EFFECT_SIZE="0.8210756243130076" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="69" I2="37.35317783877437" ID="CMP-004.03.02" LOG_CI_END="0.05075050604804359" LOG_CI_START="-0.22198418764522745" LOG_EFFECT_SIZE="-0.0856168407985919" NO="2" P_CHI2="0.20265515035287496" P_Z="0.21849374767531637" STUDIES="3" TAU2="0.0" TOTAL_1="253" TOTAL_2="270" WEIGHT="29.479042399596718" Z="1.230543295852645">
<NAME>High risk at trial entry</NAME>
<DICH_DATA CI_END="2.128846018088149" CI_START="0.6984429628920461" EFFECT_SIZE="1.2193758733115976" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="19" LOG_CI_END="0.32814424954866056" LOG_CI_START="-0.155869053991684" LOG_EFFECT_SIZE="0.08613759777848831" ORDER="113971" O_E="0.0" SE="0.28431181040409165" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.08083320553525217" WEIGHT="8.197104883570944"/>
<DICH_DATA CI_END="0.9941184152255416" CI_START="0.41059395550284916" EFFECT_SIZE="0.6388888888888888" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="40" LOG_CI_END="-0.002561881180136199" LOG_CI_START="-0.3865874483192526" LOG_EFFECT_SIZE="-0.1945746647496944" ORDER="113972" O_E="0.0" SE="0.22557851909473256" STUDY_ID="STD-Europe-2000" TOTAL_1="108" TOTAL_2="120" VAR="0.05088566827697262" WEIGHT="16.782835287324914"/>
<DICH_DATA CI_END="1.70359383064259" CI_START="0.3525634979397913" EFFECT_SIZE="0.775" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.23136605866002807" LOG_CI_START="-0.45276265364740753" LOG_EFFECT_SIZE="-0.1106982974936897" ORDER="113973" O_E="0.0" SE="0.40186059210113023" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.16149193548387097" WEIGHT="4.499102228700859"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.9287310367870647" CI_START="0.7337700961376807" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.4812137308294133" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="266" TOTAL_2="267" WEIGHT="100.0" Z="0.704351782529571">
<NAME>Prolonged gestation (&gt; 42 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9287310367870647" CI_START="0.7337700961376807" DF="0.0" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" NO="1" P_CHI2="1.0" P_Z="0.4812137308294133" STUDIES="1" TAU2="0.0" TOTAL_1="266" TOTAL_2="267" WEIGHT="100.0" Z="0.704351782529571">
<NAME>Low/moderate risk at trial entry</NAME>
<DICH_DATA CI_END="1.9287310367870647" CI_START="0.7337700961376807" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" ORDER="113974" O_E="0.0" SE="0.24654070696081104" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.060782320188736506" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>High risk at trial entry</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.143453701443088" CI_END="94.19899976573183" CI_START="1.8143553121756426" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="48.00667753895373" ESTIMABLE="YES" I2="4.563569725147591" I2_Q="0.0" ID="CMP-004.05" NO="5" P_CHI2="0.37003220553560645" P_Q="0.4783040728352298" P_Z="0.04165525192091073" Q="0.5027277496576343" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1207" TOTAL_2="1233" UNITS="" WEIGHT="100.00000000000001" Z="2.036948013391535">
<NAME>Birthweight (gm)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.6407259517854538" CI_END="106.73777539153198" CI_START="4.833516744879901" DF="2.0" EFFECT_SIZE="55.78564606820594" ESTIMABLE="YES" I2="24.263250465359526" ID="CMP-004.05.01" NO="1" P_CHI2="0.26703851553974833" P_Z="0.031881454557371056" STUDIES="3" TAU2="0.0" TOTAL_1="964" TOTAL_2="982" WEIGHT="82.18923077381791" Z="2.1458937751974756">
<NAME>Low/moderate risk at trial entry</NAME>
<CONT_DATA CI_END="184.97446927698533" CI_START="7.025530723014668" EFFECT_SIZE="96.0" ESTIMABLE="YES" MEAN_1="3571.0" MEAN_2="3475.0" ORDER="113975" SD_1="528.0" SD_2="520.0" SE="45.3959715478471" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="26.953103552216405"/>
<CONT_DATA CI_END="85.72051199256683" CI_START="-57.72051199256683" EFFECT_SIZE="14.0" ESTIMABLE="YES" MEAN_1="2512.0" MEAN_2="2498.0" ORDER="113976" SD_1="626.6" SD_2="598.5" SE="36.59277035613362" STUDY_ID="STD-Europe-2000" TOTAL_1="556" TOTAL_2="566" WEIGHT="41.48134501428566"/>
<CONT_DATA CI_END="227.5497720394755" CI_START="-21.549772039475485" EFFECT_SIZE="103.0" ESTIMABLE="YES" MEAN_1="3209.0" MEAN_2="3106.0" ORDER="113977" SD_1="533.0" SD_2="551.0" SE="63.54696975143839" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="13.75478220731584"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="121.56319863605178" CI_START="-97.34319863605153" DF="0.0" EFFECT_SIZE="12.110000000000127" ESTIMABLE="YES" I2="0.0" ID="CMP-004.05.02" NO="2" P_CHI2="1.0" P_Z="0.8283235520143976" STUDIES="1" TAU2="0.0" TOTAL_1="243" TOTAL_2="251" WEIGHT="17.8107692261821" Z="0.21685217196532827">
<NAME>High risk at trial entry</NAME>
<CONT_DATA CI_END="121.56319863605178" CI_START="-97.34319863605153" EFFECT_SIZE="12.110000000000127" ESTIMABLE="YES" MEAN_1="3025.1" MEAN_2="3012.99" ORDER="113978" SD_1="635.39" SD_2="604.78" SE="55.844494847560725" STUDY_ID="STD-Europe-2000" TOTAL_1="243" TOTAL_2="251" WEIGHT="17.8107692261821"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.4359987246256838" CI_END="1.1294519075065645" CI_START="0.8899051418916076" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0025492805889276" ESTIMABLE="YES" EVENTS_1="340" EVENTS_2="347" I2="0.0" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="0.052867743225229025" LOG_CI_START="-0.05065628385912364" LOG_EFFECT_SIZE="0.0011057296830526892" METHOD="MH" NO="6" P_CHI2="0.9794249035733219" P_Q="0.0" P_Z="0.9666036433641608" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1086" TOTAL_2="1116" WEIGHT="100.0" Z="0.04186835494052615">
<NAME>Low birthweight (&lt; 2500 g)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.2002164295340239" CI_END="1.1338625384772314" CI_START="0.8680189526334351" DF="1.0" EFFECT_SIZE="0.9920756891887303" ESTIMABLE="YES" EVENTS_1="251" EVENTS_2="258" I2="0.0" ID="CMP-004.06.01" LOG_CI_END="0.05456040693837239" LOG_CI_START="-0.06147079218035349" LOG_EFFECT_SIZE="-0.0034551926209905716" NO="1" P_CHI2="0.6545462171852869" P_Z="0.9070754892824099" STUDIES="2" TAU2="0.0" TOTAL_1="698" TOTAL_2="715" WEIGHT="74.4847494239387" Z="0.11672814119348623">
<NAME>Low/moderate risk at trial entry</NAME>
<DICH_DATA CI_END="1.146259081814557" CI_START="0.8744272269938166" EFFECT_SIZE="1.0011594030560675" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="242" LOG_CI_END="0.05928278960834827" LOG_CI_START="-0.058276328243759015" LOG_EFFECT_SIZE="5.032306822946377E-4" ORDER="113979" O_E="0.0" SE="0.06905480775334638" STUDY_ID="STD-Europe-2000" TOTAL_1="556" TOTAL_2="566" VAR="0.004768566473851628" WEIGHT="69.93180080466813"/>
<DICH_DATA CI_END="1.7079346013994083" CI_START="0.4255703380041483" EFFECT_SIZE="0.8525528169014085" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.23247123708183273" LOG_CI_START="-0.3710286497215737" LOG_EFFECT_SIZE="-0.06927870631987043" ORDER="113980" O_E="0.0" SE="0.35449882088094037" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.12566941400597703" WEIGHT="4.552948619270566"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.1720446945983351" CI_END="1.3349942058717745" CI_START="0.7995130556957357" DF="2.0" EFFECT_SIZE="1.0331240471853536" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="89" I2="0.0" ID="CMP-004.06.03" LOG_CI_END="0.12547938078420715" LOG_CI_START="-0.09717444002241098" LOG_EFFECT_SIZE="0.0141524703808981" NO="3" P_CHI2="0.9175737622369926" P_Z="0.8032361909428029" STUDIES="3" TAU2="0.0" TOTAL_1="388" TOTAL_2="401" WEIGHT="25.515250576061298" Z="0.2491610711043828">
<NAME>High risk at trial entry</NAME>
<DICH_DATA CI_END="1.481054656313895" CI_START="0.6656680934423176" EFFECT_SIZE="0.9929203539823008" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.17057108586592873" LOG_CI_START="-0.17674225899248308" LOG_EFFECT_SIZE="-0.003085586563277145" ORDER="113981" O_E="0.0" SE="0.2040135779986155" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.041621540007797164" WEIGHT="9.941133686448199"/>
<DICH_DATA CI_END="1.5008730476271124" CI_START="0.7108712283865276" EFFECT_SIZE="1.0329218106995885" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="45" LOG_CI_END="0.17634395870113337" LOG_CI_START="-0.14820906293568137" LOG_EFFECT_SIZE="0.014067447882725983" ORDER="113982" O_E="0.0" SE="0.1906440514728324" STUDY_ID="STD-Europe-2000" TOTAL_1="243" TOTAL_2="251" VAR="0.03634515436197597" WEIGHT="12.9083059274245"/>
<DICH_DATA CI_END="2.4555876018543237" CI_START="0.570910920665477" EFFECT_SIZE="1.1840277777777777" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.390155431981494" LOG_CI_START="-0.24343164951496027" LOG_EFFECT_SIZE="0.07336189123326683" ORDER="113983" O_E="0.0" SE="0.37217218797765234" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.13851213750407299" WEIGHT="2.6658109621886013"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.04322806778380559" CI_END="1.337072827957284" CI_START="0.9565514089063276" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1309194920032584" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" I2="0.0" I2_Q="0.0" ID="CMP-004.07" LOG_CI_END="0.12615506314723468" LOG_CI_START="-0.019291684283452282" LOG_EFFECT_SIZE="0.053431689431891215" METHOD="MH" NO="7" P_CHI2="0.8352965503409554" P_Q="0.0" P_Z="0.14985756149712456" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="685" TOTAL_2="689" WEIGHT="100.00000000000001" Z="1.440034772445397">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.352967413296725" CI_START="0.9286412733870394" DF="0.0" EFFECT_SIZE="1.1209020392233389" ESTIMABLE="YES" EVENTS_1="165" EVENTS_2="148" I2="0.0" ID="CMP-004.07.01" LOG_CI_END="0.13128733658591193" LOG_CI_START="-0.0321520180574158" LOG_EFFECT_SIZE="0.04956765926424805" NO="1" P_CHI2="1.0" P_Z="0.23450648087470005" STUDIES="1" TAU2="0.0" TOTAL_1="554" TOTAL_2="557" WEIGHT="80.01768383014188" Z="1.18883028102859">
<NAME>Low/moderate risk at trial entry</NAME>
<DICH_DATA CI_END="1.352967413296725" CI_START="0.9286412733870393" EFFECT_SIZE="1.1209020392233389" ESTIMABLE="YES" EVENTS_1="165" EVENTS_2="148" LOG_CI_END="0.13128733658591193" LOG_CI_START="-0.03215201805741585" LOG_EFFECT_SIZE="0.04956765926424805" ORDER="113984" O_E="0.0" SE="0.0960050859553442" STUDY_ID="STD-Europe-2000" TOTAL_1="554" TOTAL_2="557" VAR="0.009216976529293028" WEIGHT="80.01768383014188"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6903697180537964" CI_START="0.8112543343134981" DF="0.0" EFFECT_SIZE="1.1710336290488963" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="37" I2="0.0" ID="CMP-004.07.02" LOG_CI_END="0.22798170399223647" LOG_CI_START="-0.09084296986688212" LOG_EFFECT_SIZE="0.06856936706267716" NO="2" P_CHI2="1.0" P_Z="0.3991972641868877" STUDIES="1" TAU2="0.0" TOTAL_1="131" TOTAL_2="132" WEIGHT="19.982316169858134" Z="0.8430557664112265">
<NAME>High risk at trial entry</NAME>
<DICH_DATA CI_END="1.6903697180537964" CI_START="0.811254334313498" EFFECT_SIZE="1.1710336290488963" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="37" LOG_CI_END="0.22798170399223647" LOG_CI_START="-0.09084296986688217" LOG_EFFECT_SIZE="0.06856936706267716" ORDER="113985" O_E="0.0" SE="0.18727919163243492" STUDY_ID="STD-Europe-2000" TOTAL_1="131" TOTAL_2="132" VAR="0.035073495618498284" WEIGHT="19.982316169858134"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.422320475643149" CI_END="3.40724488363562" CI_START="0.16905939625089683" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7589642698483212" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-004.08" LOG_CI_END="0.5324033480644269" LOG_CI_START="-0.7719606863208087" LOG_EFFECT_SIZE="-0.11977866912819082" METHOD="MH" NO="8" P_CHI2="0.49107417180344337" P_Q="0.0" P_Z="0.7188742509787182" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="411" TOTAL_2="417" WEIGHT="100.0" Z="0.35996373929160064">
<NAME>Stillbirth (= or &gt; 24 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.964295586063871" CI_START="0.06311164339434223" DF="0.0" EFFECT_SIZE="1.0037593984962405" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.08.01" LOG_CI_END="1.203149760342757" LOG_CI_START="-1.1998905108757405" LOG_EFFECT_SIZE="0.0016296247335081983" NO="1" P_CHI2="1.0" P_Z="0.9978789827760384" STUDIES="1" TAU2="0.0" TOTAL_1="266" TOTAL_2="267" WEIGHT="25.322079075966236" Z="0.0026583040028473467">
<NAME>Low/moderate risk at trial entry</NAME>
<DICH_DATA CI_END="15.964295586063871" CI_START="0.06311164339434223" EFFECT_SIZE="1.0037593984962405" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.203149760342757" LOG_CI_START="-1.1998905108757405" LOG_EFFECT_SIZE="0.0016296247335081983" ORDER="113986" O_E="0.0" SE="1.411557750554932" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="1.9924952831516995" WEIGHT="25.322079075966236"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3886945810308369" CI_END="4.081917550081661" CI_START="0.11193745746343278" DF="1.0" EFFECT_SIZE="0.6759581881533101" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="27.989925671223286" ID="CMP-004.08.02" LOG_CI_END="0.6108642282325258" LOG_CI_START="-0.9510245618400585" LOG_EFFECT_SIZE="-0.17008016680376628" NO="2" P_CHI2="0.23862588057747147" P_Z="0.6694840291236516" STUDIES="2" TAU2="0.0" TOTAL_1="145" TOTAL_2="150" WEIGHT="74.67792092403376" Z="0.42685625703793584">
<NAME>High risk at trial entry</NAME>
<DICH_DATA CI_END="4.337849891608346" CI_START="0.010217349780966297" EFFECT_SIZE="0.21052631578947367" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6372745194683728" LOG_CI_START="-1.9906617387181058" LOG_EFFECT_SIZE="-0.6766936096248666" ORDER="113987" O_E="0.0" SE="1.543662766553014" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.3828947368421054" WEIGHT="61.79793107825093"/>
<DICH_DATA CI_END="68.80620475148235" CI_START="0.12299486576714651" EFFECT_SIZE="2.909090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8376276034655539" LOG_CI_START="-0.9101130171421922" LOG_EFFECT_SIZE="0.4637572931616809" ORDER="113988" O_E="0.0" SE="1.6140364420804247" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="2.6051136363636362" WEIGHT="12.879989845782827"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9694148540226983" CI_END="3.286836984093207" CI_START="0.4138291477946133" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1662713869709351" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-004.09" LOG_CI_END="0.5167781650903265" LOG_CI_START="-0.38317892333547265" LOG_EFFECT_SIZE="0.0667996208774269" METHOD="MH" NO="9" P_CHI2="0.5787790014964738" P_Q="0.0" P_Z="0.7710834524505518" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1136" TOTAL_2="1167" WEIGHT="100.00000000000001" Z="0.29095798629621283">
<NAME>Neonatal death</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="22.010575393900154" CI_START="0.18299065249165425" DF="0.0" EFFECT_SIZE="2.0069204152249136" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-004.09.01" LOG_CI_END="1.3426313958986205" LOG_CI_START="-0.7375710942858417" LOG_EFFECT_SIZE="0.30253015080638945" NO="1" P_CHI2="1.0" P_Z="0.5686186938017537" STUDIES="1" TAU2="0.0" TOTAL_1="289" TOTAL_2="290" WEIGHT="15.362577714441697" Z="0.5700870012567044">
<NAME>Low/moderate risk at trial entry</NAME>
<DICH_DATA CI_END="22.010575393900154" CI_START="0.18299065249165425" EFFECT_SIZE="2.0069204152249136" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3426313958986205" LOG_CI_START="-0.7375710942858417" LOG_EFFECT_SIZE="0.30253015080638945" ORDER="113989" O_E="0.0" SE="1.2219212399027501" STUDY_ID="STD-Europe-2000" TOTAL_1="289" TOTAL_2="290" VAR="1.4930915165254743" WEIGHT="15.362577714441697"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.7372819048686456" CI_END="3.2398246480055968" CI_START="0.31716434384177195" DF="2.0" EFFECT_SIZE="1.0136847925499795" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" ID="CMP-004.09.02" LOG_CI_END="0.510521505125004" LOG_CI_START="-0.4987156427389613" LOG_EFFECT_SIZE="0.0059029311930213855" NO="2" P_CHI2="0.4195216675923822" P_Z="0.9817082779143003" STUDIES="3" TAU2="0.0" TOTAL_1="847" TOTAL_2="877" WEIGHT="84.63742228555832" Z="0.022927282385565583">
<NAME>High risk at trial entry</NAME>
<DICH_DATA CI_END="76.72531804581301" CI_START="0.12997403494659443" EFFECT_SIZE="3.1578947368421053" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.884938697367859" LOG_CI_START="-0.8861433985062295" LOG_EFFECT_SIZE="0.49939764943081466" ORDER="113990" O_E="0.0" SE="1.62774734019404" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.649561403508772" WEIGHT="7.497281405224608"/>
<DICH_DATA CI_END="9.268707406152073" CI_START="0.26035021638652805" EFFECT_SIZE="1.5534188034188035" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9670191726000368" LOG_CI_START="-0.5844420570302091" LOG_EFFECT_SIZE="0.1912885577849138" ORDER="113991" O_E="0.0" SE="0.9113360061417523" STUDY_ID="STD-Europe-2000" TOTAL_1="702" TOTAL_2="727" VAR="0.8305333160903999" WEIGHT="30.239854195018868"/>
<DICH_DATA CI_END="2.9395435041096536" CI_START="0.035473254083611405" EFFECT_SIZE="0.3229166666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.46827989196342445" LOG_CI_START="-1.4500989703740157" LOG_EFFECT_SIZE="-0.4909095392052957" ORDER="113992" O_E="0.0" SE="1.1268652398655326" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="1.2698252688172043" WEIGHT="46.90028668531484"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Prostaglandin precursor supplementation versus placebo - subgroups by type of supplement</NAME>
<DICH_OUTCOME CHI2="4.246022002591104" CI_END="1.2738959558661587" CI_START="0.5862846497319659" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8642138880392739" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="51" I2="29.34563226075438" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.1051339588954047" LOG_CI_START="-0.23189147648546488" LOG_EFFECT_SIZE="-0.06337875879503013" METHOD="MH" NO="1" P_CHI2="0.23609456921009186" P_Q="0.0" P_Z="0.4610277684489331" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="827" TOTAL_2="856" WEIGHT="100.0" Z="0.7371555472228986">
<NAME>Pre-eclampsia (hypertension with proteinuria)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.1098198340196896" CI_END="1.3684844021446865" CI_START="0.6122345780354113" DF="2.0" EFFECT_SIZE="0.915332437147889" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="46" I2="35.687592634109585" ID="CMP-005.01.01" LOG_CI_END="0.1362398517270726" LOG_CI_START="-0.21308214578426302" LOG_EFFECT_SIZE="-0.0384211470285952" NO="1" P_CHI2="0.21120850797915913" P_Z="0.6663635757141932" STUDIES="3" TAU2="0.0" TOTAL_1="777" TOTAL_2="806" WEIGHT="90.08047127956254" Z="0.4311441303854395">
<NAME>Fish oil</NAME>
<DICH_DATA CI_END="1.6420362108565234" CI_START="0.005070828994107558" EFFECT_SIZE="0.09124957439564181" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2153827301292026" LOG_CI_START="-2.2949210351172256" LOG_EFFECT_SIZE="-1.0397691524940114" ORDER="113993" O_E="0.0" SE="1.474564857909797" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="2.17434152018254" WEIGHT="10.891086299784972"/>
<DICH_DATA CI_END="1.656028379777145" CI_START="0.4650576241579175" EFFECT_SIZE="0.8775811209439528" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.21906777512700218" LOG_CI_START="-0.33249323140402987" LOG_EFFECT_SIZE="-0.056712728138513795" ORDER="113994" O_E="0.0" SE="0.32398966550734376" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.10496930335556051" WEIGHT="34.78676106443066"/>
<DICH_DATA CI_END="1.9869890408152977" CI_START="0.66215751171156" EFFECT_SIZE="1.1470395455538562" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="23" LOG_CI_END="0.29819547177686706" LOG_CI_START="-0.17903868981955243" LOG_EFFECT_SIZE="0.05957839097865735" ORDER="113995" O_E="0.0" SE="0.28032970886893616" STUDY_ID="STD-Europe-2000" TOTAL_1="398" TOTAL_2="420" VAR="0.07858474567454249" WEIGHT="44.402623915346915"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9659813518147353" CI_START="0.08138429179519381" DF="0.0" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-005.01.03" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" NO="3" P_CHI2="1.0" P_Z="0.25937234174702095" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="9.919528720437453" Z="1.1278759235693374">
<NAME>Fish oil + evening primrose oil</NAME>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="113996" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="9.919528720437453"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.06443085616413978" CI_END="4.09007254271294" CI_START="1.0101933052231866" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.550132923968063" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.02" NO="2" P_CHI2="0.968297961317474" P_Q="1.0" P_Z="0.0011716579766024972" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="802" TOTAL_2="819" UNITS="" WEIGHT="100.0" Z="3.24569134135335">
<NAME>Length of gestation (days)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.06443085616413978" CI_END="4.09007254271294" CI_START="1.0101933052231866" DF="2.0" EFFECT_SIZE="2.550132923968063" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.01" NO="1" P_CHI2="0.968297961317474" P_Z="0.0011716579766024972" STUDIES="3" TAU2="0.0" TOTAL_1="802" TOTAL_2="819" WEIGHT="100.0" Z="3.24569134135335">
<NAME>Fish oil</NAME>
<CONT_DATA CI_END="4.733861386160008" CI_START="0.6661386138399696" EFFECT_SIZE="2.6999999999999886" ESTIMABLE="YES" MEAN_1="283.3" MEAN_2="280.6" ORDER="113997" SD_1="11.1" SD_2="12.8" SE="1.0377034487382717" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="57.32772171399113"/>
<CONT_DATA CI_END="5.520539578899012" CI_START="-1.120539578899034" EFFECT_SIZE="2.1999999999999886" ESTIMABLE="YES" MEAN_1="258.5" MEAN_2="256.3" ORDER="113998" SD_1="22.8" SD_2="25.0" SE="1.6941839774052048" STUDY_ID="STD-Europe-2000" TOTAL_1="394" TOTAL_2="403" WEIGHT="21.507506486636867"/>
<CONT_DATA CI_END="5.847317417244364" CI_START="-0.8473174172443643" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="274.1" MEAN_2="271.6" ORDER="113999" SD_1="13.5" SD_2="15.6" SE="1.7078463908763513" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="21.164771799372"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Fish oil + evening primrose oil</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.268922351883363" CI_END="1.0742530556494725" CI_START="0.7893805154196192" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9208661307484826" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="228" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="0.031106597682742917" LOG_CI_START="-0.10271359766456818" LOG_EFFECT_SIZE="-0.03580349999091265" METHOD="MH" NO="3" P_CHI2="0.6864328415724347" P_Q="0.0" P_Z="0.29428216371931093" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="947" TOTAL_2="969" WEIGHT="100.0" Z="1.0487739958911815">
<NAME>Preterm birth (&lt; 37 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.268922351883363" CI_END="1.0742530556494725" CI_START="0.7893805154196192" DF="4.0" EFFECT_SIZE="0.9208661307484826" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="228" I2="0.0" ID="CMP-005.03.01" LOG_CI_END="0.031106597682742917" LOG_CI_START="-0.10271359766456818" LOG_EFFECT_SIZE="-0.03580349999091265" NO="1" P_CHI2="0.6864328415724347" P_Z="0.29428216371931093" STUDIES="5" TAU2="0.0" TOTAL_1="947" TOTAL_2="969" WEIGHT="100.0" Z="1.0487739958911815">
<NAME>Fish oil</NAME>
<DICH_DATA CI_END="1.352141093422313" CI_START="0.26825000481791217" EFFECT_SIZE="0.6022556390977444" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="15" LOG_CI_END="0.13102201179615602" LOG_CI_START="-0.5714602615618523" LOG_EFFECT_SIZE="-0.22021912488284812" ORDER="114000" O_E="0.0" SE="0.4126415647138291" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.17027306092947722" WEIGHT="6.643987591724067"/>
<DICH_DATA CI_END="2.128846018088149" CI_START="0.6984429628920461" EFFECT_SIZE="1.2193758733115976" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="19" LOG_CI_END="0.32814424954866056" LOG_CI_START="-0.155869053991684" LOG_EFFECT_SIZE="0.08613759777848831" ORDER="114001" O_E="0.0" SE="0.28431181040409165" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.08083320553525217" WEIGHT="8.213479652338851"/>
<DICH_DATA CI_END="1.1037870022344882" CI_START="0.7852114186608694" EFFECT_SIZE="0.9309705462172102" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="167" LOG_CI_END="0.042885275676812655" LOG_CI_START="-0.10501339345136351" LOG_EFFECT_SIZE="-0.031064058887275425" ORDER="114002" O_E="0.0" SE="0.08687641035611014" STUDY_ID="STD-Europe-2000" TOTAL_1="394" TOTAL_2="403" VAR="0.007547510676363243" WEIGHT="73.27190747685357"/>
<DICH_DATA CI_END="1.70359383064259" CI_START="0.3525634979397913" EFFECT_SIZE="0.775" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.23136605866002807" LOG_CI_START="-0.45276265364740753" LOG_EFFECT_SIZE="-0.1106982974936897" ORDER="114003" O_E="0.0" SE="0.40186059210113023" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.16149193548387097" WEIGHT="4.50808976267835"/>
<DICH_DATA CI_END="1.6869725706932552" CI_START="0.4426353098063892" EFFECT_SIZE="0.8641259320629661" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" LOG_CI_END="0.22710802124152246" LOG_CI_START="-0.3539539445831591" LOG_EFFECT_SIZE="-0.06342296167081833" ORDER="114004" O_E="0.0" SE="0.3413186750285372" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.11649843792323619" WEIGHT="7.362535516405165"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Fish oil + evening primrose oil</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.035503792483688" CI_END="3.655891262449265" CI_START="0.7692182789856509" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6769550933343154" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="36" I2="67.05653926454866" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="0.5629932699883395" LOG_CI_START="-0.11395040414198064" LOG_EFFECT_SIZE="0.22452143292317947" METHOD="MH" NO="4" P_CHI2="0.0814614793248627" P_Q="0.0" P_Z="0.19355992746312423" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.21636109972250805" TOTALS="YES" TOTAL_1="972" TOTAL_2="998" WEIGHT="100.0" Z="1.3001197562030586">
<NAME>Prolonged gestation (&gt; 42 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.035503792483688" CI_END="3.655891262449265" CI_START="0.7692182789856509" DF="1.0" EFFECT_SIZE="1.6769550933343154" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="36" I2="67.05653926454866" ID="CMP-005.04.01" LOG_CI_END="0.5629932699883395" LOG_CI_START="-0.11395040414198064" LOG_EFFECT_SIZE="0.22452143292317947" NO="1" P_CHI2="0.0814614793248627" P_Z="0.19355992746312423" STUDIES="2" TAU2="0.21636109972250805" TOTAL_1="972" TOTAL_2="998" WEIGHT="100.0" Z="1.3001197562030586">
<NAME>Fish oil</NAME>
<DICH_DATA CI_END="1.9287310367870647" CI_START="0.7337700961376807" EFFECT_SIZE="1.189640768588137" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" LOG_CI_END="0.28527166912475077" LOG_CI_START="-0.13443999133589704" LOG_EFFECT_SIZE="0.07541583889442686" ORDER="114005" O_E="0.0" SE="0.24654070696081104" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="0.060782320188736506" WEIGHT="57.05263413103196"/>
<DICH_DATA CI_END="5.6786416994533" CI_START="1.2329672406137822" EFFECT_SIZE="2.6460497324519987" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="9" LOG_CI_END="0.7542444672290968" LOG_CI_START="0.09095153773955264" LOG_EFFECT_SIZE="0.4225980024843247" ORDER="114006" O_E="0.0" SE="0.38962155013511246" STUDY_ID="STD-Europe-2000" TOTAL_1="706" TOTAL_2="731" VAR="0.15180495232968794" WEIGHT="42.94736586896804"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Fish oil + evening primrose oil</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.2385195684063737" CI_END="93.43922940246485" CI_START="1.0494738805176667" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="47.24435164149126" ESTIMABLE="YES" I2="38.243386900880466" I2_Q="0.0" ID="CMP-005.05" NO="5" P_CHI2="0.1980453943045628" P_Q="1.0" P_Z="0.04501746462788022" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1207" TOTAL_2="1233" UNITS="" WEIGHT="100.0" Z="2.0044912375219393">
<NAME>Birthweight (gm)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours marine oil</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.2385195684063737" CI_END="93.43922940246485" CI_START="1.0494738805176667" DF="2.0" EFFECT_SIZE="47.24435164149126" ESTIMABLE="YES" I2="38.243386900880466" ID="CMP-005.05.01" NO="1" P_CHI2="0.1980453943045628" P_Z="0.04501746462788022" STUDIES="3" TAU2="0.0" TOTAL_1="1207" TOTAL_2="1233" WEIGHT="100.0" Z="2.0044912375219393">
<NAME>Fish oil</NAME>
<CONT_DATA CI_END="184.97446927698533" CI_START="7.025530723014668" EFFECT_SIZE="96.0" ESTIMABLE="YES" MEAN_1="3571.0" MEAN_2="3475.0" ORDER="114007" SD_1="528.0" SD_2="520.0" SE="45.3959715478471" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" WEIGHT="26.956085930231698"/>
<CONT_DATA CI_END="72.13455701131316" CI_START="-47.85455701131251" EFFECT_SIZE="12.140000000000327" ESTIMABLE="YES" MEAN_1="2668.34" MEAN_2="2656.2" ORDER="114008" SD_1="629.34" SD_2="600.43" SE="30.610030329405152" STUDY_ID="STD-Europe-2000" TOTAL_1="799" TOTAL_2="817" WEIGHT="59.287609887071014"/>
<CONT_DATA CI_END="227.5497720394755" CI_START="-21.549772039475485" EFFECT_SIZE="103.0" ESTIMABLE="YES" MEAN_1="3209.0" MEAN_2="3106.0" ORDER="114009" SD_1="533.0" SD_2="551.0" SE="63.54696975143839" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" WEIGHT="13.756304182697294"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Fish oil + evening primrose oil</NAME>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.712902808177433" CI_END="1.240065743370182" CI_START="0.7709521300819221" CI_STUDY="95" CI_TOTAL="95" DF="4.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9777685443359609" ESTIMABLE="YES" EVENTS_1="104" EVENTS_2="110" I2="0.0" I2_Q="0.0" ID="CMP-005.06" LOG_CI_END="0.09344471034451082" LOG_CI_START="-0.11297258730143171" LOG_EFFECT_SIZE="-0.009763938478460443" METHOD="MH" NO="6" P_CHI2="0.7883725262983737" P_Q="0.0" P_Z="0.8528994700212098" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="580" TOTAL_2="600" WEIGHT="100.0" Z="0.18542019475394922">
<NAME>Low birthweight (&lt; 2500 g)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.43306196775819783" CI_END="1.2796252287614067" CI_START="0.7905416732145613" DF="3.0" EFFECT_SIZE="1.0057818199950763" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="105" I2="0.0" ID="CMP-005.06.01" LOG_CI_END="0.10708279393461839" LOG_CI_START="-0.10207523139895609" LOG_EFFECT_SIZE="0.0025037812678311306" NO="1" P_CHI2="0.9333311077856545" P_Z="0.9625733768024046" STUDIES="4" TAU2="0.0" TOTAL_1="530" TOTAL_2="550" WEIGHT="95.37568234395957" Z="0.04692453088796032">
<NAME>Fish oil</NAME>
<DICH_DATA CI_END="1.481054656313895" CI_START="0.6656680934423176" EFFECT_SIZE="0.9929203539823008" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="0.17057108586592873" LOG_CI_START="-0.17674225899248308" LOG_EFFECT_SIZE="-0.003085586563277145" ORDER="114010" O_E="0.0" SE="0.2040135779986155" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="0.041621540007797164" WEIGHT="31.533062637310177"/>
<DICH_DATA CI_END="1.5008730476271124" CI_START="0.7108712283865276" EFFECT_SIZE="1.0329218106995885" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="45" LOG_CI_END="0.17634395870113337" LOG_CI_START="-0.14820906293568137" LOG_EFFECT_SIZE="0.014067447882725983" ORDER="114011" O_E="0.0" SE="0.1906440514728324" STUDY_ID="STD-Europe-2000" TOTAL_1="243" TOTAL_2="251" VAR="0.03634515436197597" WEIGHT="40.94486928647944"/>
<DICH_DATA CI_END="2.4555876018543237" CI_START="0.570910920665477" EFFECT_SIZE="1.1840277777777777" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.390155431981494" LOG_CI_START="-0.24343164951496027" LOG_EFFECT_SIZE="0.07336189123326683" ORDER="114012" O_E="0.0" SE="0.37217218797765234" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="0.13851213750407299" WEIGHT="8.45589514247393"/>
<DICH_DATA CI_END="1.7079346013994083" CI_START="0.4255703380041483" EFFECT_SIZE="0.8525528169014085" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.23247123708183273" LOG_CI_START="-0.3710286497215737" LOG_EFFECT_SIZE="-0.06927870631987043" ORDER="114013" O_E="0.0" SE="0.35449882088094037" STUDY_ID="STD-USA-2003" TOTAL_1="142" TOTAL_2="149" VAR="0.12566941400597703" WEIGHT="14.441855277696025"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9659813518147353" CI_START="0.08138429179519381" DF="0.0" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-005.06.03" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" NO="3" P_CHI2="1.0" P_Z="0.25937234174702095" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="4.62431765604043" Z="1.1278759235693374">
<NAME>Fish oil + evening primrose oil</NAME>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" ORDER="114014" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="4.62431765604043"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3370764439231337" CI_START="0.9564984625768858" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.130889721838627" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" I2="0.0" I2_Q="0.0" ID="CMP-005.07" LOG_CI_END="0.1261562376471265" LOG_CI_START="-0.019315723697230527" LOG_EFFECT_SIZE="0.05342025697494797" METHOD="MH" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.15001538896427305" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="685" TOTAL_2="689" WEIGHT="100.00000000000001" Z="1.4394771163898126">
<NAME>Small-for-gestational age</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3370764439231337" CI_START="0.9564984625768858" DF="0.0" EFFECT_SIZE="1.130889721838627" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" I2="0.0" ID="CMP-005.07.01" LOG_CI_END="0.1261562376471265" LOG_CI_START="-0.019315723697230527" LOG_EFFECT_SIZE="0.05342025697494797" NO="1" P_CHI2="1.0" P_Z="0.15001538896427305" STUDIES="1" TAU2="0.0" TOTAL_1="685" TOTAL_2="689" WEIGHT="100.00000000000001" Z="1.4394771163898126">
<NAME>Fish oil</NAME>
<DICH_DATA CI_END="1.3370764439231337" CI_START="0.9564984625768858" EFFECT_SIZE="1.130889721838627" ESTIMABLE="YES" EVENTS_1="208" EVENTS_2="185" LOG_CI_END="0.1261562376471265" LOG_CI_START="-0.019315723697230527" LOG_EFFECT_SIZE="0.05342025697494797" ORDER="114015" O_E="0.0" SE="0.08545095019149757" STUDY_ID="STD-Europe-2000" TOTAL_1="685" TOTAL_2="689" VAR="0.007301864888629798" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Fish oil + evening primrose oil</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4166850507132291" CI_END="1.5744851907318815" CI_START="0.4566383365822244" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8479211628855319" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-005.08" LOG_CI_END="0.19713858011154534" LOG_CI_START="-0.3404276305873392" LOG_EFFECT_SIZE="-0.07164452523789694" METHOD="MH" NO="8" P_CHI2="0.7016286034182193" P_Q="0.0" P_Z="0.6013701165356748" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1378" TOTAL_2="1424" WEIGHT="99.99999999999999" Z="0.5224312330687206">
<NAME>Stillbirth (= or &gt; 24 weeks)</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.4166850507132291" CI_END="1.5744851907318815" CI_START="0.4566383365822244" DF="3.0" EFFECT_SIZE="0.8479211628855319" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="21" I2="0.0" ID="CMP-005.08.01" LOG_CI_END="0.19713858011154534" LOG_CI_START="-0.3404276305873392" LOG_EFFECT_SIZE="-0.07164452523789694" NO="1" P_CHI2="0.7016286034182193" P_Z="0.6013701165356748" STUDIES="4" TAU2="0.0" TOTAL_1="1378" TOTAL_2="1424" WEIGHT="99.99999999999999" Z="0.5224312330687206">
<NAME>Fish oil</NAME>
<DICH_DATA CI_END="15.964295586063871" CI_START="0.06311164339434223" EFFECT_SIZE="1.0037593984962405" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.203149760342757" LOG_CI_START="-1.1998905108757405" LOG_EFFECT_SIZE="0.0016296247335081983" ORDER="114016" O_E="0.0" SE="1.411557750554932" STUDY_ID="STD-Denmark-1992" TOTAL_1="266" TOTAL_2="267" VAR="1.9924952831516995" WEIGHT="4.625875357518556"/>
<DICH_DATA CI_END="4.337849891608346" CI_START="0.010217349780966297" EFFECT_SIZE="0.21052631578947367" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6372745194683728" LOG_CI_START="-1.9906617387181058" LOG_EFFECT_SIZE="-0.6766936096248666" ORDER="114017" O_E="0.0" SE="1.543662766553014" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.3828947368421054" WEIGHT="11.28933867013457"/>
<DICH_DATA CI_END="1.712088275221757" CI_START="0.4398629147161884" EFFECT_SIZE="0.8678042054463978" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.23352615312930158" LOG_CI_START="-0.3566826522833186" LOG_EFFECT_SIZE="-0.06157824957700849" ORDER="114018" O_E="0.0" SE="0.34669157388007854" STUDY_ID="STD-Europe-2000" TOTAL_1="967" TOTAL_2="1007" VAR="0.12019504739944598" WEIGHT="81.73185012320303"/>
<DICH_DATA CI_END="68.80620475148235" CI_START="0.12299486576714651" EFFECT_SIZE="2.909090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8376276034655539" LOG_CI_START="-0.9101130171421922" LOG_EFFECT_SIZE="0.4637572931616809" ORDER="114019" O_E="0.0" SE="1.6140364420804247" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="2.6051136363636362" WEIGHT="2.352935849143837"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.08.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Fish oil + evening primrose oil</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9488592829346225" CI_END="3.290427305349286" CI_START="0.4146099552938908" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1680085264965598" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-005.09" LOG_CI_END="0.5172523004742884" LOG_CI_START="-0.382360274173428" LOG_EFFECT_SIZE="0.06744601315043018" METHOD="MH" NO="9" P_CHI2="0.37740763780856135" P_Q="0.0" P_Z="0.7688450403162719" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1136" TOTAL_2="1167" WEIGHT="100.0" Z="0.2938859691404906">
<NAME>Neonatal death</NAME>
<GROUP_LABEL_1>Marine oil</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours marine oil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.9488592829346225" CI_END="3.290427305349286" CI_START="0.4146099552938908" DF="2.0" EFFECT_SIZE="1.1680085264965598" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" I2="0.0" ID="CMP-005.09.01" LOG_CI_END="0.5172523004742884" LOG_CI_START="-0.382360274173428" LOG_EFFECT_SIZE="0.06744601315043018" NO="1" P_CHI2="0.37740763780856135" P_Z="0.7688450403162719" STUDIES="3" TAU2="0.0" TOTAL_1="1136" TOTAL_2="1167" WEIGHT="100.0" Z="0.2938859691404906">
<NAME>Fish oil</NAME>
<DICH_DATA CI_END="76.72531804581301" CI_START="0.12997403494659443" EFFECT_SIZE="3.1578947368421053" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.884938697367859" LOG_CI_START="-0.8861433985062295" LOG_EFFECT_SIZE="0.49939764943081466" ORDER="114020" O_E="0.0" SE="1.62774734019404" STUDY_ID="STD-England-1995" TOTAL_1="113" TOTAL_2="119" VAR="2.649561403508772" WEIGHT="7.499737431683094"/>
<DICH_DATA CI_END="7.13778676811069" CI_START="0.40985338496859014" EFFECT_SIZE="1.710393541876892" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.853563569843218" LOG_CI_START="-0.3873714737355668" LOG_EFFECT_SIZE="0.2330960480538256" ORDER="114021" O_E="0.0" SE="0.7289313873257125" STUDY_ID="STD-Europe-2000" TOTAL_1="991" TOTAL_2="1017" VAR="0.5313409674285879" WEIGHT="45.584611867863266"/>
<DICH_DATA CI_END="2.9395435041096536" CI_START="0.035473254083611405" EFFECT_SIZE="0.3229166666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.46827989196342445" LOG_CI_START="-1.4500989703740157" LOG_EFFECT_SIZE="-0.4909095392052957" ORDER="114022" O_E="0.0" SE="1.1268652398655326" STUDY_ID="STD-Netherlands-1994" TOTAL_1="32" TOTAL_2="31" VAR="1.2698252688172043" WEIGHT="46.91565070045364"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.09.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Evening primrose oil</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.09.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Fish oil + evening primrose oil</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-09-17 22:42:36 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-09-17 22:42:36 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-09-17 22:42:36 +0100" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-09-17 22:41:05 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>PREGNANCY*:ME</LI>
<LI>PREGNANCY-COMPLICATIONS*:ME</LI>
<LI>PREGNANCY TRIMESTERS*:ME</LI>
<LI>PREGNANCY-MULTIPLE*:ME</LI>
<LI>PREGNAN*</LI>
<LI>#1 OR #2 OR #3 OR #4 OR #5</LI>
<LI>PREECLAMP*</LI>
<LI>PRE-ECLAMP*</LI>
<LI>(PRE NEXT ECLAMP*)</LI>
<LI>ECLAMP*</LI>
<LI>HYPERTENS*</LI>
<LI>#7 OR #8 OR #9 OR #10 OR #11</LI>
<LI>PRIMROSE NEAR OIL</LI>
<LI>EVENING NEAR OIL</LI>
<LI>PROSTAGLANDIN* NEAR PRECURSOR*</LI>
<LI>FISH NEAR OIL*</LI>
<LI>N-3 NEAR POLYUNSATURATED NEAR "FATTY ACID*"</LI>
<LI>LCPUFA</LI>
<LI>EICOSAPENTAENOIC NEXT ACID</LI>
<LI>EICOSAPENTANOIC NEXT ACID</LI>
<LI>5-8-11-14-17-EICOSAPENTAENOIC ACID*:ME</LI>
<LI>EPA</LI>
<LI>DOCOSAHEXAENOIC NEXT ACID</LI>
<LI>DOCOSAHEXANOIC NEXT ACID</LI>
<LI>DOCOSAHEXAENOIC-ACIDS*:ME</LI>
<LI>DHA</LI>
<LI>#13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 or #25 or #26</LI>
<LI>#6 AND #12</LI>
<LI>#28 AND #27</LI>
</OL>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>